Node1	Edge_Type	Node2	Weight	Score	Paper_List	Original_Text
spectrum disorders	disease_to_anatomy	lymphocyte	1	5.869	34641964	PMID:34641964; Original text:A significant decrease in the CD4+ lymphocyte was found in spectrum disorders patients compared to controls [- 1.51 (95% CI - 2.99; - 0.04)
depression	disease_to_anatomy	group	1	1.0	22964266	PMID:22964266; Original text:Results showed a significant reduction in depression, anxiety and rumination in the intervention group, as opposed to the control group.
rumination	disease_to_anatomy	group	1	1.0	22964266	PMID:22964266; Original text:Results showed a significant reduction in depression, anxiety and rumination in the intervention group, as opposed to the control group.
anxiety	disease_to_anatomy	group	2	2.0	22964266|20001837	PMID:22964266; Original text:Results showed a significant reduction in depression, anxiety and rumination in the intervention group, as opposed to the control group.|PMID:20001837; Original text:However, results from the Conners' Parent Questionnaire revealed an improvement only for anxiety (p = 0.04) in the massage group, whereas when both groups were compared, a significant improvement in conduct problem (p = 0.03) and anxiety (p = 0.01) was found.
autistic symptomatology	disease_to_anatomy	of the	1	1.0	9028057	"PMID:9028057; Original text:The behavioural evaluation was conducted using the specific BSE and CARS rating scales naltrexone treatment produced a significant reduction of the autistic symptomatology in seven (""responders"") out of 12 children."
epilepsy	disease_to_anatomy	group (	1	1.0	34510916	PMID:34510916; Original text:A significantly increased prevalence of epilepsy was detected in the autistic adolescent group (11-17 years old), and a higher trend of prevalence of epilepsy was observed in the autistic pre-school group (⩽ 6 -years-old) than that of the autistic school-aged group (7-10 years-old).
epilepsy	disease_to_anatomy	of the	2	3.747	34510916|19454962	PMID:34510916; Original text:A significantly increased prevalence of epilepsy was detected in the autistic adolescent group (11-17 years old), and a higher trend of prevalence of epilepsy was observed in the autistic pre-school group (⩽ 6 -years-old) than that of the autistic school-aged group (7-10 years-old).|PMID:19454962; Original text:However, critical review of the literature reveals that the rate in idiopathic cases with normal lower intelligence quotient is still significantly above the population risk suggesting that autism itself is associated with an increased risk of epilepsy.
epilepsy	disease_to_anatomy	, and	4	10.242999999999999	34510916|20087181|19319661|24123946	PMID:34510916; Original text:A significantly increased prevalence of epilepsy was detected in the autistic adolescent group (11-17 years old), and a higher trend of prevalence of epilepsy was observed in the autistic pre-school group (⩽ 6 -years-old) than that of the autistic school-aged group (7-10 years-old).|PMID:20087181; Original text:There continues to be disagreement regarding the exact prevalence and etiological significance of gastrointestinal conditions, epilepsy and other abnormal electroencephalographic findings, and sleep problems.|PMID:19319661; Original text:The most significant clinical features were mental retardation, epilepsy and autistic behaviour, and these symptoms did not worsen, in contrast to other reports.|PMID:24123946; Original text:The del15q11.2 was found to be significantly associated with intellectual disability, schizophrenia, epilepsy, and disorder.
autistic	disease_to_anatomy	group (	3	4.890000000000001	34510916|2977280|30399531	PMID:34510916; Original text:A significantly increased prevalence of epilepsy was detected in the autistic adolescent group (11-17 years old), and a higher trend of prevalence of epilepsy was observed in the autistic pre-school group (⩽ 6 -years-old) than that of the autistic school-aged group (7-10 years-old).|PMID:2977280; Original text:Beta-endorphin was elevated significantly in the baseline autistic group (p less than .005) and was reduced toward control values during fenfluramine treatment.|PMID:30399531; Original text:There was also a higher prevalence of alexithymia in the disorder group (49.93% compared to 4.89%), with a significantly increased risk of alexithymia in autistic participants.
autistic	disease_to_anatomy	of the	15	37.354	34510916|12816888|9895151|7854533|7854533|21826280|22688012|9690938|14561452|16919132|18425890|11408327|30517284|25817280|34563942	PMID:34510916; Original text:A significantly increased prevalence of epilepsy was detected in the autistic adolescent group (11-17 years old), and a higher trend of prevalence of epilepsy was observed in the autistic pre-school group (⩽ 6 -years-old) than that of the autistic school-aged group (7-10 years-old).|PMID:12816888; Original text:Specifically, we found anterior and superior shifting of the superior frontal sulci bilaterally (P < or = 0.0003), anterior shifting of the right Sylvian fissure (P = 0.0002), the superior temporal sulcus (P = 0.0006 right, P = 0.02 left) and the left inferior frontal sulcus (P < or = 0.002) in the autistic group relative to the normal group.|PMID:9895151; Original text:In contrast, there is a lack of significant difference in the cross-sectional size of the posterior hippocampal formation between autistic and normal subjects, which is discrepant with predictions based on some autopsy studies.|PMID:7854533; Original text:By contrast, measures of vermian lobules VI and VII and the posterior portion of the corpus callosum in these same autistic and normal volunteers differed significantly, by more than 9.9%.|PMID:7854533; Original text:The lack of a significant difference in the cross-sectional size of the posterior hippocampal formation between autistic and normal 6- to 42-year-olds is discrepant with predictions based on some, but not all, autopsy studies.|PMID:21826280; Original text:We propose that alteration of the expression and/or timing of critical period circuit refinement in primary sensory brain areas may significantly contribute to autistic phenotypes, including cognitive and behavioral impairments.|PMID:22688012; Original text:The majority of the data are based on molecular, cytogenetic, linkage and association studies of autistic subjects, but newer methods, including whole-exome sequencing, are also beginning to make significant contributions to our understanding of autism.|PMID:9690938; Original text:The autistic group's performance on the false belief, belief term comprehension, and belief term expression tasks was significantly poorer than that of the Asperger, language impaired, and normal groups.|PMID:14561452; Original text:Within the task condition, a region-of-interest comparison of attend-left versus attend-right conditions indicated that modulation of activation in the autistic brain as a function of the lateral focus of spatial attention was abnormally decreased in the left ventral occipital cortex (P<0.03), abnormally increased in the left intraparietal sulcus (P<0.01), and abnormally variable in the superior parietal lobe (P<0.03).|PMID:16919132; Original text:Significant effects were found in these studies even with extremely small samples, and the findings are important because they demonstrate the potential of the medium of music for autistic children.|PMID:18425890; Original text:There were only three significant treatment effects in favour of the diet intervention: overall autistic traits, mean difference (mean difference) =|PMID:11408327; Original text:The cross-sectional area of the AD was significantly smaller than normal in autism, the largest deviation from normal size (-13.5%) being found in autistic children aged 29 months to 4 years.|PMID:30517284; Original text:The results of the identified studies confirm the significant importance of these instruments in improving the communicative process of autistic children.|PMID:25817280; Original text:The increments in the concentration of oxygenated hemoglobin in the pars opercularis of the inferior frontal gyrus in autistic subjects were significantly lower than those in the controls.|PMID:34563942; Original text:While significant variation was noted across individual study findings, much of the existing literature supported three preliminary findings about the nature of autistic camouflaging: (1) adults with more self-reported autistic traits report greater engagement in camouflaging; (2) sex and gender differences exist in camouflaging; and (3) higher self-reported camouflaging is associated with worse mental health outcomes.
autistic	disease_to_anatomy	, and	7	11.732	34510916|25729218|21299356|9690938|14561452|16919132|15730889	"PMID:34510916; Original text:A significantly increased prevalence of epilepsy was detected in the autistic adolescent group (11-17 years old), and a higher trend of prevalence of epilepsy was observed in the autistic pre-school group (⩽ 6 -years-old) than that of the autistic school-aged group (7-10 years-old).|PMID:25729218; Original text:A number of studies have shown that the cytokine levels in the blood, brain, and cerebrospinal fluid (cerebrospinal fluid) of autistic subjects differ from that of healthy individuals; for example, a series of studies suggests that interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly elevated in different tissues in autistic subjects.|PMID:21299356; Original text:Covering the literature from 1943 to the present in the PubMed and Ovid Medline databases, this review summarizes evidence of hormones, metabolites, amino acids, and other biomarkers present in significantly different quantities in autistic subjects compared to age- and sex-matched controls.|PMID:9690938; Original text:The autistic group's performance on the false belief, belief term comprehension, and belief term expression tasks was significantly poorer than that of the Asperger, language impaired, and normal groups.|PMID:14561452; Original text:Within the task condition, a region-of-interest comparison of attend-left versus attend-right conditions indicated that modulation of activation in the autistic brain as a function of the lateral focus of spatial attention was abnormally decreased in the left ventral occipital cortex (P<0.03), abnormally increased in the left intraparietal sulcus (P<0.01), and abnormally variable in the superior parietal lobe (P<0.03).|PMID:16919132; Original text:Significant effects were found in these studies even with extremely small samples, and the findings are important because they demonstrate the potential of the medium of music for autistic children.|PMID:15730889; Original text:In published reports, these animals have been found to have a significant loss of serotonin terminals, decreased metabolic activity in cortex, changes in columnar development in cortex, changes in serotonin receptors, and ""autistic-like"" behaviors."
autistic	disease_to_anatomy	facial expression	1	1.0	31096266	PMID:31096266; Original text:Quantitative facial expression analyses successfully verified the positive effects of repeated oxytocin on autistic individuals' facial expressions and demonstrated a time-course change in efficacy.
autism	disease_to_anatomy	, and	43	140.364	18427869|23455605|31994188|27105825|9672054|29498298|28378499|26313946|16083327|18626481|9809262|15749246|32149480|16160627|10425586|9934941|21690083|29286586|26359749|31665947|34627165|24061784|32563542|32168067|23782128|11573335|22070180|21629200|15090875|21863344|27721995|17367287|23766737|26551748|11525418|19284641|9442997|19736351|23471985|19948568|22457638|20969835|25861158	PMID:18427869; Original text:Catatonia should be assessed in people with autism when there is an obvious and marked deterioration in movement, vocalizations, pattern of activities, self-care, and practical skills.|PMID:23455605; Original text:The risk associated with preterm birth is not a general one, but appears to be specific to symptoms and disorders associated with anxiety, inattention and social and communication problems, and manifest in a significantly higher prevalence of emotional disorders, ADHD and Autism.|PMID:31994188; Original text:The concept of autism is a significant contribution from child psychiatry that has entered wider culture and public consciousness, and has evolved significantly over the last four decades.|PMID:27105825; Original text:Functional enrichment analysis detected significant over-representation of target gene clusters related to transcriptional activation, neuronal development, and the Simons Foundation Autism Database genes.|PMID:9672054; Original text:Risperidone was superior to placebo in reducing repetitive behavior (P<.001), aggression (P<.001), anxiety or nervousness (P<.02), depression (P<.03), irritability (P<.01), and the overall behavioral symptoms of autism (P<.02).|PMID:29498298; Original text:Some of these liabilities are not necessarily specific to ASD-those that are non-specific could account for a significant share of the 'missing heritability' of autism, would (by definition) contribute to pleiotropy, and relate to so-called 'co-morbidities', which are inappropriately named if they actually contribute to (or exacerbate) the severity of autism itself.|PMID:28378499; Original text:Significant improvements in children's behavior were observed on parent-report measures of social communication skills and autism symptoms, clinician ratings of overall autism symptom severity and degree of improvement, standardized measures of expressive vocabulary, and objective eye-tracking measures of children's attention to social stimuli, indicating that these measures may be useful endpoints in future studies.|PMID:26313946; Original text:Two-way ANOVA showed a significant sex-by-diagnosis interaction in total correct score (F(1,711) = 5.090, p = 0.024, ηp2 = 0.007) arising from a significant sex difference between control males and females (p < 0.001, Cohen's d = 0.47), and an absence of a sex difference between males and females with autism (p = 0.907, d = 0.01); significant case-control differences were observed across sexes, with effect sizes of d = 0.35 in males and d = 0.69 in females.|PMID:16083327; Original text:Autism, Asperger and other pervasive developmental disorders (other pervasive developmental disorders) are an increasingly commonly identified group of conditions wherein patients experience significant difficulty in social interactions, communicating with others, and inflexible adherence to unusual, unhelpful and frequently stereotyped routines and behaviour.|PMID:18626481; Original text:The current results from seven studies suggested a significant association of minor physical anomalies in autism with a robust pooled effect size (d=0.84), and thereby provide the strongest evidence to date about the close association between minor physical anomalies and autism.|PMID:9809262; Original text:In the experimental group, there were greater gains in language abilities, significant increases in caregivers' knowledge about autism, greater perception of control on the part of mothers, and greater parent satisfaction.|PMID:15749246; Original text:Autism is a complex developmental disorder without an established single etiology but with significant contributions from genetic studies, functional research, and neuropsychiatric and neuroradiologic investigations.|PMID:32149480; Original text:There were significant decreases in total autism treatment evaluation checklist scores (P = 0.014), sociability sub-scores (P = 0.021), and behavioral, health, and physical condition sub-scores (P = 0.011) in the Transcranial direct current stimulation treatment group.|PMID:16160627; Original text:Post hoc analysis looking at the 3 core symptoms of autism, that is, social interaction, communication, and stereotyped behaviors, revealed a significant improvement of the social interaction score after 6 months of active treatment.|PMID:10425586; Original text:Issues affecting differential diagnosis include the use of traditional diagnostic guidelines for preschoolers with developmental delays, developmental changes in behavioral characteristics, the involvement of cognitive factors in symptom expression, and the overlap between autism and mental retardation in individuals with significant cognitive impairment.|PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.|PMID:21690083; Original text:It was found that after the parents added home-based DIR/Floortime™ intervention at an average of 15.2 hours/week for three months, the intervention group made significantly greater gains in all three measures employed in the study: Functional Emotional Assessment Scale (Functional Emotional Assessment Scale) (F = 5.1, p = .031), Childhood Autism Rating Scale (F = 2.1, p = .002), and the Functional Emotional Questionnaires (F = 6.8, p = .006).|PMID:29286586; Original text:Cognitive enhancement therapy (Cognitive enhancement therapy), an 18-month cognitive remediation intervention designed to improve thinking and social understanding, was found to be more effective than supportive therapy at improving mental quickness, attention, and employment in adults living with autism.|PMID:26359749; Original text:For secondary outcomes, the intervention reduced autism-risk behaviours (0.50, CI -0.15 to 1.08), increased parental non-directiveness (0.81, 0.28 to 1.52), improved attention disengagement (0.48, -0.01 to 1.02), and improved parent-rated infant adaptive function (χ(2)[2] 15.39, p=0.0005).|PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.|PMID:34627165; Original text:Among the biological processes that were examined, genes involved in synaptic integrity, neurotransmitter metabolism, and cell adhesion molecules were significantly involved in the development of autism.|PMID:24061784; Original text:Several baseline predictors of response were identified, and a principal component analysis yielded 3 composite measures (disruptive behavior, autism/mood, and caregiver strain) that significantly predicted response at week 12.|PMID:32563542; Original text:Recently, significant progress has been possible with the prospective calculation of the prevalence of autism in Tuberous sclerosis complex, identification of early clinical and neurophysiological biomarkers to predict autism, and investigation of different therapies to prevent autism in this high-risk population.|PMID:32168067; Original text:Repeated-measures analysis demonstrated significant effect for time-treatment interaction in the Childhood Autism Rating Scale (F (1, 2.23) = 13.22, P < 0.001), as well as 4 subscales of the ABC-C including: irritability (F (1, 2.12) = 3.84, P = 0.026), hyperactivity (F (1, 2.09) = 3.56, P = 0.039), lethargy (F (1, 2.18) = 31.50, P < 0.001), and stereotypy (F (1, 1.89) = 4.04, P = 0.026).|PMID:23782128; Original text:(DSM-IV-TR) criteria for an autism spectrum disorder (disorder) on the Autism Diagnostic Interview-Revised (-Revised) and the Autism Diagnostic Observation Schedule (the Autism Diagnostic Observation Schedule), and had significant symptoms of attention-deficit/hyperactivity disorder (attention-deficit/hyperactivity disorder).|PMID:11573335; Original text:Autism is a behaviorally defined disorder that comprises a controversial diagnostic category due to heterogeneity in symptomatology, causation, and etiology and significant variance in response to intervention.|PMID:22070180; Original text:Serum levels of epidermal growth factor were elevated in subjects with autism (median=103 pg/mL, n=75) in comparison to healthy controls (75 pg/mL, n=19; p<0.05), and levels of IL-13 were decreased in autism (median=0.8 pg/mL, n=77) in comparison to controls (9.8 pg/mL, n=19; p=0.0003).|PMID:21629200; Original text:Significant correlations between changes in serum free-carnitine levels and positive clinical changes were observed for hand muscle strength (R2=0.23, P=0.046), cognitive scores (R2=0.27, P=0.019), and Childhood Autism Rating Scale scores (R2=0.20, P=0.047).|PMID:15090875; Original text:Recent oculomotor studies have made significant contributions to the understanding of neurodevelopmental disorders, most notably in autism, attention-deficit/hyperactivity disorder, and Tourette's syndrome.|PMID:21863344; Original text:Empathy, for instance, is a rather elaborated human ability, and several recent studies point to significant impairments in patients suffering from psychiatric disorders, such as schizophrenia or autism.|PMID:27721995; Original text:An intention-to-treat analysis showed significant overall gains for a wide range of symptoms in these children, including learning, memory, anxiety, attention span, motor skills, eating, sleeping, sensory processing, self-awareness, communication, social skills, and mood/autism behaviors.|PMID:17367287; Original text:A number of endogenous biomarkers associated with autism risk have been investigated, and these may help identify significant biologic pathways that, in turn, will aid in the discovery of specific genes and exposures.|PMID:23766737; Original text:It was observed by the parents, coaches, and study investigators that the children who were less than 3 years of age showed improvements in autism symptoms; however, the group was too small to reach statistical significance.|PMID:26551748; Original text:We found significant differences between before and after the therapy in the length of the gait cycle that became more stable in the sagital plane and concluded that our results proved that horse therapy may be successfully used as an additional therapy for children with autism, and it may be a form of rehabilitation in cases when other therapies are not successful.|PMID:11525418; Original text:These data support the contribution of chromosomal abnormalities to a small but significant number of cases of autism, and highlight the involvement of chromosome 15 and the sex chromosomes.|PMID:19284641; Original text:Children with autism who received hyperbaric tre1.3 atmosphereent at 1.3 1.3 atmosphere and 24% oxygen for 40 hourly sessions had significant improvements in overall functioning, receptive language, social interaction, eye contact, and sensory/cognitive awareness compared to children who received slightly pressurized room air.|PMID:9442997; Original text:A significant effect of informant was found for the PDD group, and this effect was particularly pronounced when children with autism were considered separately.|PMID:19736351; Original text:The collective frequency of rare copy number variations at these loci is significantly increased in cases with autism, in cases with schizophrenia, and in cases with mental retardation compared with controls (P < .001, P = .01, and P = .001, respectively, Fisher exact test).|PMID:23471985; Original text:As a posthoc analysis, we conducted genome-wide association scans on several organizational and topological network measures derived from the matrices to discover variants in and around genes associated with autism (autism), development (NEDD4), and mental retardation (UBE2A) significantly associated with connectivity.|PMID:19948568; Original text:Compared with children who received community-intervention, children who received the Early Start Denver Model showed significant improvements in IQ, adaptive behavior, and autism diagnosis.|PMID:22457638; Original text:Genes regulating cell cycle also exhibited autism-specific number variations in DNA derived from prefrontal cortex, and these genes were significantly associated with autism in genome-wide association study datasets.|PMID:20969835; Original text:We present initial evidence offering proof of concept that brain anatomy can be used to accurately distinguish adults with autism from healthy controls, and from some other neurodevelopmental disorders (some other neurodevelopmental disorders).|PMID:25861158; Original text:tDCS also significantly increased at the stimulation site, and an increase in tDCS was significantly associated with improvements in the two domains of autism treatment evaluation checklist impacted by tDCS.
catatonia	disease_to_anatomy	, and	2	6.568	18427869|16697303	PMID:18427869; Original text:Catatonia should be assessed in people with autism when there is an obvious and marked deterioration in movement, vocalizations, pattern of activities, self-care, and practical skills.|PMID:16697303; Original text:Catatonia should be assessed in any patient with spectrum disorders when there is an obvious and marked deterioration in movement, pattern of activities, self-care, and practical skills, compared with previous levels, through a comprehensive diagnostic evaluation of medical and psychiatric symptoms.
irritability	disease_to_anatomy	, oral	1	12.095	22342106	PMID:22342106; Original text:Compared with placebo, oral N-acetylcysteine resulted in significant improvements on ABC irritability subscale (F = 6.80; p < .001; d = .96).
asd	disease_to_anatomy	of the	10	27.293	24518398|29498298|22638012|28314733|23893101|19823139|28036350|26559825|28000020|27746319	PMID:24518398; Original text:Notably, many of the reviewed studies had significant limitations, including lack of replication, limited sample sizes, retrospective design, recall and publication biases, inadequate matching of cases and controls, and the use of nonstandard tools to diagnose ASD.|PMID:29498298; Original text:Some of these liabilities are not necessarily specific to ASD-those that are non-specific could account for a significant share of the 'missing heritability' of autism, would (by definition) contribute to pleiotropy, and relate to so-called 'co-morbidities', which are inappropriately named if they actually contribute to (or exacerbate) the severity of autism itself.|PMID:22638012; Original text:Modulation of the processing of facial expressions of emotion by serotonin significantly differs in people with ASD compared with control subjects.|PMID:28314733; Original text:The poor understanding of the genetics of ASD and SCHZ is a significant hurdle to developing effective treatments for these costly conditions.|PMID:23893101; Original text:This study provides the first independent replication and extension of the empirically-supported PEERS social skills intervention for adolescents with ASD.|PMID:19823139; Original text:There have been significant advances in our knowledge of the early signs of ASD through the use of retrospective videotape analysis, parental report, screening studies, and more recently, studies on high-risk infant siblings.|PMID:28036350; Original text:Physician use of the 2.8MM probe-chromosomal microarray test significantly improves overall quality as well as diagnosis and treatment quality for simulated cases of pediatric Developmental disorders/ASD/intellectual disability patients, and delivers additional clinical utility over existing chromosomal microarray tests.|PMID:26559825; Original text:A significant association for the carriers of the T-allele of the rs7794745 with high functioning ASD was found in the case-control sample [OR = 1.547; (95 % CI 1.056-2.266); p = 0.025].|PMID:28000020; Original text:The aim of the present narrative review was to explore if structural brain imaging studies may shed light on key brain areas that are linked to both ASD and ADHD symptoms and undergo significant changes during development.|PMID:27746319; Original text:We highlight new avenues for the analysis of cortical oscillation patterns in ASD which are sensitive to trial-to-trial variability within the participant, in order to validate the significance of increased response variability as possible endophenotype of the disorder.
asd	disease_to_anatomy	, and	14	57.155	24518398|29498298|33456050|22546059|34499230|31665947|21263444|32305492|20694583|19823139|21692142|28036350|30446273|26559825	PMID:24518398; Original text:Notably, many of the reviewed studies had significant limitations, including lack of replication, limited sample sizes, retrospective design, recall and publication biases, inadequate matching of cases and controls, and the use of nonstandard tools to diagnose ASD.|PMID:29498298; Original text:Some of these liabilities are not necessarily specific to ASD-those that are non-specific could account for a significant share of the 'missing heritability' of autism, would (by definition) contribute to pleiotropy, and relate to so-called 'co-morbidities', which are inappropriately named if they actually contribute to (or exacerbate) the severity of autism itself.|PMID:33456050; Original text:The standardized mean differences were significantly correlated between SCZ and bipolar disorder, obsessive compulsive disorder, major depressive disorder, and ASD.|PMID:22546059; Original text:The findings indicate that, as adults, many people with ASD, including those of normal IQ, are significantly disadvantaged regarding employment, social relationships, physical and mental health, and quality of life.|PMID:34499230; Original text:In ASD, bulimia nervosa, and PTSD samples, significantly increased rates of Polycystic ovary syndrome were reported compared with healthy control samples, although studies were relatively small.|PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.|PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.|PMID:32305492; Original text:Compared to children in the control group, significantly lower levels of acetic acid, propionic acid and butyric acid were found, and a hyperserotonergic state (increased serotonin) and dopamine metabolism disorder (decreased homovanillic acid) were observed in children with ASD.|PMID:20694583; Original text:Individuals with co-occurring ASD and attention-deficit/hyperactivity disorder symptoms are more severely impaired, with significant deficits seen in social processing, adaptive functioning, and executive control.|PMID:19823139; Original text:There have been significant advances in our knowledge of the early signs of ASD through the use of retrospective videotape analysis, parental report, screening studies, and more recently, studies on high-risk infant siblings.|PMID:21692142; Original text:We found six significant clusters of convergence indicating disturbances in the brain structure of ASD patients, including the lateral occipital lobe, the pericentral region, the medial temporal lobe, the basal ganglia, and proximate to the right parietal operculum.|PMID:28036350; Original text:Physician use of the 2.8MM probe-chromosomal microarray test significantly improves overall quality as well as diagnosis and treatment quality for simulated cases of pediatric Developmental disorders/ASD/intellectual disability patients, and delivers additional clinical utility over existing chromosomal microarray tests.|PMID:30446273; Original text:Assessing the occurrence of ASD and Attention-Deficit/Hyperactivity Disorder would improve the significant cost of healthcare, therapies, and overall daily living for families with children affected by Cerebral Palsy.|PMID:26559825; Original text:Overall, including case-control, sibs, and meta-analysis, we could not detect any significant association with the CNTNAP2 gene and high functioning ASD.
adhd	disease_to_anatomy	, and	1	1.969	23455605	PMID:23455605; Original text:The risk associated with preterm birth is not a general one, but appears to be specific to symptoms and disorders associated with anxiety, inattention and social and communication problems, and manifest in a significantly higher prevalence of emotional disorders, ADHD and Autism.
anxiety	disease_to_anatomy	, and	7	18.353	23455605|28477505|9934941|32090389|27721995|23965288|19365716	PMID:23455605; Original text:The risk associated with preterm birth is not a general one, but appears to be specific to symptoms and disorders associated with anxiety, inattention and social and communication problems, and manifest in a significantly higher prevalence of emotional disorders, ADHD and Autism.|PMID:28477505; Original text:At post- assessment, compared to children in the a waitlist control condition, children in the either the BRAVE-ONLINE condition condition demonstrated a significantly greater reduction in number of anxiety diagnoses, clinical severity of diagnosis, and self and parent reported anxiety symptoms, as well as significantly greater increases in overall functioning.|PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.|PMID:32090389; Original text:Only the mindfulness-based stress reduction group demonstrated significant reductions in depression, and neither group significantly changed in anxiety.|PMID:27721995; Original text:An intention-to-treat analysis showed significant overall gains for a wide range of symptoms in these children, including learning, memory, anxiety, attention span, motor skills, eating, sleeping, sensory processing, self-awareness, communication, social skills, and mood/autism behaviors.|PMID:23965288; Original text:Pretreatment Developmental Disability-Child Global Assessment Scale scores correlated with severity of autism spectrum disorders core symptoms (r = -.388, p = .034), pragmatic communication (r = .407, p = .032), and verbal ability (r = .449, p = .013) and did not correlate with severity of anxiety symptoms or with parent-reported adaptive behavior.|PMID:19365716; Original text:The findings indicated that each Autism Spectrum Disorders intervention group demonstrated significant gains on the WMS and significant improvement in the areas of anxiety management, joint attention, and flexibility/transitions.
social	disease_to_anatomy	, and	1	1.969	23455605	PMID:23455605; Original text:The risk associated with preterm birth is not a general one, but appears to be specific to symptoms and disorders associated with anxiety, inattention and social and communication problems, and manifest in a significantly higher prevalence of emotional disorders, ADHD and Autism.
emotional disorders	disease_to_anatomy	, and	1	1.969	23455605	PMID:23455605; Original text:The risk associated with preterm birth is not a general one, but appears to be specific to symptoms and disorders associated with anxiety, inattention and social and communication problems, and manifest in a significantly higher prevalence of emotional disorders, ADHD and Autism.
autism spectrum	disease_to_anatomy	, and	5	15.088	33734889|34387753|24757919|29587698|23530174	PMID:33734889; Original text:For direct stakeholders such as individuals with autism spectrum disorder (disorder), social validation has mostly included participants who do not experience significant speech, language, and communication limitations while frequently omitting individuals with disorder who have complex communication needs (complex communication needs).|PMID:34387753; Original text:This review synthesizes recent, clinically relevant findings on the scope, significance, and centrality of motor skill differences in autism spectrum disorder (disorder).|PMID:24757919; Original text:Autism spectrum disorders (disorders) are a group of developmental disabilities that can cause significant social, communication, and behavioral challenges for children and families.|PMID:29587698; Original text:Significant racial, ethnic, and socioeconomic disparities exist in access to evidence-based treatment services for children with autism spectrum disorder (disorder).|PMID:23530174; Original text:Results indicated that 54% of children who screened positive on the Toddlers and Toddlers/F presented with an autism spectrum disorder (disorder), and 98% presented with clinically significant developmental concerns warranting intervention.
irritability	disease_to_anatomy	of the	7	23.216	26088658|26262902|32168067|30980177|28719227|32947424|15492353	PMID:26088658; Original text:Intent-to-treat analysis conducted on the 116 participants who completed a baseline assessment (therapeutic horseback riding n = 58; a barn activity control n = 58) revealed significant improvements in the therapeutic horseback riding group compared to the control on measures of irritability (primary outcome) (p = .02; effect size [ES] = 0.50) and hyperactivity (p = .01; ES = 0.53), beginning by week 5 of the intervention.|PMID:26262902; Original text:Insistence on sameness and irritability symptoms significantly improved over the course of the 6 week treatment period (p<0.0001) in this open-label trial.|PMID:32168067; Original text:Repeated-measures analysis demonstrated significant effect for time-treatment interaction in the Childhood Autism Rating Scale (F (1, 2.23) = 13.22, P < 0.001), as well as 4 subscales of the ABC-C including: irritability (F (1, 2.12) = 3.84, P = 0.026), hyperactivity (F (1, 2.09) = 3.56, P = 0.039), lethargy (F (1, 2.18) = 31.50, P < 0.001), and stereotypy (F (1, 1.89) = 4.04, P = 0.026).|PMID:30980177; Original text:Analysis of the combined data revealed significant improvement for all the ABC subscales (irritability: F = 51.644, df = 1.66, p < 0.001, lethargy: F = 39.734, df = 1.38, p < 0.001, stereotypic behavior: F = 25.495, df = 1.56, p < 0.001, hyperactivity: F = 54.135, df = 1.35, p < 0.001, and inappropriate speech: F = 19.277, df = 1.47, p = 0.004).|PMID:28719227; Original text:Significant differences in change of the ABC-C scale irritability (mean difference [95% confidence interval (95% confidence interval)] = -3.45|PMID:32947424; Original text:Repeated measures analysis was suggestive of greater exhibited improvement for the pregnenolone group on irritability, stereotypy, and hyperactivity subscales of the Aberrant Behavior Checklist-Community Edition over the trial period (F = 3.84, df = 1.96, P = 0.025; F = 4.29, df = 1.39, P = 0.029; F = 6.55, df = 1.67, P = 0.004, respectively).|PMID:15492353; Original text:Subjects who were taking risperidone (mean dosage: 0.04 mg/kg/day; 1.17 mg/day) experienced a significantly greater mean decrease on the irritability subscale of the the Aberrant Behavior Checklist (primary endpoint) compared with those who were taking placebo.
irritability	disease_to_anatomy	(p	11	33.086999999999996	26088658|16190799|20973712|18685284|32347624|19284641|19284641|23821414|23101743|25580916|26361994	PMID:26088658; Original text:Intent-to-treat analysis conducted on the 116 participants who completed a baseline assessment (therapeutic horseback riding n = 58; a barn activity control n = 58) revealed significant improvements in the therapeutic horseback riding group compared to the control on measures of irritability (primary outcome) (p = .02; effect size [ES] = 0.50) and hyperactivity (p = .01; ES = 0.53), beginning by week 5 of the intervention.|PMID:16190799; Original text:Irritability subscale was the primary outcome measure (p = 0.65), and CGI--Improvement (p = 0.16) and OAS (p = 0.96) were secondary outcome measures.|PMID:20973712; Original text:Statistically significantly greater improvement was seen with aripiprazole versus placebo (p < 0.05) for all arms in both trials on the the Aberrant Behavior Checklist-Irritability total subscale score and on the following individual the Aberrant Behavior Checklist-Irritability items: Mood changes quickly, cries/screams inappropriately, and stamps feet/bangs objects.|PMID:18685284; Original text:Paired comparison of baseline and 13-week endpoint scores showed significant reductions in Aberrant Behavior Checklist subscale scores for irritability (p < 0.0001), lethargy (p < 0.0001), stereotyped behavior (p < 0.005), hyperactivity (p < 0.0001) and inappropriate speech (p < 0.005).|PMID:32347624; Original text:Compared to the placebo group, disorder patients in the sulforaphane group showed greater improvements in Irritability score (primary outcome measure; P = 0.001) and Hyperactivity/Noncompliance score (secondary outcome measure; P = 0.015), and significant Time × Treatment effect for Irritability (P = 0.007) and Hyperactivity/Noncompliance (P = 0.008).|PMID:19284641; Original text:On the Aberrant Behavior Checklist, significant improvements were observed in the tre1.3 atmosphereent group in total score, irritability, stereotypy, hyperactivity, and speech (p < 0.03 for each), but not in the control group.|PMID:19284641; Original text:In the tre1.3 atmosphereent group compared to the control group, mean changes on the Aberrant Behavior Checklist total score and subscales were similar except a greater number of children improved in irritability (p = 0.0311).|PMID:23821414; Original text:A significantly greater improvement in the study primary outcome (the ABC-C irritability subscale score) was achieved by the riluzole-treated children compared with the placebo group (P = 0.03).|PMID:23101743; Original text:The the behavior management treatment had shown a significant advantage for child behavioral noncompliance (p = .006, d = 0.34), irritability (p = .01, d = 0.48), and hyperactivity/noncompliance (p = .04, d = 0.55) with a lower medication dose.|PMID:25580916; Original text:Repeated-measures analysis showed significant effect for time × treatment interaction in irritability (P = 0.01) and hyperactivity/noncompliance (P = 0.02) subscales.|PMID:26361994; Original text:Univariate analyses showed that the symptom of irritability improved in the entire sample (p = 0.023 after 2 weeks, p = 0.061 at study endpoint), although no difference was observed between the venlafaxine and placebo groups.
irritability	disease_to_anatomy	(primary	4	16.646	26088658|23212807|32347624|15492353	PMID:26088658; Original text:Intent-to-treat analysis conducted on the 116 participants who completed a baseline assessment (therapeutic horseback riding n = 58; a barn activity control n = 58) revealed significant improvements in the therapeutic horseback riding group compared to the control on measures of irritability (primary outcome) (p = .02; effect size [ES] = 0.50) and hyperactivity (p = .01; ES = 0.53), beginning by week 5 of the intervention.|PMID:23212807; Original text:Mean baseline (range 27-29) to endpoint change in Aberrant Behavior Checklist-Irritability (primary endpoint) was significantly greater in the high-dose-(-12.4 [6.5]; p < 0.001), but not low-dose (-7.4 [8.1]; p = 0.164) group, versus placebo (-3.5 [10.7]).|PMID:32347624; Original text:Compared to the placebo group, disorder patients in the sulforaphane group showed greater improvements in Irritability score (primary outcome measure; P = 0.001) and Hyperactivity/Noncompliance score (secondary outcome measure; P = 0.015), and significant Time × Treatment effect for Irritability (P = 0.007) and Hyperactivity/Noncompliance (P = 0.008).|PMID:15492353; Original text:Subjects who were taking risperidone (mean dosage: 0.04 mg/kg/day; 1.17 mg/day) experienced a significantly greater mean decrease on the irritability subscale of the the Aberrant Behavior Checklist (primary endpoint) compared with those who were taking placebo.
hyperactivity	disease_to_anatomy	of the	6	15.467	26088658|18552703|32168067|30980177|29159857|32947424	PMID:26088658; Original text:Intent-to-treat analysis conducted on the 116 participants who completed a baseline assessment (therapeutic horseback riding n = 58; a barn activity control n = 58) revealed significant improvements in the therapeutic horseback riding group compared to the control on measures of irritability (primary outcome) (p = .02; effect size [ES] = 0.50) and hyperactivity (p = .01; ES = 0.53), beginning by week 5 of the intervention.|PMID:18552703; Original text:Significant benefits were observed on the Hyperactivity subscale of the parent and teacher Aberrant Behavior Checklist (Aberrant Behavior Checklist) and Global Improvement Ratings.|PMID:32168067; Original text:Repeated-measures analysis demonstrated significant effect for time-treatment interaction in the Childhood Autism Rating Scale (F (1, 2.23) = 13.22, P < 0.001), as well as 4 subscales of the ABC-C including: irritability (F (1, 2.12) = 3.84, P = 0.026), hyperactivity (F (1, 2.09) = 3.56, P = 0.039), lethargy (F (1, 2.18) = 31.50, P < 0.001), and stereotypy (F (1, 1.89) = 4.04, P = 0.026).|PMID:30980177; Original text:Analysis of the combined data revealed significant improvement for all the ABC subscales (irritability: F = 51.644, df = 1.66, p < 0.001, lethargy: F = 39.734, df = 1.38, p < 0.001, stereotypic behavior: F = 25.495, df = 1.56, p < 0.001, hyperactivity: F = 54.135, df = 1.35, p < 0.001, and inappropriate speech: F = 19.277, df = 1.47, p = 0.004).|PMID:29159857; Original text:-1.13 to -0.43; 4 studies, 73 participants; P < 0.001; low-quality evidence) and parents (mean difference (mean difference) -6.61 points, 95% 95% confidence interval -12.19 to -1.03, rated on the hyperactivity subscale of the Aberrant Behviour Checklist, range 0 to 48; 2 studies, 71 participants; P = 0.02; low-quality evidence).|PMID:32947424; Original text:Repeated measures analysis was suggestive of greater exhibited improvement for the pregnenolone group on irritability, stereotypy, and hyperactivity subscales of the Aberrant Behavior Checklist-Community Edition over the trial period (F = 3.84, df = 1.96, P = 0.025; F = 4.29, df = 1.39, P = 0.029; F = 6.55, df = 1.67, P = 0.004, respectively).
hyperactivity	disease_to_anatomy	(p	8	25.531	26088658|20166790|18685284|22151477|32347624|19284641|23101743|25580916	PMID:26088658; Original text:Intent-to-treat analysis conducted on the 116 participants who completed a baseline assessment (therapeutic horseback riding n = 58; a barn activity control n = 58) revealed significant improvements in the therapeutic horseback riding group compared to the control on measures of irritability (primary outcome) (p = .02; effect size [ES] = 0.50) and hyperactivity (p = .01; ES = 0.53), beginning by week 5 of the intervention.|PMID:20166790; Original text:Subjects with either C/T or C/C (n = 16) genotypes showed a three-fold greater improvement than T/T MDR1 C3435T genotype (n = 6) (mean decrease of 15.1 +/- 12.6, or 50.7% from baseline, versus 4.5 +/- 5.1, or 15.6% from baseline) in parent-rated ABC Hyperactivity scores over 8 weeks (p = 0.03).|PMID:18685284; Original text:Paired comparison of baseline and 13-week endpoint scores showed significant reductions in Aberrant Behavior Checklist subscale scores for irritability (p < 0.0001), lethargy (p < 0.0001), stereotyped behavior (p < 0.005), hyperactivity (p < 0.0001) and inappropriate speech (p < 0.005).|PMID:22151477; Original text:The supplement group had significantly greater improvements than the placebo group on the Parental Global Impressions-Revised (PGI-R, Average Change, p = 0.008), and on the subscores for Hyperactivity (p = 0.003), Tantrumming (p = 0.009), Overall (p = 0.02), and Receptive Language (p = 0.03).|PMID:32347624; Original text:Compared to the placebo group, disorder patients in the sulforaphane group showed greater improvements in Irritability score (primary outcome measure; P = 0.001) and Hyperactivity/Noncompliance score (secondary outcome measure; P = 0.015), and significant Time × Treatment effect for Irritability (P = 0.007) and Hyperactivity/Noncompliance (P = 0.008).|PMID:19284641; Original text:On the Aberrant Behavior Checklist, significant improvements were observed in the tre1.3 atmosphereent group in total score, irritability, stereotypy, hyperactivity, and speech (p < 0.03 for each), but not in the control group.|PMID:23101743; Original text:The the behavior management treatment had shown a significant advantage for child behavioral noncompliance (p = .006, d = 0.34), irritability (p = .01, d = 0.48), and hyperactivity/noncompliance (p = .04, d = 0.55) with a lower medication dose.|PMID:25580916; Original text:Repeated-measures analysis showed significant effect for time × treatment interaction in irritability (P = 0.01) and hyperactivity/noncompliance (P = 0.02) subscales.
hyperactivity	disease_to_anatomy	(primary	2	10.286999999999999	26088658|32347624	PMID:26088658; Original text:Intent-to-treat analysis conducted on the 116 participants who completed a baseline assessment (therapeutic horseback riding n = 58; a barn activity control n = 58) revealed significant improvements in the therapeutic horseback riding group compared to the control on measures of irritability (primary outcome) (p = .02; effect size [ES] = 0.50) and hyperactivity (p = .01; ES = 0.53), beginning by week 5 of the intervention.|PMID:32347624; Original text:Compared to the placebo group, disorder patients in the sulforaphane group showed greater improvements in Irritability score (primary outcome measure; P = 0.001) and Hyperactivity/Noncompliance score (secondary outcome measure; P = 0.015), and significant Time × Treatment effect for Irritability (P = 0.007) and Hyperactivity/Noncompliance (P = 0.008).
autism	disease_to_anatomy	(p	13	21.084000000000003	29430839|26313946|32149480|29763417|22987458|26336909|29211740|26746121|20440023|16948927|32966919|19736351|19736351	"PMID:29430839; Original text:Carnosine supplementation did not change anthropometric indices (p > 0.05) and showed no effect on autism severity (p > 0.05), whereas it significantly reduced sleep duration (p = 0.04), parasomnias (p = 0.02) and total sleep disorders score by 7.59% (p = 0.006) when compared with the control group.|PMID:26313946; Original text:Two-way ANOVA showed a significant sex-by-diagnosis interaction in total correct score (F(1,711) = 5.090, p = 0.024, ηp2 = 0.007) arising from a significant sex difference between control males and females (p < 0.001, Cohen's d = 0.47), and an absence of a sex difference between males and females with autism (p = 0.907, d = 0.01); significant case-control differences were observed across sexes, with effect sizes of d = 0.35 in males and d = 0.69 in females.|PMID:32149480; Original text:There were significant decreases in total autism treatment evaluation checklist scores (P = 0.014), sociability sub-scores (P = 0.021), and behavioral, health, and physical condition sub-scores (P = 0.011) in the Transcranial direct current stimulation treatment group.|PMID:29763417; Original text:Our results showed no significant differences between individual and group interventions in effects on ""autism general symptoms"" (no study available for group intervention), ""developmental quotient"" (no study available for group intervention), ""expressive language"" (p = 0.56), ""receptive language"" (p = 0.29), ""reciprocity of social interaction towards others"" (p = 0.62), or ""adaptive behaviour"" (p = 0.43).|PMID:22987458; Original text:The mean total the Autism Treatment Evaluation Checklist score scores by both parents and clinicians were significantly improved after intervention in both arms of the study compared to the score before intervention (P < 0.001 in both groups by parents, P = 0.015 in hyperbaric oxygen therapy group and P = 0.004 in sham group by clinician).|PMID:26336909; Original text:Data obtained from 18 participants who completed the trial showed that 6-week intranasal administration of oxytocin significantly reduced autism core symptoms specific to social reciprocity, which was clinically evaluated by Autism Diagnostic Observation Scale (P = 0.034, PFDR < 0.05, Cohen's d = 0.78).|PMID:29211740; Original text:There was no statistically significant difference in the effects on autism general symptoms between the social-communication-focused model and the multimodal developmental model (p = 0.83).|PMID:26746121; Original text:There was no difference in the the Autism Diagnostic Observation Schedule Composite Total Score between baseline and 24 weeks among the 3 treatment groups (P = .400); however, the the Autism Diagnostic Observation Schedule Restricted and Repetitive Behavior score showed a time-by-treatment effect (P = .006); the 2.5-mg buspirone group showed significant improvement (P = .003), whereas placebo and 5.0-mg buspirone groups showed no change.|PMID:20440023; Original text:Children with autism in this study showed improved motor proficiency and sensory integrative functions after 20-week Simulated Developmental Horse-Riding Program (p < .01).|PMID:16948927; Original text:In the risperidone group, 12 of 19 children showed improvement in the total Childhood Autism Rating Scale score and 17 of 19 children in the Children's Global Assessment Scale score compared with 0 of 20 children for the Childhood Autism Rating Scale score and 2 of 20 children for the Children's Global Assessment Scale score in the placebo group (P < .001 and P = .035, respectively).|PMID:32966919; Original text:The clinical symptoms of autism measured by CARS and the Autism Treatment Assessment Checklist scales were alleviated significantly (P = 0.021 and P |PMID:19736351; Original text:The collective frequency of rare copy number variations at these loci is significantly increased in cases with autism, in cases with schizophrenia, and in cases with mental retardation compared with controls (P < .001, P = .01, and P = .001, respectively, Fisher exact test).|PMID:19736351; Original text:Individual significance (P = .02 without correction for multiple testing) was reached for the association between autism and a 350-kilobase deletion located at 22q11 and spanning the PRODH and DGCR6 genes."
sleep	disease_to_anatomy	(p	1	2.651	29430839	PMID:29430839; Original text:Carnosine supplementation did not change anthropometric indices (p > 0.05) and showed no effect on autism severity (p > 0.05), whereas it significantly reduced sleep duration (p = 0.04), parasomnias (p = 0.02) and total sleep disorders score by 7.59% (p = 0.006) when compared with the control group.
parasomnias	disease_to_anatomy	(p	1	2.651	29430839	PMID:29430839; Original text:Carnosine supplementation did not change anthropometric indices (p > 0.05) and showed no effect on autism severity (p > 0.05), whereas it significantly reduced sleep duration (p = 0.04), parasomnias (p = 0.02) and total sleep disorders score by 7.59% (p = 0.006) when compared with the control group.
sleep disorders	disease_to_anatomy	(p	1	2.651	29430839	PMID:29430839; Original text:Carnosine supplementation did not change anthropometric indices (p > 0.05) and showed no effect on autism severity (p > 0.05), whereas it significantly reduced sleep duration (p = 0.04), parasomnias (p = 0.02) and total sleep disorders score by 7.59% (p = 0.006) when compared with the control group.
autistic	disease_to_anatomy	superior frontal	1	1.0	12816888	PMID:12816888; Original text:Specifically, we found anterior and superior shifting of the superior frontal sulci bilaterally (P < or = 0.0003), anterior shifting of the right Sylvian fissure (P = 0.0002), the superior temporal sulcus (P = 0.0006 right, P = 0.02 left) and the left inferior frontal sulcus (P < or = 0.002) in the autistic group relative to the normal group.
autistic	disease_to_anatomy	, anterior	1	1.0	12816888	PMID:12816888; Original text:Specifically, we found anterior and superior shifting of the superior frontal sulci bilaterally (P < or = 0.0003), anterior shifting of the right Sylvian fissure (P = 0.0002), the superior temporal sulcus (P = 0.0006 right, P = 0.02 left) and the left inferior frontal sulcus (P < or = 0.002) in the autistic group relative to the normal group.
autistic	disease_to_anatomy	superior temporal	1	1.0	12816888	PMID:12816888; Original text:Specifically, we found anterior and superior shifting of the superior frontal sulci bilaterally (P < or = 0.0003), anterior shifting of the right Sylvian fissure (P = 0.0002), the superior temporal sulcus (P = 0.0006 right, P = 0.02 left) and the left inferior frontal sulcus (P < or = 0.002) in the autistic group relative to the normal group.
autistic	disease_to_anatomy	the superior	2	2.0	12816888|14561452	PMID:12816888; Original text:Specifically, we found anterior and superior shifting of the superior frontal sulci bilaterally (P < or = 0.0003), anterior shifting of the right Sylvian fissure (P = 0.0002), the superior temporal sulcus (P = 0.0006 right, P = 0.02 left) and the left inferior frontal sulcus (P < or = 0.002) in the autistic group relative to the normal group.|PMID:14561452; Original text:Within the task condition, a region-of-interest comparison of attend-left versus attend-right conditions indicated that modulation of activation in the autistic brain as a function of the lateral focus of spatial attention was abnormally decreased in the left ventral occipital cortex (P<0.03), abnormally increased in the left intraparietal sulcus (P<0.01), and abnormally variable in the superior parietal lobe (P<0.03).
autistic	disease_to_anatomy	(p	7	11.433	12816888|15292671|32745763|20623006|2977280|12858328|10382134	PMID:12816888; Original text:Specifically, we found anterior and superior shifting of the superior frontal sulci bilaterally (P < or = 0.0003), anterior shifting of the right Sylvian fissure (P = 0.0002), the superior temporal sulcus (P = 0.0006 right, P = 0.02 left) and the left inferior frontal sulcus (P < or = 0.002) in the autistic group relative to the normal group.|PMID:15292671; Original text:Significantly lower platelet-poor plasma serotonin levels were observed in the autistic group as compared to the controls (p = 0.03).|PMID:32745763; Original text:Review analysis including research studies meeting the required criteria for analysis showed statistically significant differences between the plasma reduced glutathione and oxidized glutathione levels as well as reduced glutathione:oxidized glutathione ratio in autistic patients compared with healthy individuals (P = 0.0145, P = 0.0150 and P = 0.0202, respectively).|PMID:20623006; Original text:Out of total of 48 acupuncture points present on ten fingertips of both hands and associated to organs/organ systems, autistic children differed significantly from controls (p < 0.05) in 36 (images without filter) and 12 (images with filter), siblings differed significantly from controls (p < 0.05) in 12 (images without filter) and seven (images with filter), autistic children differed significantly (p < 0.05) from siblings in eight (images without filter) and one (images with filter), fathers of autistic children differed significantly (p < 0.05) from controls in 14 (images without filter) and three (images with filter) and mothers of autistic children differed significantly (p < 0.05) from controls in five (images without filter) and nine (images with filter|PMID:2977280; Original text:Beta-endorphin was elevated significantly in the baseline autistic group (p less than .005) and was reduced toward control values during fenfluramine treatment.|PMID:12858328; Original text:A significant elevation in platelet-poor plasma 5-HT levels in adult autistic patients was reached 60 min after meal administration (p < 0.03 vs control and p = 0.05 vs baseline) and a significant decrease was noted after 120 min (p < 0.01 vs baseline).|PMID:10382134; Original text:While the employment of questionnaires disclosed that autistic children had an earlier morning awakening time and multiple and early night arousals, actigraphic monitoring showed that with the exception of an earlier morning arousal time (p = .045), sleep patterns of autistic children were similar to that of normal children.
autistic	disease_to_anatomy	of the superior	1	1.0	12816888	PMID:12816888; Original text:Specifically, we found anterior and superior shifting of the superior frontal sulci bilaterally (P < or = 0.0003), anterior shifting of the right Sylvian fissure (P = 0.0002), the superior temporal sulcus (P = 0.0006 right, P = 0.02 left) and the left inferior frontal sulcus (P < or = 0.002) in the autistic group relative to the normal group.
autistic	disease_to_anatomy	temporal	1	1.0	12816888	PMID:12816888; Original text:Specifically, we found anterior and superior shifting of the superior frontal sulci bilaterally (P < or = 0.0003), anterior shifting of the right Sylvian fissure (P = 0.0002), the superior temporal sulcus (P = 0.0006 right, P = 0.02 left) and the left inferior frontal sulcus (P < or = 0.002) in the autistic group relative to the normal group.
autistic	disease_to_anatomy	inferior frontal	2	2.0	12816888|25817280	PMID:12816888; Original text:Specifically, we found anterior and superior shifting of the superior frontal sulci bilaterally (P < or = 0.0003), anterior shifting of the right Sylvian fissure (P = 0.0002), the superior temporal sulcus (P = 0.0006 right, P = 0.02 left) and the left inferior frontal sulcus (P < or = 0.002) in the autistic group relative to the normal group.|PMID:25817280; Original text:The increments in the concentration of oxygenated hemoglobin in the pars opercularis of the inferior frontal gyrus in autistic subjects were significantly lower than those in the controls.
autistic	disease_to_anatomy	temporal sulcus	1	1.0	12816888	PMID:12816888; Original text:Specifically, we found anterior and superior shifting of the superior frontal sulci bilaterally (P < or = 0.0003), anterior shifting of the right Sylvian fissure (P = 0.0002), the superior temporal sulcus (P = 0.0006 right, P = 0.02 left) and the left inferior frontal sulcus (P < or = 0.002) in the autistic group relative to the normal group.
autistic	disease_to_anatomy	frontal sulcus	1	1.0	12816888	PMID:12816888; Original text:Specifically, we found anterior and superior shifting of the superior frontal sulci bilaterally (P < or = 0.0003), anterior shifting of the right Sylvian fissure (P = 0.0002), the superior temporal sulcus (P = 0.0006 right, P = 0.02 left) and the left inferior frontal sulcus (P < or = 0.002) in the autistic group relative to the normal group.
hyperactivity	disease_to_anatomy	, and	15	46.366	31714621|19858761|9934941|23782127|22782459|27278054|22151477|32168067|8282676|30980177|32347624|19284641|32947424|23101743|33029705	PMID:31714621; Original text:In contrast, patients in the resveratrol group showed greater decline in hyperactivity/non-compliance score as a secondary outcome measure (mean difference [CI = 95%] = 4.51 [0.10-8.92], t = 2.04; P = .04), and repeated measures analysis showed significant effect for time × treatment effect on this subscale score (F = 3.81; df = 1.30; P = .043).|PMID:19858761; Original text:Secondary: groups did not differ on Clinical Global Impressions-Improvement scores at endpoint; compared with MED, combined treatment showed significant reductions on Aberrant Behavior Checklist Irritability (d = 0.48; p = .01), Stereotypic Behavior (d = 0.23; p = .04), and Hyperactivity/Noncompliance subscales (d = 0.55; p = .04).|PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.|PMID:23782127; Original text:The ABC irritability/agitation subscale (subscale 1) was significantly improved from 8 weeks, and the hyperactivity/noncompliance subscale (subscale 4) was significantly improved in 12 weeks.|PMID:22782459; Original text:Primary outcome measure was the change in irritability subscale of ABC-C. Significant time × treatment interaction was observed for Irritability (F (1.658, 63.0χ1) = 13.580, P < 0.001), Lethargy/Social Withdrawal (F (1.948, 74.03χ) = 16.811, P < 0.001), and Stereotypic Behavior (F(1.74χ, 66.198) = 1χ.104, P < 0.001), but not for Hyperactivity/Noncompliance (F (χ.564, 97.4χ4) = 1.469, P = 0.χ3χ), and Inappropriate Speech subscales (F (1.607, 61.075) = 0.173, P = 0.794).|PMID:27278054; Original text:Both groups showed a significant improvement in attention-deficit/hyperactivity disorder symptoms after 24 weeks of treatment (attention-deficit/hyperactivity disorder Rating Scale, Conners Parent Rating Scale-Hyperactivity, and Clinical Global Improvement-Severity Scale).|PMID:22151477; Original text:The supplement group had significantly greater improvements than the placebo group on the Parental Global Impressions-Revised (PGI-R, Average Change, p = 0.008), and on the subscores for Hyperactivity (p = 0.003), Tantrumming (p = 0.009), Overall (p = 0.02), and Receptive Language (p = 0.03).|PMID:32168067; Original text:Repeated-measures analysis demonstrated significant effect for time-treatment interaction in the Childhood Autism Rating Scale (F (1, 2.23) = 13.22, P < 0.001), as well as 4 subscales of the ABC-C including: irritability (F (1, 2.12) = 3.84, P = 0.026), hyperactivity (F (1, 2.09) = 3.56, P = 0.039), lethargy (F (1, 2.18) = 31.50, P < 0.001), and stereotypy (F (1, 1.89) = 4.04, P = 0.026).|PMID:8282676; Original text:In the present study, naltrexone significantly reduced only hyperactivity, and no serious untoward effects were observed.|PMID:30980177; Original text:Analysis of the combined data revealed significant improvement for all the ABC subscales (irritability: F = 51.644, df = 1.66, p < 0.001, lethargy: F = 39.734, df = 1.38, p < 0.001, stereotypic behavior: F = 25.495, df = 1.56, p < 0.001, hyperactivity: F = 54.135, df = 1.35, p < 0.001, and inappropriate speech: F = 19.277, df = 1.47, p = 0.004).|PMID:32347624; Original text:Compared to the placebo group, disorder patients in the sulforaphane group showed greater improvements in Irritability score (primary outcome measure; P = 0.001) and Hyperactivity/Noncompliance score (secondary outcome measure; P = 0.015), and significant Time × Treatment effect for Irritability (P = 0.007) and Hyperactivity/Noncompliance (P = 0.008).|PMID:19284641; Original text:On the Aberrant Behavior Checklist, significant improvements were observed in the tre1.3 atmosphereent group in total score, irritability, stereotypy, hyperactivity, and speech (p < 0.03 for each), but not in the control group.|PMID:32947424; Original text:Repeated measures analysis was suggestive of greater exhibited improvement for the pregnenolone group on irritability, stereotypy, and hyperactivity subscales of the Aberrant Behavior Checklist-Community Edition over the trial period (F = 3.84, df = 1.96, P = 0.025; F = 4.29, df = 1.39, P = 0.029; F = 6.55, df = 1.67, P = 0.004, respectively).|PMID:23101743; Original text:The the behavior management treatment had shown a significant advantage for child behavioral noncompliance (p = .006, d = 0.34), irritability (p = .01, d = 0.48), and hyperactivity/noncompliance (p = .04, d = 0.55) with a lower medication dose.|PMID:33029705; Original text:The repeated measures analysis showed significant effect for time × treatment interaction on inappropriate speech (F = 3.51; df = 1.61; P = 0.044), stereotypic behavior (F = 4.02; df = 1.37; P = 0.036), and hyperactivity/noncompliance (F = 6.79; df = 1.66; P = 0.003) subscale scores.
hyperactivity	disease_to_anatomy	, t	1	1.833	31714621	PMID:31714621; Original text:In contrast, patients in the resveratrol group showed greater decline in hyperactivity/non-compliance score as a secondary outcome measure (mean difference [CI = 95%] = 4.51 [0.10-8.92], t = 2.04; P = .04), and repeated measures analysis showed significant effect for time × treatment effect on this subscale score (F = 3.81; df = 1.30; P = .043).
loneliness	disease_to_anatomy	, and	1	1.0	21915740	PMID:21915740; Original text:Results revealed that treated young adults reported significantly less loneliness and improved social skills knowledge, while caregivers reported significant improvements in young adults' overall social skills, social responsiveness, empathy, and frequency of get-togethers.
autism	disease_to_anatomy	of the	34	106.37100000000001	26068453|16460701|29498298|11699803|11241879|26448791|33720503|14959806|26258842|27752075|28393350|16160627|8879465|20804367|18286633|19454962|22688012|22987458|15590241|12693778|15358868|30563709|32563542|32168067|31744938|26769980|11408327|11466160|26551748|27868194|9232480|2047330|8986845|8759044	"PMID:26068453; Original text:On the basis of this review, suggestions are offered for further research and its significance for our understanding of the genetic determinants of autism.|PMID:16460701; Original text:Traditional morphometric methods detected a significant reduction in the total callosal area and in the anterior third of the the corpus callosum in patients with autism; however, 3D maps revealed significant reductions in both the splenium and genu of the the corpus callosum in patients.|PMID:29498298; Original text:Some of these liabilities are not necessarily specific to ASD-those that are non-specific could account for a significant share of the 'missing heritability' of autism, would (by definition) contribute to pleiotropy, and relate to so-called 'co-morbidities', which are inappropriately named if they actually contribute to (or exacerbate) the severity of autism itself.|PMID:11699803; Original text:For the primary efficacy analysis, change of the Autism Diagnostic Observation Schedule social-communication total score from week 0 to week 4, no statistically significant difference was obtained between placebo (-0.8 +/- 2.9) and secretin groups (-0.6 +/- 1.4; t54 = 0.346, p < .73).|PMID:11241879; Original text:Although we are far from having a complete understanding of the causes and deficits that define autism, significant progress has been made over the past few years.|PMID:26448791; Original text:However, by 12 and 24 months post-implementation there was a significant difference between intervention and control clinics in terms of the intervention clinics consistently screening eligible patients with a validated autism tool.|PMID:33720503; Original text:This study is a meta-analysis of the association of maternal infection during pregnancy and subsequent autism in offspring.|PMID:14959806; Original text:Psychological research has helped to develop new developmental models for the disorder and there have also been significant advances in the molecular genetics of autism and understanding of the underlying neurobiological processes.|PMID:26258842; Original text:The total scores of the the Autism Behavior Checklist and the Cglobal improvement were significantly (p<0.05) lower in the combined treatment group than in the single treatment group.|PMID:27752075; Original text:Improvements in subscales of the Vineland Adaptive Behavior Scale, the Aberrant Behavior Checklist, the Autism Symptom Questionnaire and the Behavioral Assessment System for Children were significantly greater in the folinic acid group as compared with the placebo group.|PMID:28393350; Original text:Effect estimates in favour of intervention on autism prodromal symptoms, maximal at 27 months, had confidence intervals (confidence intervals) at each separate time point including the null, but showed a significant overall effect over the course of the intervention and follow-up period (effect size [ES]|PMID:16160627; Original text:Post hoc analysis looking at the 3 core symptoms of autism, that is, social interaction, communication, and stereotyped behaviors, revealed a significant improvement of the social interaction score after 6 months of active treatment.|PMID:8879465; Original text:These preliminary results encourage our research on this chromosome, which could be considered as a significant genetic component of the multifactorial etiology of autism.|PMID:20804367; Original text:Comparison of the overall means between groups suggests that methyl B12 is ineffective in treating behavioral symptoms of autism.|PMID:18286633; Original text:The meta-analysis failed to find a significant overall association between either of the The serotonin transporter gene polymorphisms examined and autism.|PMID:19454962; Original text:However, critical review of the literature reveals that the rate in idiopathic cases with normal lower intelligence quotient is still significantly above the population risk suggesting that autism itself is associated with an increased risk of epilepsy.|PMID:22688012; Original text:The majority of the data are based on molecular, cytogenetic, linkage and association studies of autistic subjects, but newer methods, including whole-exome sequencing, are also beginning to make significant contributions to our understanding of autism.|PMID:22987458; Original text:The mean total the Autism Treatment Evaluation Checklist score scores by both parents and clinicians were significantly improved after intervention in both arms of the study compared to the score before intervention (P < 0.001 in both groups by parents, P = 0.015 in hyperbaric oxygen therapy group and P = 0.004 in sham group by clinician).|PMID:15590241; Original text:Journal of the Association of the Academy of Minority Physicians, 9, 9-15] reported an uncontrolled trial of secretin with three participants with autism, which apparently resulted in significant behavioral improvement.|PMID:12693778; Original text:Significant improvement (> 12 units of the Childhood Autism Rating Scale) was recorded in two patients (pre-Scale: 35.00 +/- 1.41[mean +/- SD]), average improvement (> 8-12 units) in eight patients (pre-Scale: 41.88 +/-|PMID:15358868; Original text:Experiment 3 showed that increases in target-distractor similarity slowed the visual search performance of the control group significantly more than that of the autism group, suggesting that the adults with autism have a superior visual discrimination ability.|PMID:30563709; Original text:Advances in sequencing technology have significantly expanded our understanding of the genetics of autism and neurodevelopmental disorders (neurodevelopmental disorders).|PMID:32563542; Original text:Recently, significant progress has been possible with the prospective calculation of the prevalence of autism in Tuberous sclerosis complex, identification of early clinical and neurophysiological biomarkers to predict autism, and investigation of different therapies to prevent autism in this high-risk population.|PMID:32168067; Original text:Repeated-measures analysis demonstrated significant effect for time-treatment interaction in the Childhood Autism Rating Scale (F (1, 2.23) = 13.22, P < 0.001), as well as 4 subscales of the ABC-C including: irritability (F (1, 2.12) = 3.84, P = 0.026), hyperactivity (F (1, 2.09) = 3.56, P = 0.039), lethargy (F (1, 2.18) = 31.50, P < 0.001), and stereotypy (F (1, 1.89) = 4.04, P = 0.026).|PMID:31744938; Original text:The considerable significance of the genetics associated with autism has led to the identification of many risk genes for disorder used for the probing of disorder specificity and shared cognitive features over the past few decades.|PMID:26769980; Original text:Variations in gray matter volume were significantly associated with the mean age and mean total IQ score of the patients, as well as with the percentage of male patients with autism.|PMID:11408327; Original text:The cross-sectional area of the AD was significantly smaller than normal in autism, the largest deviation from normal size (-13.5%) being found in autistic children aged 29 months to 4 years.|PMID:11466160; Original text:After treatment, the patients showed significant improvement on the scores of the Yale--Brown Obsessive--Compulsive Scale -- Obsessions subscale and the Hamilton Anxiety Scale; Clinical Global Impressions -- Autism scores showed 3 of the patients much improved and 3 unchanged.|PMID:26551748; Original text:We found significant differences between before and after the therapy in the length of the gait cycle that became more stable in the sagital plane and concluded that our results proved that horse therapy may be successfully used as an additional therapy for children with autism, and it may be a form of rehabilitation in cases when other therapies are not successful.|PMID:27868194; Original text:The autism symptoms of the children improved significantly, following 4-month vitamin D3 supplementation, but not in the placebo group.|PMID:9232480; Original text:Both the clinical significance of the immune changes and the causal connection between immune changes and psychopathological phenomena in autism remain to be elucidated.|PMID:2047330; Original text:This is the human significance of the term autism.|PMID:8986845; Original text:13 (76%) of the Asperger syndrome patients were rated as pedantic compared to 4 (31%) of the high-functioning autism group (chi 2 = 6.3; p = .01).|PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
schizophrenia	disease_to_anatomy	nervous system	1	1.0	23640545	PMID:23640545; Original text:The TCF4 gene is also a risk factor with highly significant linkage to schizophrenia, presumably via overexpression of the TCF4 gene product in the central nervous system.
schizophrenia	disease_to_anatomy	of the	1	1.0	23640545	PMID:23640545; Original text:The TCF4 gene is also a risk factor with highly significant linkage to schizophrenia, presumably via overexpression of the TCF4 gene product in the central nervous system.
schizophrenia	disease_to_anatomy	gene product	1	1.0	23640545	PMID:23640545; Original text:The TCF4 gene is also a risk factor with highly significant linkage to schizophrenia, presumably via overexpression of the TCF4 gene product in the central nervous system.
schizophrenia	disease_to_anatomy	central nervous	1	1.0	23640545	PMID:23640545; Original text:The TCF4 gene is also a risk factor with highly significant linkage to schizophrenia, presumably via overexpression of the TCF4 gene product in the central nervous system.
schizophrenia	disease_to_anatomy	central nervous system	1	1.0	23640545	PMID:23640545; Original text:The TCF4 gene is also a risk factor with highly significant linkage to schizophrenia, presumably via overexpression of the TCF4 gene product in the central nervous system.
autism spectrum disorder	disease_to_anatomy	of the	8	34.106	26418822|29443933|27056845|29146048|32294031|23965928|27501063|19538990	PMID:26418822; Original text:When asked about the effects of the gluten-free and casein-free diet, 20-29% of the parents reported significant improvements on the autism spectrum disorder core dimensions.|PMID:29443933; Original text:Unmet parent carer mental health needs pose a significant risk to the psychological, physical, and social well-being of the parents of the child affected by Autism Spectrum Disorder and jeopardize the adaptive functioning of the family as well as the potential of the child affected by Autism Spectrum Disorder.|PMID:27056845; Original text:The main findings were that both groups of children with autism spectrum disorder significantly exhibited improvements in motor skill proficiency (the total motor composite and two motor-area composites) and executive function (three indices of the Wisconsin Card Sorting Test) after 12 weeks of physical activity intervention.|PMID:29146048; Original text:The meta-analysis of the literature suggested a weak but significant association between autism spectrum disorder diagnosis and increased cerebellar volume (p = .049, uncorrected), but the analysis of ABIDE did not show any relationship.|PMID:32294031; Original text:Significant vitamin D deficiency is described within children affected by Autism Spectrum Disorder and in pregnant mothers whose offspring will later develop Autism Spectrum Disorder, suggesting a possible role of the hormone as a contributing risk factor in the etiopathogenesis of Autism Spectrum Disorder.|PMID:23965928; Original text:Autism spectrum disorder (disorder) is a neurological disorder in which a significant number of the children experience a developmental regression characterized by a loss of previously acquired skills and abilities.|PMID:27501063; Original text:We performed meta-analyses of the univariate studies, identifying significant differences in mean pitch and pitch range between individuals with Autism Spectrum Disorder and comparison participants (Cohen's d of 0.4-0.5 and discriminatory accuracy of about 61-64%).|PMID:19538990; Original text:An atypical pattern of eye contact behaviour is one of the most significant symptoms of Autism Spectrum Disorder (Autism Spectrum Disorder).
autism	disease_to_anatomy	, neuronal	1	1.909	27105825	PMID:27105825; Original text:Functional enrichment analysis detected significant over-representation of target gene clusters related to transcriptional activation, neuronal development, and the Simons Foundation Autism Database genes.
autism	disease_to_anatomy	neuronal	2	8.766	27105825|8759044	"PMID:27105825; Original text:Functional enrichment analysis detected significant over-representation of target gene clusters related to transcriptional activation, neuronal development, and the Simons Foundation Autism Database genes.|PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
schizophrenia	disease_to_anatomy	levels of	1	7.958	22987847	PMID:22987847; Original text:From the perspective of those of us working on the genetics of schizophrenia, recent progress in identifying specific genetic risk factors at highly robust levels of statistical significance has been striking.
neuro	disease_to_anatomy	, sex	1	1.0	2487481	PMID:2487481; Original text:On the basis of the examinations of visual perception (retinal pathology, tunnel vision) perceptual processing (recognition of feelings, sex and age) and the disintegration of multimodal stimuli it can be presumed that social and emotional deficits are to be seen in connection with a deviant perceptive interpretation of the world and irregular processing on the basis of a neuro-biological handicap (the absence of a genetic determined reference-system for emotionally significant stimuli), which can have various causes (comp.
neuro	disease_to_anatomy	of the	1	1.0	2487481	PMID:2487481; Original text:On the basis of the examinations of visual perception (retinal pathology, tunnel vision) perceptual processing (recognition of feelings, sex and age) and the disintegration of multimodal stimuli it can be presumed that social and emotional deficits are to be seen in connection with a deviant perceptive interpretation of the world and irregular processing on the basis of a neuro-biological handicap (the absence of a genetic determined reference-system for emotionally significant stimuli), which can have various causes (comp.
social	disease_to_anatomy	, sex	1	1.0	2487481	PMID:2487481; Original text:On the basis of the examinations of visual perception (retinal pathology, tunnel vision) perceptual processing (recognition of feelings, sex and age) and the disintegration of multimodal stimuli it can be presumed that social and emotional deficits are to be seen in connection with a deviant perceptive interpretation of the world and irregular processing on the basis of a neuro-biological handicap (the absence of a genetic determined reference-system for emotionally significant stimuli), which can have various causes (comp.
social	disease_to_anatomy	of the	2	4.291	2487481|25804268	PMID:2487481; Original text:On the basis of the examinations of visual perception (retinal pathology, tunnel vision) perceptual processing (recognition of feelings, sex and age) and the disintegration of multimodal stimuli it can be presumed that social and emotional deficits are to be seen in connection with a deviant perceptive interpretation of the world and irregular processing on the basis of a neuro-biological handicap (the absence of a genetic determined reference-system for emotionally significant stimuli), which can have various causes (comp.|PMID:25804268; Original text:At post-treatment, participants showed significant improvements on all subscales of the Social Responsiveness Scale (P < 0.01) and the Social and Attention Problems syndrome scales of the Child Behavior Checklist (P < 0.05).
developmental disabilities	disease_to_anatomy	group of	2	2.541	23823984|24757919	PMID:23823984; Original text:Autism spectrum disorders (disorders) are a group of developmental disabilities that can cause significant social, communication and behavioral challenges.|PMID:24757919; Original text:Autism spectrum disorders (disorders) are a group of developmental disabilities that can cause significant social, communication, and behavioral challenges for children and families.
disorders	disease_to_anatomy	group of	2	2.541	23823984|24757919	PMID:23823984; Original text:Autism spectrum disorders (disorders) are a group of developmental disabilities that can cause significant social, communication and behavioral challenges.|PMID:24757919; Original text:Autism spectrum disorders (disorders) are a group of developmental disabilities that can cause significant social, communication, and behavioral challenges for children and families.
autism spectrum	disease_to_anatomy	group of	2	2.541	23823984|24757919	PMID:23823984; Original text:Autism spectrum disorders (disorders) are a group of developmental disabilities that can cause significant social, communication and behavioral challenges.|PMID:24757919; Original text:Autism spectrum disorders (disorders) are a group of developmental disabilities that can cause significant social, communication, and behavioral challenges for children and families.
autism	disease_to_anatomy	corpus callosum	2	24.19	16460701|19748080	PMID:16460701; Original text:Traditional morphometric methods detected a significant reduction in the total callosal area and in the anterior third of the the corpus callosum in patients with autism; however, 3D maps revealed significant reductions in both the splenium and genu of the the corpus callosum in patients.|PMID:19748080; Original text:The present study determined the significance and magnitude of reductions in corpus callosum total and regional area measures in autism.
necrosis	disease_to_anatomy	blood	1	3.758	25729218	PMID:25729218; Original text:A number of studies have shown that the cytokine levels in the blood, brain, and cerebrospinal fluid (cerebrospinal fluid) of autistic subjects differ from that of healthy individuals; for example, a series of studies suggests that interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly elevated in different tissues in autistic subjects.
necrosis	disease_to_anatomy	, brain	1	3.758	25729218	PMID:25729218; Original text:A number of studies have shown that the cytokine levels in the blood, brain, and cerebrospinal fluid (cerebrospinal fluid) of autistic subjects differ from that of healthy individuals; for example, a series of studies suggests that interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly elevated in different tissues in autistic subjects.
necrosis	disease_to_anatomy	cerebrospinal fluid	1	3.758	25729218	PMID:25729218; Original text:A number of studies have shown that the cytokine levels in the blood, brain, and cerebrospinal fluid (cerebrospinal fluid) of autistic subjects differ from that of healthy individuals; for example, a series of studies suggests that interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly elevated in different tissues in autistic subjects.
necrosis	disease_to_anatomy	, and	1	3.758	25729218	PMID:25729218; Original text:A number of studies have shown that the cytokine levels in the blood, brain, and cerebrospinal fluid (cerebrospinal fluid) of autistic subjects differ from that of healthy individuals; for example, a series of studies suggests that interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly elevated in different tissues in autistic subjects.
necrosis	disease_to_anatomy	, a	1	3.758	25729218	PMID:25729218; Original text:A number of studies have shown that the cytokine levels in the blood, brain, and cerebrospinal fluid (cerebrospinal fluid) of autistic subjects differ from that of healthy individuals; for example, a series of studies suggests that interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly elevated in different tissues in autistic subjects.
necrosis	disease_to_anatomy	brain	1	3.758	25729218	PMID:25729218; Original text:A number of studies have shown that the cytokine levels in the blood, brain, and cerebrospinal fluid (cerebrospinal fluid) of autistic subjects differ from that of healthy individuals; for example, a series of studies suggests that interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly elevated in different tissues in autistic subjects.
necrosis	disease_to_anatomy	, tumor	1	3.758	25729218	PMID:25729218; Original text:A number of studies have shown that the cytokine levels in the blood, brain, and cerebrospinal fluid (cerebrospinal fluid) of autistic subjects differ from that of healthy individuals; for example, a series of studies suggests that interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly elevated in different tissues in autistic subjects.
autistic	disease_to_anatomy	blood	1	3.758	25729218	PMID:25729218; Original text:A number of studies have shown that the cytokine levels in the blood, brain, and cerebrospinal fluid (cerebrospinal fluid) of autistic subjects differ from that of healthy individuals; for example, a series of studies suggests that interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly elevated in different tissues in autistic subjects.
autistic	disease_to_anatomy	, brain	1	3.758	25729218	PMID:25729218; Original text:A number of studies have shown that the cytokine levels in the blood, brain, and cerebrospinal fluid (cerebrospinal fluid) of autistic subjects differ from that of healthy individuals; for example, a series of studies suggests that interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly elevated in different tissues in autistic subjects.
autistic	disease_to_anatomy	cerebrospinal fluid	1	3.758	25729218	PMID:25729218; Original text:A number of studies have shown that the cytokine levels in the blood, brain, and cerebrospinal fluid (cerebrospinal fluid) of autistic subjects differ from that of healthy individuals; for example, a series of studies suggests that interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly elevated in different tissues in autistic subjects.
autistic	disease_to_anatomy	, a	3	10.95	25729218|28217829|14561452	PMID:25729218; Original text:A number of studies have shown that the cytokine levels in the blood, brain, and cerebrospinal fluid (cerebrospinal fluid) of autistic subjects differ from that of healthy individuals; for example, a series of studies suggests that interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly elevated in different tissues in autistic subjects.|PMID:28217829; Original text:In terms of prevention, a recent small study showed vitamin D supplementation during pregnancy (5000 IU/day) and during infancy and early childhood (1000 IU/day) significantly reduced the expected incidence of autism in mothers who already had one autistic child from 20% to 5%.|PMID:14561452; Original text:Within the task condition, a region-of-interest comparison of attend-left versus attend-right conditions indicated that modulation of activation in the autistic brain as a function of the lateral focus of spatial attention was abnormally decreased in the left ventral occipital cortex (P<0.03), abnormally increased in the left intraparietal sulcus (P<0.01), and abnormally variable in the superior parietal lobe (P<0.03).
autistic	disease_to_anatomy	brain	1	3.758	25729218	PMID:25729218; Original text:A number of studies have shown that the cytokine levels in the blood, brain, and cerebrospinal fluid (cerebrospinal fluid) of autistic subjects differ from that of healthy individuals; for example, a series of studies suggests that interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly elevated in different tissues in autistic subjects.
autistic	disease_to_anatomy	, tumor	1	3.758	25729218	PMID:25729218; Original text:A number of studies have shown that the cytokine levels in the blood, brain, and cerebrospinal fluid (cerebrospinal fluid) of autistic subjects differ from that of healthy individuals; for example, a series of studies suggests that interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly elevated in different tissues in autistic subjects.
tumor	disease_to_anatomy	blood	1	3.758	25729218	PMID:25729218; Original text:A number of studies have shown that the cytokine levels in the blood, brain, and cerebrospinal fluid (cerebrospinal fluid) of autistic subjects differ from that of healthy individuals; for example, a series of studies suggests that interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly elevated in different tissues in autistic subjects.
tumor	disease_to_anatomy	, brain	1	3.758	25729218	PMID:25729218; Original text:A number of studies have shown that the cytokine levels in the blood, brain, and cerebrospinal fluid (cerebrospinal fluid) of autistic subjects differ from that of healthy individuals; for example, a series of studies suggests that interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly elevated in different tissues in autistic subjects.
tumor	disease_to_anatomy	cerebrospinal fluid	1	3.758	25729218	PMID:25729218; Original text:A number of studies have shown that the cytokine levels in the blood, brain, and cerebrospinal fluid (cerebrospinal fluid) of autistic subjects differ from that of healthy individuals; for example, a series of studies suggests that interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly elevated in different tissues in autistic subjects.
tumor	disease_to_anatomy	, and	1	3.758	25729218	PMID:25729218; Original text:A number of studies have shown that the cytokine levels in the blood, brain, and cerebrospinal fluid (cerebrospinal fluid) of autistic subjects differ from that of healthy individuals; for example, a series of studies suggests that interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly elevated in different tissues in autistic subjects.
tumor	disease_to_anatomy	, a	1	3.758	25729218	PMID:25729218; Original text:A number of studies have shown that the cytokine levels in the blood, brain, and cerebrospinal fluid (cerebrospinal fluid) of autistic subjects differ from that of healthy individuals; for example, a series of studies suggests that interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly elevated in different tissues in autistic subjects.
tumor	disease_to_anatomy	brain	1	3.758	25729218	PMID:25729218; Original text:A number of studies have shown that the cytokine levels in the blood, brain, and cerebrospinal fluid (cerebrospinal fluid) of autistic subjects differ from that of healthy individuals; for example, a series of studies suggests that interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly elevated in different tissues in autistic subjects.
tumor	disease_to_anatomy	, tumor	1	3.758	25729218	PMID:25729218; Original text:A number of studies have shown that the cytokine levels in the blood, brain, and cerebrospinal fluid (cerebrospinal fluid) of autistic subjects differ from that of healthy individuals; for example, a series of studies suggests that interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are significantly elevated in different tissues in autistic subjects.
viral myocarditis	disease_to_anatomy	of the	1	2.118	31685286	PMID:31685286; Original text:Pathway enrichment analysis of the genes identified by Tissue specific transcriptome-wide association study detected 3 pathways for Attention-deficit/hyperactivity disorder, including Other glycan degradation (P value=0.021), Viral myocarditis (P value=0.034) and Endocytosis (P value=0.041).
viral myocarditis	disease_to_anatomy	(p	1	2.118	31685286	PMID:31685286; Original text:Pathway enrichment analysis of the genes identified by Tissue specific transcriptome-wide association study detected 3 pathways for Attention-deficit/hyperactivity disorder, including Other glycan degradation (P value=0.021), Viral myocarditis (P value=0.034) and Endocytosis (P value=0.041).
viral myocarditis	disease_to_anatomy	, viral	1	2.118	31685286	PMID:31685286; Original text:Pathway enrichment analysis of the genes identified by Tissue specific transcriptome-wide association study detected 3 pathways for Attention-deficit/hyperactivity disorder, including Other glycan degradation (P value=0.021), Viral myocarditis (P value=0.034) and Endocytosis (P value=0.041).
endocytosis	disease_to_anatomy	of the	1	2.118	31685286	PMID:31685286; Original text:Pathway enrichment analysis of the genes identified by Tissue specific transcriptome-wide association study detected 3 pathways for Attention-deficit/hyperactivity disorder, including Other glycan degradation (P value=0.021), Viral myocarditis (P value=0.034) and Endocytosis (P value=0.041).
endocytosis	disease_to_anatomy	(p	1	2.118	31685286	PMID:31685286; Original text:Pathway enrichment analysis of the genes identified by Tissue specific transcriptome-wide association study detected 3 pathways for Attention-deficit/hyperactivity disorder, including Other glycan degradation (P value=0.021), Viral myocarditis (P value=0.034) and Endocytosis (P value=0.041).
endocytosis	disease_to_anatomy	, viral	1	2.118	31685286	PMID:31685286; Original text:Pathway enrichment analysis of the genes identified by Tissue specific transcriptome-wide association study detected 3 pathways for Attention-deficit/hyperactivity disorder, including Other glycan degradation (P value=0.021), Viral myocarditis (P value=0.034) and Endocytosis (P value=0.041).
attention-deficit/hyperactivity disorder	disease_to_anatomy	of the	2	3.413	31685286|23503544	PMID:31685286; Original text:Pathway enrichment analysis of the genes identified by Tissue specific transcriptome-wide association study detected 3 pathways for Attention-deficit/hyperactivity disorder, including Other glycan degradation (P value=0.021), Viral myocarditis (P value=0.034) and Endocytosis (P value=0.041).|PMID:23503544; Original text:A significant positive correlation was found between the changes in the total scores of the depression and the attention-deficit/hyperactivity disorder severity (Spearman correlation r = 0.65
attention-deficit/hyperactivity disorder	disease_to_anatomy	(p	2	4.313	31685286|20166790	PMID:31685286; Original text:Pathway enrichment analysis of the genes identified by Tissue specific transcriptome-wide association study detected 3 pathways for Attention-deficit/hyperactivity disorder, including Other glycan degradation (P value=0.021), Viral myocarditis (P value=0.034) and Endocytosis (P value=0.041).|PMID:20166790; Original text:Parent-rated attention-deficit/hyperactivity disorder Pelham scores also differed by genotype (p = 0.05).
attention-deficit/hyperactivity disorder	disease_to_anatomy	, viral	1	2.118	31685286	PMID:31685286; Original text:Pathway enrichment analysis of the genes identified by Tissue specific transcriptome-wide association study detected 3 pathways for Attention-deficit/hyperactivity disorder, including Other glycan degradation (P value=0.021), Viral myocarditis (P value=0.034) and Endocytosis (P value=0.041).
autism spectrum disorder	disease_to_anatomy	, and	10	26.29	29443933|32222129|30230414|28929285|24231171|28218722|23782128|26769980|33434711|26975670	PMID:29443933; Original text:Unmet parent carer mental health needs pose a significant risk to the psychological, physical, and social well-being of the parents of the child affected by Autism Spectrum Disorder and jeopardize the adaptive functioning of the family as well as the potential of the child affected by Autism Spectrum Disorder.|PMID:32222129; Original text:Tuberous sclerosis complex associated neuropsychiatric disorders (neuropsychiatric disorders), including intellectual disability, mood disorders, and autism spectrum disorder, represent significant challenges but remain underdiagnosed and undertreated.|PMID:30230414; Original text:Autism spectrum disorder is associated with significant healthcare costs, and early diagnosis can substantially reduce these.|PMID:28929285; Original text:Although individually rare, genomic disorders collectively account for a significant minority of intellectual disability, autism spectrum disorder, and schizophrenia.|PMID:24231171; Original text:For children diagnosed with an autism spectrum disorder and/or intellectual disability, the co-occurrence of serious behavioral disturbance can pose significant health and safety risks, impede normal learning and development, and put great stress on family systems.|PMID:28218722; Original text:Compared with typically developed, Autism Spectrum Disorder populations had lower DHA (-2.14 [95% CI -3.22 to -1.07]; p < 0.0001; I² = 97%), EPA (-0.72 [95% CI -1.25 to -0.18]; p = 0.008; I² = 88%), and acid (-0.83 [95% CI, -1.48 to -0.17]; p = 0.01; I² = 96%) and higher total n-6 LCPUFA to n-3 LCPUFA ratio (0.42 [95% CI 0.06 to 0.78]; p = 0.02; I² = 74%).|PMID:23782128; Original text:(DSM-IV-TR) criteria for an autism spectrum disorder (disorder) on the Autism Diagnostic Interview-Revised (-Revised) and the Autism Diagnostic Observation Schedule (the Autism Diagnostic Observation Schedule), and had significant symptoms of attention-deficit/hyperactivity disorder (attention-deficit/hyperactivity disorder).|PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.|PMID:33434711; Original text:Advances in laboratory testing have significantly increased the detection of rare genetic etiologies of neurodevelopmental psychiatric disorders (neurodevelopmental psychiatric disorders), particularly developmental delay/ intellectual disability, autism spectrum disorder, and schizophrenia.|PMID:26975670; Original text:Nevertheless, significant progress has been made in characterizing the neuroanatomical underpinnings of autism spectrum disorder across the human life span, and in identifying the molecular pathways that may be affected in autism spectrum disorder.
infections	disease_to_anatomy	stem cells	1	3.341	25302490	PMID:25302490; Original text:No adverse events of significance were observed in ASD children treated with fetal stem cells, including no transmitted infections or immunological complications.
infections	disease_to_anatomy	fetal stem cells	1	3.341	25302490	PMID:25302490; Original text:No adverse events of significance were observed in ASD children treated with fetal stem cells, including no transmitted infections or immunological complications.
infections	disease_to_anatomy	cells	1	3.341	25302490	PMID:25302490; Original text:No adverse events of significance were observed in ASD children treated with fetal stem cells, including no transmitted infections or immunological complications.
infections	disease_to_anatomy	fetal stem	1	3.341	25302490	PMID:25302490; Original text:No adverse events of significance were observed in ASD children treated with fetal stem cells, including no transmitted infections or immunological complications.
asd	disease_to_anatomy	stem cells	1	3.341	25302490	PMID:25302490; Original text:No adverse events of significance were observed in ASD children treated with fetal stem cells, including no transmitted infections or immunological complications.
asd	disease_to_anatomy	fetal stem cells	1	3.341	25302490	PMID:25302490; Original text:No adverse events of significance were observed in ASD children treated with fetal stem cells, including no transmitted infections or immunological complications.
asd	disease_to_anatomy	cells	1	3.341	25302490	PMID:25302490; Original text:No adverse events of significance were observed in ASD children treated with fetal stem cells, including no transmitted infections or immunological complications.
asd	disease_to_anatomy	fetal stem	1	3.341	25302490	PMID:25302490; Original text:No adverse events of significance were observed in ASD children treated with fetal stem cells, including no transmitted infections or immunological complications.
autism spectrum disorders	disease_to_anatomy	of sensory	1	1.0	18512135	PMID:18512135; Original text:Results from 14 studies indicated a significant high difference between autism spectrum disorders and typical groups in the presence/frequency of sensory symptoms, with the greatest difference in under-responsivity, followed by over-responsivity and sensation seeking.
irritability	disease_to_anatomy	, and	16	46.116	9672054|16190799|15529462|19858761|20973712|9934941|23782127|22782459|32168067|30980177|19519261|22549762|32347624|19284641|32947424|23101743	PMID:9672054; Original text:Risperidone was superior to placebo in reducing repetitive behavior (P<.001), aggression (P<.001), anxiety or nervousness (P<.02), depression (P<.03), irritability (P<.01), and the overall behavioral symptoms of autism (P<.02).|PMID:16190799; Original text:Irritability subscale was the primary outcome measure (p = 0.65), and CGI--Improvement (p = 0.16) and OAS (p = 0.96) were secondary outcome measures.|PMID:15529462; Original text:Clinicians need to inquire about not only classic symptoms of depression such as anhedonia but also less obvious symptoms such as unprovoked irritability, unsubstantiated complaints of lack of love from family members, somatic complaints, and problems with concentration and poor school performance.|PMID:19858761; Original text:Secondary: groups did not differ on Clinical Global Impressions-Improvement scores at endpoint; compared with MED, combined treatment showed significant reductions on Aberrant Behavior Checklist Irritability (d = 0.48; p = .01), Stereotypic Behavior (d = 0.23; p = .04), and Hyperactivity/Noncompliance subscales (d = 0.55; p = .04).|PMID:20973712; Original text:Statistically significantly greater improvement was seen with aripiprazole versus placebo (p < 0.05) for all arms in both trials on the the Aberrant Behavior Checklist-Irritability total subscale score and on the following individual the Aberrant Behavior Checklist-Irritability items: Mood changes quickly, cries/screams inappropriately, and stamps feet/bangs objects.|PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.|PMID:23782127; Original text:The ABC irritability/agitation subscale (subscale 1) was significantly improved from 8 weeks, and the hyperactivity/noncompliance subscale (subscale 4) was significantly improved in 12 weeks.|PMID:22782459; Original text:Primary outcome measure was the change in irritability subscale of ABC-C. Significant time × treatment interaction was observed for Irritability (F (1.658, 63.0χ1) = 13.580, P < 0.001), Lethargy/Social Withdrawal (F (1.948, 74.03χ) = 16.811, P < 0.001), and Stereotypic Behavior (F(1.74χ, 66.198) = 1χ.104, P < 0.001), but not for Hyperactivity/Noncompliance (F (χ.564, 97.4χ4) = 1.469, P = 0.χ3χ), and Inappropriate Speech subscales (F (1.607, 61.075) = 0.173, P = 0.794).|PMID:32168067; Original text:Repeated-measures analysis demonstrated significant effect for time-treatment interaction in the Childhood Autism Rating Scale (F (1, 2.23) = 13.22, P < 0.001), as well as 4 subscales of the ABC-C including: irritability (F (1, 2.12) = 3.84, P = 0.026), hyperactivity (F (1, 2.09) = 3.56, P = 0.039), lethargy (F (1, 2.18) = 31.50, P < 0.001), and stereotypy (F (1, 1.89) = 4.04, P = 0.026).|PMID:30980177; Original text:Analysis of the combined data revealed significant improvement for all the ABC subscales (irritability: F = 51.644, df = 1.66, p < 0.001, lethargy: F = 39.734, df = 1.38, p < 0.001, stereotypic behavior: F = 25.495, df = 1.56, p < 0.001, hyperactivity: F = 54.135, df = 1.35, p < 0.001, and inappropriate speech: F = 19.277, df = 1.47, p = 0.004).|PMID:19519261; Original text:Twenty-two (88%) of 25 subjects were responders in regard to interfering symptoms of irritability, including aggression, self-injury, and tantrums, with a final the Clinical Global Impressions-Improvement of 1 or 2 (very much or much improved) and a 25% or greater improvement on the the Aberrant Behavior Checklist.|PMID:22549762; Original text:Individuals with autistic disorder (autistic disorder) frequently exhibit significant irritability marked by severe tantrums, aggression, and self-injury.|PMID:32347624; Original text:Compared to the placebo group, disorder patients in the sulforaphane group showed greater improvements in Irritability score (primary outcome measure; P = 0.001) and Hyperactivity/Noncompliance score (secondary outcome measure; P = 0.015), and significant Time × Treatment effect for Irritability (P = 0.007) and Hyperactivity/Noncompliance (P = 0.008).|PMID:19284641; Original text:On the Aberrant Behavior Checklist, significant improvements were observed in the tre1.3 atmosphereent group in total score, irritability, stereotypy, hyperactivity, and speech (p < 0.03 for each), but not in the control group.|PMID:32947424; Original text:Repeated measures analysis was suggestive of greater exhibited improvement for the pregnenolone group on irritability, stereotypy, and hyperactivity subscales of the Aberrant Behavior Checklist-Community Edition over the trial period (F = 3.84, df = 1.96, P = 0.025; F = 4.29, df = 1.39, P = 0.029; F = 6.55, df = 1.67, P = 0.004, respectively).|PMID:23101743; Original text:The the behavior management treatment had shown a significant advantage for child behavioral noncompliance (p = .006, d = 0.34), irritability (p = .01, d = 0.48), and hyperactivity/noncompliance (p = .04, d = 0.55) with a lower medication dose.
depression	disease_to_anatomy	, and	5	11.112	9672054|15529462|9934941|24408892|32090389	PMID:9672054; Original text:Risperidone was superior to placebo in reducing repetitive behavior (P<.001), aggression (P<.001), anxiety or nervousness (P<.02), depression (P<.03), irritability (P<.01), and the overall behavioral symptoms of autism (P<.02).|PMID:15529462; Original text:Clinicians need to inquire about not only classic symptoms of depression such as anhedonia but also less obvious symptoms such as unprovoked irritability, unsubstantiated complaints of lack of love from family members, somatic complaints, and problems with concentration and poor school performance.|PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.|PMID:24408892; Original text:Results for treatment outcome suggest that the a treatment group showed significant improvement in communication and social interaction domain scores on the Autism Diagnostic Observation Schedule, interpersonal relationship and play/leisure time on the subdomain scores of the Korean version of the Vineland Adaptive Behavior Scale (p's < 0.01), social skills knowledge total scores on the Test of Adolescent Social Skills Knowledge-Revised (p < 0.01), and decreased depressive symptoms on the Child Depression Inventory following treatment (p < 0.05).|PMID:32090389; Original text:Only the mindfulness-based stress reduction group demonstrated significant reductions in depression, and neither group significantly changed in anxiety.
nervousness	disease_to_anatomy	, and	1	1.0	9672054	PMID:9672054; Original text:Risperidone was superior to placebo in reducing repetitive behavior (P<.001), aggression (P<.001), anxiety or nervousness (P<.02), depression (P<.03), irritability (P<.01), and the overall behavioral symptoms of autism (P<.02).
repetitive behavior	disease_to_anatomy	, and	1	1.0	9672054	PMID:9672054; Original text:Risperidone was superior to placebo in reducing repetitive behavior (P<.001), aggression (P<.001), anxiety or nervousness (P<.02), depression (P<.03), irritability (P<.01), and the overall behavioral symptoms of autism (P<.02).
aggression	disease_to_anatomy	, and	5	10.024999999999999	9672054|9934941|8911223|19519261|22549762	PMID:9672054; Original text:Risperidone was superior to placebo in reducing repetitive behavior (P<.001), aggression (P<.001), anxiety or nervousness (P<.02), depression (P<.03), irritability (P<.01), and the overall behavioral symptoms of autism (P<.02).|PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.|PMID:8911223; Original text:Fluvoxamine was superior to placebo in reducing repetitive thoughts and behavior (P < .001), maladaptive behavior (P < .001), and aggression (P < .03), and in improving some aspects of social relatedness (P < .04), especially language usage (P < .008).|PMID:19519261; Original text:Twenty-two (88%) of 25 subjects were responders in regard to interfering symptoms of irritability, including aggression, self-injury, and tantrums, with a final the Clinical Global Impressions-Improvement of 1 or 2 (very much or much improved) and a 25% or greater improvement on the the Aberrant Behavior Checklist.|PMID:22549762; Original text:Individuals with autistic disorder (autistic disorder) frequently exhibit significant irritability marked by severe tantrums, aggression, and self-injury.
anxiety or	disease_to_anatomy	, and	1	1.0	9672054	PMID:9672054; Original text:Risperidone was superior to placebo in reducing repetitive behavior (P<.001), aggression (P<.001), anxiety or nervousness (P<.02), depression (P<.03), irritability (P<.01), and the overall behavioral symptoms of autism (P<.02).
autism	disease_to_anatomy	definition)	1	1.0	29498298	PMID:29498298; Original text:Some of these liabilities are not necessarily specific to ASD-those that are non-specific could account for a significant share of the 'missing heritability' of autism, would (by definition) contribute to pleiotropy, and relate to so-called 'co-morbidities', which are inappropriately named if they actually contribute to (or exacerbate) the severity of autism itself.
asd	disease_to_anatomy	definition)	1	1.0	29498298	PMID:29498298; Original text:Some of these liabilities are not necessarily specific to ASD-those that are non-specific could account for a significant share of the 'missing heritability' of autism, would (by definition) contribute to pleiotropy, and relate to so-called 'co-morbidities', which are inappropriately named if they actually contribute to (or exacerbate) the severity of autism itself.
tuberous sclerosis	disease_to_anatomy	, and	3	4.324	32222129|32222129|32563542	PMID:32222129; Original text:Animal studies have demonstrated the benefit of using mTOR inhibitors for various symptoms of Tuberous sclerosis complex, and they have been successfully translated into clinical trials with significant improvement in symptom burden.|PMID:32222129; Original text:Tuberous sclerosis complex associated neuropsychiatric disorders (neuropsychiatric disorders), including intellectual disability, mood disorders, and autism spectrum disorder, represent significant challenges but remain underdiagnosed and undertreated.|PMID:32563542; Original text:Recently, significant progress has been possible with the prospective calculation of the prevalence of autism in Tuberous sclerosis complex, identification of early clinical and neurophysiological biomarkers to predict autism, and investigation of different therapies to prevent autism in this high-risk population.
tuberous sclerosis	disease_to_anatomy	complex	2	3.607	32222129|32563542	PMID:32222129; Original text:Animal studies have demonstrated the benefit of using mTOR inhibitors for various symptoms of Tuberous sclerosis complex, and they have been successfully translated into clinical trials with significant improvement in symptom burden.|PMID:32563542; Original text:Recently, significant progress has been possible with the prospective calculation of the prevalence of autism in Tuberous sclerosis complex, identification of early clinical and neurophysiological biomarkers to predict autism, and investigation of different therapies to prevent autism in this high-risk population.
neuropsychiatric disorders	disease_to_anatomy	, and	1	0.717	32222129	PMID:32222129; Original text:Tuberous sclerosis complex associated neuropsychiatric disorders (neuropsychiatric disorders), including intellectual disability, mood disorders, and autism spectrum disorder, represent significant challenges but remain underdiagnosed and undertreated.
mood disorders	disease_to_anatomy	, and	1	0.717	32222129	PMID:32222129; Original text:Tuberous sclerosis complex associated neuropsychiatric disorders (neuropsychiatric disorders), including intellectual disability, mood disorders, and autism spectrum disorder, represent significant challenges but remain underdiagnosed and undertreated.
intellectual disability	disease_to_anatomy	, and	8	18.057000000000002	32222129|28929285|24231171|31018221|33434711|24123946|28036350|24246273	PMID:32222129; Original text:Tuberous sclerosis complex associated neuropsychiatric disorders (neuropsychiatric disorders), including intellectual disability, mood disorders, and autism spectrum disorder, represent significant challenges but remain underdiagnosed and undertreated.|PMID:28929285; Original text:Although individually rare, genomic disorders collectively account for a significant minority of intellectual disability, autism spectrum disorder, and schizophrenia.|PMID:24231171; Original text:For children diagnosed with an autism spectrum disorder and/or intellectual disability, the co-occurrence of serious behavioral disturbance can pose significant health and safety risks, impede normal learning and development, and put great stress on family systems.|PMID:31018221; Original text:Type of spasticity (hemiplegia > diplegia > tri/quadriplegia; OR [odds ratio] = 1.76, SE [standard error] = 0.2785, p = 0.04), communication disorders (OR = 7.442, SE = 0.59, p < 0.001), intellectual disability (OR = 2.27, SE = 0.43, p = 0.05), feeding abilities (OR = 0.35, SE = 0.35, p = 0.002), and motor function (OR = 0.59, SE = 0.22, p = 0.01) were significantly associated with disorder.|PMID:33434711; Original text:Advances in laboratory testing have significantly increased the detection of rare genetic etiologies of neurodevelopmental psychiatric disorders (neurodevelopmental psychiatric disorders), particularly developmental delay/ intellectual disability, autism spectrum disorder, and schizophrenia.|PMID:24123946; Original text:The del15q11.2 was found to be significantly associated with intellectual disability, schizophrenia, epilepsy, and disorder.|PMID:28036350; Original text:Physician use of the 2.8MM probe-chromosomal microarray test significantly improves overall quality as well as diagnosis and treatment quality for simulated cases of pediatric Developmental disorders/ASD/intellectual disability patients, and delivers additional clinical utility over existing chromosomal microarray tests.|PMID:24246273; Original text:Although there are numerous quality of life instruments in the, field of intellectual disability, most of them are addressed to those, people with the highest levels of functioning, while only a few are, suitable for people with the lowest levels (i.e., people with profound, and severe intellectual disabilities, or people with intellectual and, developmental disabilities and other significant medical conditions or, disabilities).
autistic	disease_to_anatomy	growth hormone	1	2.118	10808042	PMID:10808042; Original text:This suggests that autistic patients had significantly greater growth hormone response to sumatriptan than normal controls, independent of placebo effects.
fragile	disease_to_anatomy	groups	1	8.33	17097142	PMID:17097142; Original text:The scores representing communication and social interaction were continuously distributed across the two fragile X groups, and they were significantly elevated compared with the non-fragile X controls.
fragile	disease_to_anatomy	, and	1	8.33	17097142	PMID:17097142; Original text:The scores representing communication and social interaction were continuously distributed across the two fragile X groups, and they were significantly elevated compared with the non-fragile X controls.
autism	disease_to_anatomy	gastrointestinal system	1	4.546	33573238	PMID:33573238; Original text:There has been a growing interest in the gastrointestinal system and its significance for autism spectrum disorder (spectrum disorder), including the significance of adopting a gluten-free and casein-free (GFCF) diet.
spectrum disorder	disease_to_anatomy	gastrointestinal system	1	4.546	33573238	PMID:33573238; Original text:There has been a growing interest in the gastrointestinal system and its significance for autism spectrum disorder (spectrum disorder), including the significance of adopting a gluten-free and casein-free (GFCF) diet.
attention deficit hyperactivity disorder	disease_to_anatomy	group (	2	6.117	31965841|25760553	PMID:31965841; Original text:attention deficit hyperactivity disorder or Asperger syndrome was diagnosed at the age of 13 years in 17.1% children in the placebo and none in the probiotic group (P=0.008).|PMID:25760553; Original text:At the age of 13 y, attention deficit hyperactivity disorder or Asperger syndrome was diagnosed in 6/35 (17.1%) children in the placebo and none in the probiotic group (P = 0.008).
asperger syndrome	disease_to_anatomy	group (	3	7.117	31965841|25760553|8986845	PMID:31965841; Original text:attention deficit hyperactivity disorder or Asperger syndrome was diagnosed at the age of 13 years in 17.1% children in the placebo and none in the probiotic group (P=0.008).|PMID:25760553; Original text:At the age of 13 y, attention deficit hyperactivity disorder or Asperger syndrome was diagnosed in 6/35 (17.1%) children in the placebo and none in the probiotic group (P = 0.008).|PMID:8986845; Original text:13 (76%) of the Asperger syndrome patients were rated as pedantic compared to 4 (31%) of the high-functioning autism group (chi 2 = 6.3; p = .01).
autism spectrum disorders	disease_to_anatomy	(p	4	11.276	28918862|28918862|28342168|25944453	PMID:28918862; Original text:Overall, we found autism spectrum disorders patients exhibited an impaired Prepulse inhibition compared with healthy controls (p = 0.008).|PMID:28918862; Original text:Specifically, significant Prepulse inhibition deficits were observed among autism spectrum disorders children/adolescents, compared with their healthy counterparts (p = 0.019).|PMID:28342168; Original text:After adjusting for potential covariates, having autism spectrum disorders was associated with significantly lower trabecular bone mineral density and bone strength at the radius, and with marginally lower total body less head bone mineral content (p < 0.09).|PMID:25944453; Original text:Only patients with symptomatic Infantile spasms developed autism spectrum disorders (p = 0.003).
hypersensitivity to sound	disease_to_anatomy	, and	1	3.998	30287864	PMID:30287864; Original text:Statistically significant variables for vitamin B6 responsiveness, including combination of hypersensitivity to sound and clumsiness, and plasma glutamine level, were included.
clumsiness	disease_to_anatomy	, and	1	3.998	30287864	PMID:30287864; Original text:Statistically significant variables for vitamin B6 responsiveness, including combination of hypersensitivity to sound and clumsiness, and plasma glutamine level, were included.
autism	disease_to_anatomy	group of	2	8.709	16083327|16115783	PMID:16083327; Original text:Autism, Asperger and other pervasive developmental disorders (other pervasive developmental disorders) are an increasingly commonly identified group of conditions wherein patients experience significant difficulty in social interactions, communicating with others, and inflexible adherence to unusual, unhelpful and frequently stereotyped routines and behaviour.|PMID:16115783; Original text:10- to 15-year-old children with autism and a group of 12 age- and sex-matched healthy controls.
developmental disorders	disease_to_anatomy	, and	2	5.547000000000001	16083327|28036350	PMID:16083327; Original text:Autism, Asperger and other pervasive developmental disorders (other pervasive developmental disorders) are an increasingly commonly identified group of conditions wherein patients experience significant difficulty in social interactions, communicating with others, and inflexible adherence to unusual, unhelpful and frequently stereotyped routines and behaviour.|PMID:28036350; Original text:Physician use of the 2.8MM probe-chromosomal microarray test significantly improves overall quality as well as diagnosis and treatment quality for simulated cases of pediatric Developmental disorders/ASD/intellectual disability patients, and delivers additional clinical utility over existing chromosomal microarray tests.
developmental disorders	disease_to_anatomy	group of	1	2.807	16083327	PMID:16083327; Original text:Autism, Asperger and other pervasive developmental disorders (other pervasive developmental disorders) are an increasingly commonly identified group of conditions wherein patients experience significant difficulty in social interactions, communicating with others, and inflexible adherence to unusual, unhelpful and frequently stereotyped routines and behaviour.
asperger	disease_to_anatomy	, and	2	3.807	16083327|9690938	PMID:16083327; Original text:Autism, Asperger and other pervasive developmental disorders (other pervasive developmental disorders) are an increasingly commonly identified group of conditions wherein patients experience significant difficulty in social interactions, communicating with others, and inflexible adherence to unusual, unhelpful and frequently stereotyped routines and behaviour.|PMID:9690938; Original text:The autistic group's performance on the false belief, belief term comprehension, and belief term expression tasks was significantly poorer than that of the Asperger, language impaired, and normal groups.
asperger	disease_to_anatomy	group of	1	2.807	16083327	PMID:16083327; Original text:Autism, Asperger and other pervasive developmental disorders (other pervasive developmental disorders) are an increasingly commonly identified group of conditions wherein patients experience significant difficulty in social interactions, communicating with others, and inflexible adherence to unusual, unhelpful and frequently stereotyped routines and behaviour.
asd	disease_to_anatomy	mitochondrial	4	33.68	23570274|23688533|21263444|21263444	PMID:23570274; Original text:neurotensin is significantly increased in serum of ASD children along with mitochondrial DNA (mitochondrial DNA).|PMID:23688533; Original text:Neurotensin is significantly increased in serum of children with ASD and stimulates mast cell secretion of mitochondrial adenosine triphosphate and DNA, which is increased in these children; these mitochondrial components are misconstrued as innate pathogens, triggering an autoallergic response in the brain.|PMID:21263444; Original text:Variances and mean values of many mitochondrial biomarkers (lactate, pyruvate, carnitine and ubiquinone) were significantly different between ASD and controls.|PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
asd	disease_to_anatomy	, mast	1	5.793	23570274	PMID:23570274; Original text:The natural flavonoid luteolin inhibits rapamycin, mast cells and microglia and could have a significant benefit in ASD.
asd	disease_to_anatomy	mast cells	1	5.793	23570274	PMID:23570274; Original text:The natural flavonoid luteolin inhibits rapamycin, mast cells and microglia and could have a significant benefit in ASD.
asd	disease_to_anatomy	microglia	1	5.793	23570274	PMID:23570274; Original text:The natural flavonoid luteolin inhibits rapamycin, mast cells and microglia and could have a significant benefit in ASD.
autism	disease_to_anatomy	areas	1	1.0	23404617	PMID:23404617; Original text:For a significant proportion of children with autism, it appears early intensive behavioural intervention may be capable of promoting brain connectivity in specific cerebral areas, which is one of autism's underlying challenges.
irritability	disease_to_anatomy	group (	3	3.0	12151468|12151468|23821414	PMID:12151468; Original text:Treatment with risperidone for eight weeks (dose range, 0.5 to 3.5 mg per day) resulted in a 56.9 percent reduction in the Irritability score, as compared with a 14.1 percent decrease in the placebo group (P<0.001).|PMID:12151468; Original text:The rate of a positive response, defined as at least a 25 percent decrease in the Irritability score and a rating of much improved or very much improved on the the Clinical Global Impressions - Improvement scale, was 69 percent in the risperidone group (34 of 49 children had a positive response) and 12 percent in the placebo group (6 of placebo, P<0.001).|PMID:23821414; Original text:A significantly greater improvement in the study primary outcome (the ABC-C irritability subscale score) was achieved by the riluzole-treated children compared with the placebo group (P = 0.03).
irritability	disease_to_anatomy	scale	1	1.0	12151468	PMID:12151468; Original text:The rate of a positive response, defined as at least a 25 percent decrease in the Irritability score and a rating of much improved or very much improved on the the Clinical Global Impressions - Improvement scale, was 69 percent in the risperidone group (34 of 49 children had a positive response) and 12 percent in the placebo group (6 of placebo, P<0.001).
fatigue	disease_to_anatomy	group (	1	1.0	12151468	PMID:12151468; Original text:Increased appetite, fatigue, drowsiness, dizziness, and drooling were more common in the risperidone group than in the placebo group (P<0.05 for each comparison).
fatigue	disease_to_anatomy	, and	1	1.0	12151468	PMID:12151468; Original text:Increased appetite, fatigue, drowsiness, dizziness, and drooling were more common in the risperidone group than in the placebo group (P<0.05 for each comparison).
drooling	disease_to_anatomy	group (	1	1.0	12151468	PMID:12151468; Original text:Increased appetite, fatigue, drowsiness, dizziness, and drooling were more common in the risperidone group than in the placebo group (P<0.05 for each comparison).
drooling	disease_to_anatomy	, and	1	1.0	12151468	PMID:12151468; Original text:Increased appetite, fatigue, drowsiness, dizziness, and drooling were more common in the risperidone group than in the placebo group (P<0.05 for each comparison).
drowsiness	disease_to_anatomy	group (	1	1.0	12151468	PMID:12151468; Original text:Increased appetite, fatigue, drowsiness, dizziness, and drooling were more common in the risperidone group than in the placebo group (P<0.05 for each comparison).
drowsiness	disease_to_anatomy	, and	1	1.0	12151468	PMID:12151468; Original text:Increased appetite, fatigue, drowsiness, dizziness, and drooling were more common in the risperidone group than in the placebo group (P<0.05 for each comparison).
dizziness	disease_to_anatomy	group (	1	1.0	12151468	PMID:12151468; Original text:Increased appetite, fatigue, drowsiness, dizziness, and drooling were more common in the risperidone group than in the placebo group (P<0.05 for each comparison).
dizziness	disease_to_anatomy	, and	1	1.0	12151468	PMID:12151468; Original text:Increased appetite, fatigue, drowsiness, dizziness, and drooling were more common in the risperidone group than in the placebo group (P<0.05 for each comparison).
increased appetite	disease_to_anatomy	group (	1	1.0	12151468	PMID:12151468; Original text:Increased appetite, fatigue, drowsiness, dizziness, and drooling were more common in the risperidone group than in the placebo group (P<0.05 for each comparison).
increased appetite	disease_to_anatomy	, and	1	1.0	12151468	PMID:12151468; Original text:Increased appetite, fatigue, drowsiness, dizziness, and drooling were more common in the risperidone group than in the placebo group (P<0.05 for each comparison).
central nervous system diseases	disease_to_anatomy	nervous system	1	1.0	27180342	PMID:27180342; Original text:These developments underline the significance of microRNAs as potential biomarkers for diagnosing and prognosing central nervous system diseases.
central nervous system diseases	disease_to_anatomy	central nervous	1	1.0	27180342	PMID:27180342; Original text:These developments underline the significance of microRNAs as potential biomarkers for diagnosing and prognosing central nervous system diseases.
central nervous system diseases	disease_to_anatomy	central nervous system	1	1.0	27180342	PMID:27180342; Original text:These developments underline the significance of microRNAs as potential biomarkers for diagnosing and prognosing central nervous system diseases.
autism	disease_to_anatomy	levels of	2	6.600999999999999	11570630|22070180	PMID:11570630; Original text:Levels of I in the CSF were statistically significantly lower in the children with autism than in the control children (p=0.03).|PMID:22070180; Original text:Serum levels of epidermal growth factor were elevated in subjects with autism (median=103 pg/mL, n=75) in comparison to healthy controls (75 pg/mL, n=19; p<0.05), and levels of IL-13 were decreased in autism (median=0.8 pg/mL, n=77) in comparison to controls (9.8 pg/mL, n=19; p=0.0003).
autism	disease_to_anatomy	4	1	6.936	11699803	PMID:11699803; Original text:For the primary efficacy analysis, change of the Autism Diagnostic Observation Schedule social-communication total score from week 0 to week 4, no statistically significant difference was obtained between placebo (-0.8 +/- 2.9) and secretin groups (-0.6 +/- 1.4; t54 = 0.346, p < .73).
autism	disease_to_anatomy	level of	2	3.747	24375082|16494569	PMID:24375082; Original text:camel milk administered for 2 wk significantly improved clinical measurements of autism severity and decreased serum level of activation-regulated chemokine in autistic children, but subsequent studies are recommended.|PMID:16494569; Original text:Children with autism had a 75% higher level of total vitamin B6 than the controls (medians of 56 versus 32 ng/mL, respectively, p = 0.00002).
autistic	disease_to_anatomy	level of	3	4.747	24375082|24676906|24676906	PMID:24375082; Original text:camel milk administered for 2 wk significantly improved clinical measurements of autism severity and decreased serum level of activation-regulated chemokine in autistic children, but subsequent studies are recommended.|PMID:24676906; Original text:The serum level of glutathione in autistic subjects was significantly below control levels, while levels of homocysteine and S-adenosylhomocysteine were elevated, indicative of oxidative stress and decreased methionine synthase activity.|PMID:24676906; Original text:We investigated the status of redox and methylation metabolites, as well as the level of protein homocysteinylation and hair mercury levels, in autistic and neurotypical control Omani children, who were previously shown to exhibit significant nutritional deficiencies in serum folate and vitamin B₁₂.
physical anomalies	disease_to_anatomy	, and	1	12.384	18626481	PMID:18626481; Original text:The current results from seven studies suggested a significant association of minor physical anomalies in autism with a robust pooled effect size (d=0.84), and thereby provide the strongest evidence to date about the close association between minor physical anomalies and autism.
deficits in social communication	disease_to_anatomy	areas of	1	1.0	28296862	PMID:28296862; Original text:It is characterized by persistent deficits in social communication and social interaction, restricted and repetitive patterns of behavior, interests, or activities, and causes clinically significant impairment in social, occupational, or other important areas of functioning.
deficits in social communication	disease_to_anatomy	, and	1	1.0	28296862	PMID:28296862; Original text:It is characterized by persistent deficits in social communication and social interaction, restricted and repetitive patterns of behavior, interests, or activities, and causes clinically significant impairment in social, occupational, or other important areas of functioning.
autism	disease_to_anatomy	the brain	1	1.541	29694338	PMID:29694338; Original text:Moreover, correlations between symptom scores and hypoperfusion in the brains of individuals diagnosed with an disorder were found indicating that the greater the autism symptom pathology, the more significant the cerebral hypoperfusion or vascular pathology in the brain.
autism	disease_to_anatomy	the cerebral	1	1.541	29694338	PMID:29694338; Original text:Moreover, correlations between symptom scores and hypoperfusion in the brains of individuals diagnosed with an disorder were found indicating that the greater the autism symptom pathology, the more significant the cerebral hypoperfusion or vascular pathology in the brain.
vascular pathology	disease_to_anatomy	the brain	1	1.541	29694338	PMID:29694338; Original text:Moreover, correlations between symptom scores and hypoperfusion in the brains of individuals diagnosed with an disorder were found indicating that the greater the autism symptom pathology, the more significant the cerebral hypoperfusion or vascular pathology in the brain.
vascular pathology	disease_to_anatomy	the cerebral	1	1.541	29694338	PMID:29694338; Original text:Moreover, correlations between symptom scores and hypoperfusion in the brains of individuals diagnosed with an disorder were found indicating that the greater the autism symptom pathology, the more significant the cerebral hypoperfusion or vascular pathology in the brain.
cerebral hypoperfusion	disease_to_anatomy	the brain	1	1.541	29694338	PMID:29694338; Original text:Moreover, correlations between symptom scores and hypoperfusion in the brains of individuals diagnosed with an disorder were found indicating that the greater the autism symptom pathology, the more significant the cerebral hypoperfusion or vascular pathology in the brain.
cerebral hypoperfusion	disease_to_anatomy	the cerebral	1	1.541	29694338	PMID:29694338; Original text:Moreover, correlations between symptom scores and hypoperfusion in the brains of individuals diagnosed with an disorder were found indicating that the greater the autism symptom pathology, the more significant the cerebral hypoperfusion or vascular pathology in the brain.
brain growth abnormalities	disease_to_anatomy	is	1	1.0	17919128	PMID:17919128; Original text:The significance of future controlled studies should be judged based on their explanatory powers; that is, how well do they relate to brain growth abnormalities and/or provide useful clinicopathological correlates.
neurodevelopmental disorders	disease_to_anatomy	, and	3	15.27	29608989|15090875|20969835	PMID:29608989; Original text:Significant advances have been made already, and future decades will continue to see innovative progress in neuroimaging research endeavors of neurodevelopmental disorders.|PMID:15090875; Original text:Recent oculomotor studies have made significant contributions to the understanding of neurodevelopmental disorders, most notably in autism, attention-deficit/hyperactivity disorder, and Tourette's syndrome.|PMID:20969835; Original text:We present initial evidence offering proof of concept that brain anatomy can be used to accurately distinguish adults with autism from healthy controls, and from some other neurodevelopmental disorders (some other neurodevelopmental disorders).
neuroimaging	disease_to_anatomy	, and	1	8.33	29608989	PMID:29608989; Original text:Significant advances have been made already, and future decades will continue to see innovative progress in neuroimaging research endeavors of neurodevelopmental disorders.
autistic	disease_to_anatomy	hippocampal formation	2	12.120999999999999	9895151|7854533	PMID:9895151; Original text:In contrast, there is a lack of significant difference in the cross-sectional size of the posterior hippocampal formation between autistic and normal subjects, which is discrepant with predictions based on some autopsy studies.|PMID:7854533; Original text:The lack of a significant difference in the cross-sectional size of the posterior hippocampal formation between autistic and normal 6- to 42-year-olds is discrepant with predictions based on some, but not all, autopsy studies.
panic disorder	disease_to_anatomy	, and	1	6.189	11085201	PMID:11085201; Original text:Fluvoxamine < or = 300 mg/day for 6 to 8 weeks was as effective as imipramine in patients with panic disorder, and significantly more effective than placebo.
inflammation	disease_to_anatomy	of systemic	1	3.935	33942547	PMID:33942547; Original text:Oxidative stress (Oxidative stress) is one of the most significant propagators of systemic damage with implications for widespread pathologies such as vascular disease, accelerated aging, degenerative disease, inflammation, and traumatic injury.
inflammation	disease_to_anatomy	of the	1	3.935	33942547	PMID:33942547; Original text:Oxidative stress (Oxidative stress) is one of the most significant propagators of systemic damage with implications for widespread pathologies such as vascular disease, accelerated aging, degenerative disease, inflammation, and traumatic injury.
inflammation	disease_to_anatomy	, and	2	4.9350000000000005	33942547|19852789	PMID:33942547; Original text:Oxidative stress (Oxidative stress) is one of the most significant propagators of systemic damage with implications for widespread pathologies such as vascular disease, accelerated aging, degenerative disease, inflammation, and traumatic injury.|PMID:19852789; Original text:The Phase 1 single round of DMSA led to a dramatic normalization of RBC glutathione in almost all cases, and greatly improved abnormal platelet counts, suggesting a significant decrease in inflammation.
vascular disease	disease_to_anatomy	of systemic	1	3.935	33942547	PMID:33942547; Original text:Oxidative stress (Oxidative stress) is one of the most significant propagators of systemic damage with implications for widespread pathologies such as vascular disease, accelerated aging, degenerative disease, inflammation, and traumatic injury.
vascular disease	disease_to_anatomy	of the	1	3.935	33942547	PMID:33942547; Original text:Oxidative stress (Oxidative stress) is one of the most significant propagators of systemic damage with implications for widespread pathologies such as vascular disease, accelerated aging, degenerative disease, inflammation, and traumatic injury.
vascular disease	disease_to_anatomy	, and	1	3.935	33942547	PMID:33942547; Original text:Oxidative stress (Oxidative stress) is one of the most significant propagators of systemic damage with implications for widespread pathologies such as vascular disease, accelerated aging, degenerative disease, inflammation, and traumatic injury.
traumatic injury	disease_to_anatomy	of systemic	1	3.935	33942547	PMID:33942547; Original text:Oxidative stress (Oxidative stress) is one of the most significant propagators of systemic damage with implications for widespread pathologies such as vascular disease, accelerated aging, degenerative disease, inflammation, and traumatic injury.
traumatic injury	disease_to_anatomy	of the	1	3.935	33942547	PMID:33942547; Original text:Oxidative stress (Oxidative stress) is one of the most significant propagators of systemic damage with implications for widespread pathologies such as vascular disease, accelerated aging, degenerative disease, inflammation, and traumatic injury.
traumatic injury	disease_to_anatomy	, and	1	3.935	33942547	PMID:33942547; Original text:Oxidative stress (Oxidative stress) is one of the most significant propagators of systemic damage with implications for widespread pathologies such as vascular disease, accelerated aging, degenerative disease, inflammation, and traumatic injury.
degenerative disease	disease_to_anatomy	of systemic	1	3.935	33942547	PMID:33942547; Original text:Oxidative stress (Oxidative stress) is one of the most significant propagators of systemic damage with implications for widespread pathologies such as vascular disease, accelerated aging, degenerative disease, inflammation, and traumatic injury.
degenerative disease	disease_to_anatomy	of the	1	3.935	33942547	PMID:33942547; Original text:Oxidative stress (Oxidative stress) is one of the most significant propagators of systemic damage with implications for widespread pathologies such as vascular disease, accelerated aging, degenerative disease, inflammation, and traumatic injury.
degenerative disease	disease_to_anatomy	, and	1	3.935	33942547	PMID:33942547; Original text:Oxidative stress (Oxidative stress) is one of the most significant propagators of systemic damage with implications for widespread pathologies such as vascular disease, accelerated aging, degenerative disease, inflammation, and traumatic injury.
spectrum disorders	disease_to_anatomy	of the	1	3.74	28734011	PMID:28734011; Original text:The pooled point estimates of the latter cohorts showed a significant association with spectrum disorders which strengthens our previous suggestion of confounding by indication.
autism	disease_to_anatomy	part of	1	1.0	9809262	PMID:9809262; Original text:In the experimental group, there were greater gains in language abilities, significant increases in caregivers' knowledge about autism, greater perception of control on the part of mothers, and greater parent satisfaction.
autism	disease_to_anatomy	group	5	12.2	9809262|15358868|29562612|16948927|9442997	PMID:9809262; Original text:In the experimental group, there were greater gains in language abilities, significant increases in caregivers' knowledge about autism, greater perception of control on the part of mothers, and greater parent satisfaction.|PMID:15358868; Original text:Experiment 3 showed that increases in target-distractor similarity slowed the visual search performance of the control group significantly more than that of the autism group, suggesting that the adults with autism have a superior visual discrimination ability.|PMID:29562612; Original text:Based on semi-blinded assessment, the treatment group, compared to the non-treatment group, had significantly greater improvement in autism symptoms and developmental age.|PMID:16948927; Original text:In the risperidone group, 12 of 19 children showed improvement in the total Childhood Autism Rating Scale score and 17 of 19 children in the Children's Global Assessment Scale score compared with 0 of 20 children for the Childhood Autism Rating Scale score and 2 of 20 children for the Children's Global Assessment Scale score in the placebo group (P < .001 and P = .035, respectively).|PMID:9442997; Original text:A significant effect of informant was found for the PDD group, and this effect was particularly pronounced when children with autism were considered separately.
autism	disease_to_anatomy	, greater	1	1.0	9809262	PMID:9809262; Original text:In the experimental group, there were greater gains in language abilities, significant increases in caregivers' knowledge about autism, greater perception of control on the part of mothers, and greater parent satisfaction.
autism spectrum disorders	disease_to_anatomy	region of	1	2.248	24988218	PMID:24988218; Original text:The results reveal that children with autism spectrum disorders have significantly reduced gaze fixation to the eye region of faces.
autism spectrum disorders	disease_to_anatomy	the eye	1	2.248	24988218	PMID:24988218; Original text:The results reveal that children with autism spectrum disorders have significantly reduced gaze fixation to the eye region of faces.
autism spectrum disorders	disease_to_anatomy	of the	8	26.303	24988218|22784311|28065825|15863467|23123089|16649827|22801412|32840005	PMID:24988218; Original text:The results of the meta-analyses indicate that autism spectrum disorders patients have significant impairments in gaze fixation to the eyes.|PMID:22784311; Original text:Since the 2006 review, significant developments occurred in the use of atypical antipsychotics, including FDA approval of the atypical antipsychotics asenapine, iloperidone, and paliperidone and FDA approval of previous off-label uses: (a) quetiapine and quetiapine XR as monotherapy in bipolar depression; (b) quetiapine XR as augmentation therapy for MDD; (c) aripiprazole as augmentation therapy for MDD; (d) olanzapine/fluoxetine combination for MDD; (e) olanzapine/fluoxetine combination for bipolar depression; and (f) risperidone and aripiprazole for autism spectrum disorders.|PMID:28065825; Original text:There is general consensus that electroencephalogram coherence patterns differ between individuals with and without autism spectrum disorders; however, the exact nature of the differences and their clinical significance remain unclear.|PMID:15863467; Original text:Diagnostic criteria, age of the sample, and urban or rural location were associated with estimated prevalence of all all autism spectrum disorders.|PMID:23123089; Original text:Use of the a frequency modulation system resulted in significant average improvements in speech recognition in noise for the children with autism spectrum disorders and attention-deficit hyperactivity disorder as well as large effect sizes.|PMID:16649827; Original text:Awareness of the impact and prevalence of autism spectrum disorders has significantly increased in recent years.|PMID:22801412; Original text:Second, neuroimaging studies have advanced our understanding of the 'wider' neural systems underlying Autism Spectrum Disorders; and significantly contributed to our knowledge of the complex neurobiology associated with the condition.|PMID:32840005; Original text:Most of the meta-analyses reported that compared to non-users, the risks of preterm birth, low birth weight, spontaneous abortion, persistent pulmonary hypertension, autism spectrum disorders, and attention deficit hyperactivity disorder in offspring of antidepressant users were significantly higher.
impairments in gaze fixation to the eyes	disease_to_anatomy	of the	1	2.248	24988218	PMID:24988218; Original text:The results of the meta-analyses indicate that autism spectrum disorders patients have significant impairments in gaze fixation to the eyes.
autistic	disease_to_anatomy	platelet	3	3.694	15292671|24613076|12858328	PMID:15292671; Original text:Significantly lower platelet-poor plasma serotonin levels were observed in the autistic group as compared to the controls (p = 0.03).|PMID:24613076; Original text:Altogether, elevated 5-HT blood levels were recorded in 28.3% in whole blood and 22.5% in platelet-rich plasma samples of autistic individuals, as reported in 15 and 4 studies, respectively.|PMID:12858328; Original text:A significant elevation in platelet-poor plasma 5-HT levels in adult autistic patients was reached 60 min after meal administration (p < 0.03 vs control and p = 0.05 vs baseline) and a significant decrease was noted after 120 min (p < 0.01 vs baseline).
autism	disease_to_anatomy	platelet	1	1.694	15292671	PMID:15292671; Original text:In addition, platelet-poor plasma serotonin levels were inversely correlated with the Overt Aggression Scale scores among subjects with autism (r = -0.64, p < 0.05).
schizophrenia	disease_to_anatomy	, and	6	16.339	28929285|29688876|33434711|21863344|24123946|19736351	PMID:28929285; Original text:Although individually rare, genomic disorders collectively account for a significant minority of intellectual disability, autism spectrum disorder, and schizophrenia.|PMID:29688876; Original text:Specifically, cortical thickness showed significant enrichment between patients with if autism-spectrum disorders and those with attention-deficit/hyperactivity disorder in the default mode network, between patients with if autism-spectrum disorders and those with schizophrenia in the frontoparietal and limbic networks, and between patients with attention-deficit/hyperactivity disorder and those with schizophrenia in the ventral attention network.|PMID:33434711; Original text:Advances in laboratory testing have significantly increased the detection of rare genetic etiologies of neurodevelopmental psychiatric disorders (neurodevelopmental psychiatric disorders), particularly developmental delay/ intellectual disability, autism spectrum disorder, and schizophrenia.|PMID:21863344; Original text:Empathy, for instance, is a rather elaborated human ability, and several recent studies point to significant impairments in patients suffering from psychiatric disorders, such as schizophrenia or autism.|PMID:24123946; Original text:The del15q11.2 was found to be significantly associated with intellectual disability, schizophrenia, epilepsy, and disorder.|PMID:19736351; Original text:The collective frequency of rare copy number variations at these loci is significantly increased in cases with autism, in cases with schizophrenia, and in cases with mental retardation compared with controls (P < .001, P = .01, and P = .001, respectively, Fisher exact test).
genomic disorders	disease_to_anatomy	, and	1	4.539	28929285	PMID:28929285; Original text:Although individually rare, genomic disorders collectively account for a significant minority of intellectual disability, autism spectrum disorder, and schizophrenia.
mdd	disease_to_anatomy	of the	1	1.0	22784311	PMID:22784311; Original text:Since the 2006 review, significant developments occurred in the use of atypical antipsychotics, including FDA approval of the atypical antipsychotics asenapine, iloperidone, and paliperidone and FDA approval of previous off-label uses: (a) quetiapine and quetiapine XR as monotherapy in bipolar depression; (b) quetiapine XR as augmentation therapy for MDD; (c) aripiprazole as augmentation therapy for MDD; (d) olanzapine/fluoxetine combination for MDD; (e) olanzapine/fluoxetine combination for bipolar depression; and (f) risperidone and aripiprazole for autism spectrum disorders.
mdd	disease_to_anatomy	, and	1	1.0	22784311	PMID:22784311; Original text:Since the 2006 review, significant developments occurred in the use of atypical antipsychotics, including FDA approval of the atypical antipsychotics asenapine, iloperidone, and paliperidone and FDA approval of previous off-label uses: (a) quetiapine and quetiapine XR as monotherapy in bipolar depression; (b) quetiapine XR as augmentation therapy for MDD; (c) aripiprazole as augmentation therapy for MDD; (d) olanzapine/fluoxetine combination for MDD; (e) olanzapine/fluoxetine combination for bipolar depression; and (f) risperidone and aripiprazole for autism spectrum disorders.
autism spectrum disorders	disease_to_anatomy	, and	13	42.550999999999995	22784311|15863467|31665947|23123089|23452684|23452684|26210844|28342168|23965288|22801412|19365716|32840005|22118062	PMID:22784311; Original text:Since the 2006 review, significant developments occurred in the use of atypical antipsychotics, including FDA approval of the atypical antipsychotics asenapine, iloperidone, and paliperidone and FDA approval of previous off-label uses: (a) quetiapine and quetiapine XR as monotherapy in bipolar depression; (b) quetiapine XR as augmentation therapy for MDD; (c) aripiprazole as augmentation therapy for MDD; (d) olanzapine/fluoxetine combination for MDD; (e) olanzapine/fluoxetine combination for bipolar depression; and (f) risperidone and aripiprazole for autism spectrum disorders.|PMID:15863467; Original text:Diagnostic criteria, age of the sample, and urban or rural location were associated with estimated prevalence of all all autism spectrum disorders.|PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.|PMID:23123089; Original text:Given the significantly better speech recognition in noise, increased on-task behaviors, and improved teacher ratings of listening behaviors with the a frequency modulation system, these devices may be a viable option for children who have autism spectrum disorders and attention-deficit hyperactivity disorder in the classroom.|PMID:23452684; Original text:activation likelihood estimation meta-analyses of social tasks showed that children and adolescents with autism spectrum disorders versus adults had significantly greater hyperactivation in the left post-central gyrus, and greater hypoactivation in the right hippocampus and right superior temporal gyrus.|PMID:23452684; Original text:activation likelihood estimation meta-analyses of nonsocial tasks showed that children with autism spectrum disorders versus adults had significantly greater hyperactivation in the right insula and left cingulate gyrus, and hypoactivation in the right middle frontal gyrus.|PMID:26210844; Original text:Mean scores were significantly different in subjects with autism spectrum disorders, those with developmental delay/non-autism spectrum disorders, and those with no developmental concerns (20.8 vs 13 vs 10.6, respectively; P < .0001).|PMID:28342168; Original text:After adjusting for potential covariates, having autism spectrum disorders was associated with significantly lower trabecular bone mineral density and bone strength at the radius, and with marginally lower total body less head bone mineral content (p < 0.09).|PMID:23965288; Original text:Pretreatment Developmental Disability-Child Global Assessment Scale scores correlated with severity of autism spectrum disorders core symptoms (r = -.388, p = .034), pragmatic communication (r = .407, p = .032), and verbal ability (r = .449, p = .013) and did not correlate with severity of anxiety symptoms or with parent-reported adaptive behavior.|PMID:22801412; Original text:Most important, several risk gene variants have now been identified that significantly contribute to Autism Spectrum Disorders susceptibility, many linked to synaptic functioning, excitation-inhibition balance, and brain connectivity.|PMID:19365716; Original text:The findings indicated that each Autism Spectrum Disorders intervention group demonstrated significant gains on the WMS and significant improvement in the areas of anxiety management, joint attention, and flexibility/transitions.|PMID:32840005; Original text:Most of the meta-analyses reported that compared to non-users, the risks of preterm birth, low birth weight, spontaneous abortion, persistent pulmonary hypertension, autism spectrum disorders, and attention deficit hyperactivity disorder in offspring of antidepressant users were significantly higher.|PMID:22118062; Original text:  These data suggest that significant improvements can be made in peer social connections for children with autism spectrum disorders in general education classrooms with a brief intervention, and that these gains persist over time.
bipolar depression	disease_to_anatomy	of the	1	1.0	22784311	PMID:22784311; Original text:Since the 2006 review, significant developments occurred in the use of atypical antipsychotics, including FDA approval of the atypical antipsychotics asenapine, iloperidone, and paliperidone and FDA approval of previous off-label uses: (a) quetiapine and quetiapine XR as monotherapy in bipolar depression; (b) quetiapine XR as augmentation therapy for MDD; (c) aripiprazole as augmentation therapy for MDD; (d) olanzapine/fluoxetine combination for MDD; (e) olanzapine/fluoxetine combination for bipolar depression; and (f) risperidone and aripiprazole for autism spectrum disorders.
bipolar depression	disease_to_anatomy	, and	1	1.0	22784311	PMID:22784311; Original text:Since the 2006 review, significant developments occurred in the use of atypical antipsychotics, including FDA approval of the atypical antipsychotics asenapine, iloperidone, and paliperidone and FDA approval of previous off-label uses: (a) quetiapine and quetiapine XR as monotherapy in bipolar depression; (b) quetiapine XR as augmentation therapy for MDD; (c) aripiprazole as augmentation therapy for MDD; (d) olanzapine/fluoxetine combination for MDD; (e) olanzapine/fluoxetine combination for bipolar depression; and (f) risperidone and aripiprazole for autism spectrum disorders.
anxiety disorder	disease_to_anatomy	, and	1	1.0	22784311	PMID:22784311; Original text:The significant findings in the updated review include (a) small but statistically significant benefits for olanzapine, aripiprazole, and risperidone for elderly patients with dementia; (b) quetiapine appears superior to placebo for general anxiety disorder (general anxiety disorder); (c) risperidone was associated with benefits in the treatment of obsessive-compulsive disorder; and (d) adverse events are common.
olanzapine	disease_to_anatomy	, and	1	1.0	22784311	PMID:22784311; Original text:The significant findings in the updated review include (a) small but statistically significant benefits for olanzapine, aripiprazole, and risperidone for elderly patients with dementia; (b) quetiapine appears superior to placebo for general anxiety disorder (general anxiety disorder); (c) risperidone was associated with benefits in the treatment of obsessive-compulsive disorder; and (d) adverse events are common.
dementia	disease_to_anatomy	, and	1	1.0	22784311	PMID:22784311; Original text:The significant findings in the updated review include (a) small but statistically significant benefits for olanzapine, aripiprazole, and risperidone for elderly patients with dementia; (b) quetiapine appears superior to placebo for general anxiety disorder (general anxiety disorder); (c) risperidone was associated with benefits in the treatment of obsessive-compulsive disorder; and (d) adverse events are common.
obsessive-compulsive disorder	disease_to_anatomy	, and	1	1.0	22784311	PMID:22784311; Original text:The significant findings in the updated review include (a) small but statistically significant benefits for olanzapine, aripiprazole, and risperidone for elderly patients with dementia; (b) quetiapine appears superior to placebo for general anxiety disorder (general anxiety disorder); (c) risperidone was associated with benefits in the treatment of obsessive-compulsive disorder; and (d) adverse events are common.
sah	disease_to_anatomy	levels of	1	5.362	32173856	PMID:32173856; Original text:Our overall analyses revealed that individuals with disorder had significantly decreased levels of methionine (22 studies; Hedges' g = -0.62; 95% confidence interval [CI]: -0.89, -0.35), SAM (8 studies; Hedges' g = -0.60; 95% CI: -0.86, -0.34), and the SAM/SAH ratio (8 studies; Hedges' g = -0.98; 95% CI: -1.30, -0.66) and significantly increased levels of SAH (8 studies; Hedges' g = 0.69; 95% CI: 0.43, 0.94).
sah	disease_to_anatomy	, and	1	5.362	32173856	PMID:32173856; Original text:Our overall analyses revealed that individuals with disorder had significantly decreased levels of methionine (22 studies; Hedges' g = -0.62; 95% confidence interval [CI]: -0.89, -0.35), SAM (8 studies; Hedges' g = -0.60; 95% CI: -0.86, -0.34), and the SAM/SAH ratio (8 studies; Hedges' g = -0.98; 95% CI: -1.30, -0.66) and significantly increased levels of SAH (8 studies; Hedges' g = 0.69; 95% CI: 0.43, 0.94).
sam	disease_to_anatomy	levels of	1	5.362	32173856	PMID:32173856; Original text:Our overall analyses revealed that individuals with disorder had significantly decreased levels of methionine (22 studies; Hedges' g = -0.62; 95% confidence interval [CI]: -0.89, -0.35), SAM (8 studies; Hedges' g = -0.60; 95% CI: -0.86, -0.34), and the SAM/SAH ratio (8 studies; Hedges' g = -0.98; 95% CI: -1.30, -0.66) and significantly increased levels of SAH (8 studies; Hedges' g = 0.69; 95% CI: 0.43, 0.94).
sam	disease_to_anatomy	, and	1	5.362	32173856	PMID:32173856; Original text:Our overall analyses revealed that individuals with disorder had significantly decreased levels of methionine (22 studies; Hedges' g = -0.62; 95% confidence interval [CI]: -0.89, -0.35), SAM (8 studies; Hedges' g = -0.60; 95% CI: -0.86, -0.34), and the SAM/SAH ratio (8 studies; Hedges' g = -0.98; 95% CI: -1.30, -0.66) and significantly increased levels of SAH (8 studies; Hedges' g = 0.69; 95% CI: 0.43, 0.94).
infection	disease_to_anatomy	of the	1	1.0	33720503	PMID:33720503; Original text:This study is a meta-analysis of the association of maternal infection during pregnancy and subsequent autism in offspring.
depression	disease_to_anatomy	, a	1	2.1	27748930	PMID:27748930; Original text:Recent evidence has indicated that microRNAs (miRNAs or miRs), a large group of small non‑coding oligonoucleotides, may play a significant role in the development of cancer and major psychiatric disorders, such as Schizophrenia, bipolar disorder, autism spectrum disorders, suicidality and depression, through their interference with the expression of multiple genes.
depression	disease_to_anatomy	group of	1	2.1	27748930	PMID:27748930; Original text:Recent evidence has indicated that microRNAs (miRNAs or miRs), a large group of small non‑coding oligonoucleotides, may play a significant role in the development of cancer and major psychiatric disorders, such as Schizophrenia, bipolar disorder, autism spectrum disorders, suicidality and depression, through their interference with the expression of multiple genes.
psychiatric disorders	disease_to_anatomy	, a	1	2.1	27748930	PMID:27748930; Original text:Recent evidence has indicated that microRNAs (miRNAs or miRs), a large group of small non‑coding oligonoucleotides, may play a significant role in the development of cancer and major psychiatric disorders, such as Schizophrenia, bipolar disorder, autism spectrum disorders, suicidality and depression, through their interference with the expression of multiple genes.
psychiatric disorders	disease_to_anatomy	group of	1	2.1	27748930	PMID:27748930; Original text:Recent evidence has indicated that microRNAs (miRNAs or miRs), a large group of small non‑coding oligonoucleotides, may play a significant role in the development of cancer and major psychiatric disorders, such as Schizophrenia, bipolar disorder, autism spectrum disorders, suicidality and depression, through their interference with the expression of multiple genes.
suicidality	disease_to_anatomy	, a	1	2.1	27748930	PMID:27748930; Original text:Recent evidence has indicated that microRNAs (miRNAs or miRs), a large group of small non‑coding oligonoucleotides, may play a significant role in the development of cancer and major psychiatric disorders, such as Schizophrenia, bipolar disorder, autism spectrum disorders, suicidality and depression, through their interference with the expression of multiple genes.
suicidality	disease_to_anatomy	group of	1	2.1	27748930	PMID:27748930; Original text:Recent evidence has indicated that microRNAs (miRNAs or miRs), a large group of small non‑coding oligonoucleotides, may play a significant role in the development of cancer and major psychiatric disorders, such as Schizophrenia, bipolar disorder, autism spectrum disorders, suicidality and depression, through their interference with the expression of multiple genes.
cancer	disease_to_anatomy	, a	1	2.1	27748930	PMID:27748930; Original text:Recent evidence has indicated that microRNAs (miRNAs or miRs), a large group of small non‑coding oligonoucleotides, may play a significant role in the development of cancer and major psychiatric disorders, such as Schizophrenia, bipolar disorder, autism spectrum disorders, suicidality and depression, through their interference with the expression of multiple genes.
cancer	disease_to_anatomy	group of	1	2.1	27748930	PMID:27748930; Original text:Recent evidence has indicated that microRNAs (miRNAs or miRs), a large group of small non‑coding oligonoucleotides, may play a significant role in the development of cancer and major psychiatric disorders, such as Schizophrenia, bipolar disorder, autism spectrum disorders, suicidality and depression, through their interference with the expression of multiple genes.
schizophrenia	disease_to_anatomy	, a	1	2.1	27748930	PMID:27748930; Original text:Recent evidence has indicated that microRNAs (miRNAs or miRs), a large group of small non‑coding oligonoucleotides, may play a significant role in the development of cancer and major psychiatric disorders, such as Schizophrenia, bipolar disorder, autism spectrum disorders, suicidality and depression, through their interference with the expression of multiple genes.
schizophrenia	disease_to_anatomy	group of	1	2.1	27748930	PMID:27748930; Original text:Recent evidence has indicated that microRNAs (miRNAs or miRs), a large group of small non‑coding oligonoucleotides, may play a significant role in the development of cancer and major psychiatric disorders, such as Schizophrenia, bipolar disorder, autism spectrum disorders, suicidality and depression, through their interference with the expression of multiple genes.
bipolar disorder	disease_to_anatomy	, a	1	2.1	27748930	PMID:27748930; Original text:Recent evidence has indicated that microRNAs (miRNAs or miRs), a large group of small non‑coding oligonoucleotides, may play a significant role in the development of cancer and major psychiatric disorders, such as Schizophrenia, bipolar disorder, autism spectrum disorders, suicidality and depression, through their interference with the expression of multiple genes.
bipolar disorder	disease_to_anatomy	group of	2	3.29	27748930|26276916	PMID:27748930; Original text:Recent evidence has indicated that microRNAs (miRNAs or miRs), a large group of small non‑coding oligonoucleotides, may play a significant role in the development of cancer and major psychiatric disorders, such as Schizophrenia, bipolar disorder, autism spectrum disorders, suicidality and depression, through their interference with the expression of multiple genes.|PMID:26276916; Original text:Previous studies have clearly indicated that in the group of patients with an early onset of the bipolar disorder the occurrence of suicidal thoughts and intentions were significantly increased.
autism spectrum disorders	disease_to_anatomy	, a	2	5.614	27748930|31665947	PMID:27748930; Original text:Recent evidence has indicated that microRNAs (miRNAs or miRs), a large group of small non‑coding oligonoucleotides, may play a significant role in the development of cancer and major psychiatric disorders, such as Schizophrenia, bipolar disorder, autism spectrum disorders, suicidality and depression, through their interference with the expression of multiple genes.|PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.
autism spectrum disorders	disease_to_anatomy	group of	1	2.1	27748930	PMID:27748930; Original text:Recent evidence has indicated that microRNAs (miRNAs or miRs), a large group of small non‑coding oligonoucleotides, may play a significant role in the development of cancer and major psychiatric disorders, such as Schizophrenia, bipolar disorder, autism spectrum disorders, suicidality and depression, through their interference with the expression of multiple genes.
autistic	disease_to_anatomy	levels of	5	9.385	15733932|24676906|24167375|15673999|34049201	PMID:15733932; Original text:serotoninP administration significantly increased the levels of serotonin in autistic youngsters but not in normal controls.|PMID:24676906; Original text:The serum level of glutathione in autistic subjects was significantly below control levels, while levels of homocysteine and S-adenosylhomocysteine were elevated, indicative of oxidative stress and decreased methionine synthase activity.|PMID:24167375; Original text:The urinary levels of homocysteine and essential amino acids in both the untreated and treated autistic children are significantly less than those in the controls.|PMID:15673999; Original text:An evaluation of vitamin B(6) levels prior to the study found that the autistic children had substantially elevated levels of B6 compared to a control group of typical children (75% higher, p < 0.0000001).|PMID:34049201; Original text:There were significant differences in the levels of copper (copper) in the hair and serum between autistic children and the control group.
neurologically	disease_to_anatomy	hematopoietic stem	1	2.747	28985203	PMID:28985203; Original text:hematopoietic stem cell transplantation is currently an established therapy for certain neurologically devastating inherited metabolic diseases, in which engrafting donor cells provide lifelong enzyme replacement that prevents neurological deterioration and significantly extends the lives of affected children.
neurologically	disease_to_anatomy	stem cell	1	2.747	28985203	PMID:28985203; Original text:hematopoietic stem cell transplantation is currently an established therapy for certain neurologically devastating inherited metabolic diseases, in which engrafting donor cells provide lifelong enzyme replacement that prevents neurological deterioration and significantly extends the lives of affected children.
neurologically	disease_to_anatomy	hematopoietic stem cell	1	2.747	28985203	PMID:28985203; Original text:hematopoietic stem cell transplantation is currently an established therapy for certain neurologically devastating inherited metabolic diseases, in which engrafting donor cells provide lifelong enzyme replacement that prevents neurological deterioration and significantly extends the lives of affected children.
neurologically	disease_to_anatomy	transplantation	1	2.747	28985203	PMID:28985203; Original text:hematopoietic stem cell transplantation is currently an established therapy for certain neurologically devastating inherited metabolic diseases, in which engrafting donor cells provide lifelong enzyme replacement that prevents neurological deterioration and significantly extends the lives of affected children.
inherited	disease_to_anatomy	hematopoietic stem	1	2.747	28985203	PMID:28985203; Original text:hematopoietic stem cell transplantation is currently an established therapy for certain neurologically devastating inherited metabolic diseases, in which engrafting donor cells provide lifelong enzyme replacement that prevents neurological deterioration and significantly extends the lives of affected children.
inherited	disease_to_anatomy	stem cell	1	2.747	28985203	PMID:28985203; Original text:hematopoietic stem cell transplantation is currently an established therapy for certain neurologically devastating inherited metabolic diseases, in which engrafting donor cells provide lifelong enzyme replacement that prevents neurological deterioration and significantly extends the lives of affected children.
inherited	disease_to_anatomy	hematopoietic stem cell	1	2.747	28985203	PMID:28985203; Original text:hematopoietic stem cell transplantation is currently an established therapy for certain neurologically devastating inherited metabolic diseases, in which engrafting donor cells provide lifelong enzyme replacement that prevents neurological deterioration and significantly extends the lives of affected children.
inherited	disease_to_anatomy	transplantation	1	2.747	28985203	PMID:28985203; Original text:hematopoietic stem cell transplantation is currently an established therapy for certain neurologically devastating inherited metabolic diseases, in which engrafting donor cells provide lifelong enzyme replacement that prevents neurological deterioration and significantly extends the lives of affected children.
neurological deterioration	disease_to_anatomy	hematopoietic stem	1	2.747	28985203	PMID:28985203; Original text:hematopoietic stem cell transplantation is currently an established therapy for certain neurologically devastating inherited metabolic diseases, in which engrafting donor cells provide lifelong enzyme replacement that prevents neurological deterioration and significantly extends the lives of affected children.
neurological deterioration	disease_to_anatomy	stem cell	1	2.747	28985203	PMID:28985203; Original text:hematopoietic stem cell transplantation is currently an established therapy for certain neurologically devastating inherited metabolic diseases, in which engrafting donor cells provide lifelong enzyme replacement that prevents neurological deterioration and significantly extends the lives of affected children.
neurological deterioration	disease_to_anatomy	hematopoietic stem cell	1	2.747	28985203	PMID:28985203; Original text:hematopoietic stem cell transplantation is currently an established therapy for certain neurologically devastating inherited metabolic diseases, in which engrafting donor cells provide lifelong enzyme replacement that prevents neurological deterioration and significantly extends the lives of affected children.
neurological deterioration	disease_to_anatomy	transplantation	1	2.747	28985203	PMID:28985203; Original text:hematopoietic stem cell transplantation is currently an established therapy for certain neurologically devastating inherited metabolic diseases, in which engrafting donor cells provide lifelong enzyme replacement that prevents neurological deterioration and significantly extends the lives of affected children.
metabolic diseases	disease_to_anatomy	hematopoietic stem	1	2.747	28985203	PMID:28985203; Original text:hematopoietic stem cell transplantation is currently an established therapy for certain neurologically devastating inherited metabolic diseases, in which engrafting donor cells provide lifelong enzyme replacement that prevents neurological deterioration and significantly extends the lives of affected children.
metabolic diseases	disease_to_anatomy	stem cell	1	2.747	28985203	PMID:28985203; Original text:hematopoietic stem cell transplantation is currently an established therapy for certain neurologically devastating inherited metabolic diseases, in which engrafting donor cells provide lifelong enzyme replacement that prevents neurological deterioration and significantly extends the lives of affected children.
metabolic diseases	disease_to_anatomy	hematopoietic stem cell	1	2.747	28985203	PMID:28985203; Original text:hematopoietic stem cell transplantation is currently an established therapy for certain neurologically devastating inherited metabolic diseases, in which engrafting donor cells provide lifelong enzyme replacement that prevents neurological deterioration and significantly extends the lives of affected children.
metabolic diseases	disease_to_anatomy	transplantation	1	2.747	28985203	PMID:28985203; Original text:hematopoietic stem cell transplantation is currently an established therapy for certain neurologically devastating inherited metabolic diseases, in which engrafting donor cells provide lifelong enzyme replacement that prevents neurological deterioration and significantly extends the lives of affected children.
autism	disease_to_anatomy	scales	1	1.0	26577969	PMID:26577969; Original text:Significant differences were detected on Autism Spectrum Disorder (Autism Spectrum Disorder) by Childhood Autism Rating Scale, Social Responsiveness Scale and Autism Treatment Evaluation Checklist scales, following 2 weeks of camel milk consumption, but not in the placebo group.
autism	disease_to_anatomy	scale	3	15.579	26577969|26258842|27752075	PMID:26577969; Original text:Significant differences were detected on Autism Spectrum Disorder (Autism Spectrum Disorder) by Childhood Autism Rating Scale, Social Responsiveness Scale and Autism Treatment Evaluation Checklist scales, following 2 weeks of camel milk consumption, but not in the placebo group.|PMID:26258842; Original text:Prior to intervention(s) no statistically significant differences in scores on the the Autism Behavior Checklist, the Childhood Autism Rating Scale, disease, or global improvement were found between the two groups.|PMID:27752075; Original text:Improvements in subscales of the Vineland Adaptive Behavior Scale, the Aberrant Behavior Checklist, the Autism Symptom Questionnaire and the Behavioral Assessment System for Children were significantly greater in the folinic acid group as compared with the placebo group.
autism spectrum disorder	disease_to_anatomy	scales	1	1.0	26577969	PMID:26577969; Original text:Significant differences were detected on Autism Spectrum Disorder (Autism Spectrum Disorder) by Childhood Autism Rating Scale, Social Responsiveness Scale and Autism Treatment Evaluation Checklist scales, following 2 weeks of camel milk consumption, but not in the placebo group.
autism spectrum disorder	disease_to_anatomy	scale	1	1.0	26577969	PMID:26577969; Original text:Significant differences were detected on Autism Spectrum Disorder (Autism Spectrum Disorder) by Childhood Autism Rating Scale, Social Responsiveness Scale and Autism Treatment Evaluation Checklist scales, following 2 weeks of camel milk consumption, but not in the placebo group.
irritability	disease_to_anatomy	group	3	6.26	23212807|32347624|19284641	PMID:23212807; Original text:Mean baseline (range 27-29) to endpoint change in Aberrant Behavior Checklist-Irritability (primary endpoint) was significantly greater in the high-dose-(-12.4 [6.5]; p < 0.001), but not low-dose (-7.4 [8.1]; p = 0.164) group, versus placebo (-3.5 [10.7]).|PMID:32347624; Original text:Compared to the placebo group, disorder patients in the sulforaphane group showed greater improvements in Irritability score (primary outcome measure; P = 0.001) and Hyperactivity/Noncompliance score (secondary outcome measure; P = 0.015), and significant Time × Treatment effect for Irritability (P = 0.007) and Hyperactivity/Noncompliance (P = 0.008).|PMID:19284641; Original text:In the tre1.3 atmosphereent group compared to the control group, mean changes on the Aberrant Behavior Checklist total score and subscales were similar except a greater number of children improved in irritability (p = 0.0311).
autistic traits	disease_to_anatomy	, 3	1	1.0	34325098	PMID:34325098; Original text:Results included 27 studies that found a positive correlation (15 of significance, 12 of unknown significance) between a behavioral addiction and either disorder or Autistic traits, 1 found a significant negative correlation, 3 did not find a correlation.
autistic traits	disease_to_anatomy	, 1	1	1.0	34325098	PMID:34325098; Original text:Results included 27 studies that found a positive correlation (15 of significance, 12 of unknown significance) between a behavioral addiction and either disorder or Autistic traits, 1 found a significant negative correlation, 3 did not find a correlation.
behavioral addiction	disease_to_anatomy	, 3	1	1.0	34325098	PMID:34325098; Original text:Results included 27 studies that found a positive correlation (15 of significance, 12 of unknown significance) between a behavioral addiction and either disorder or Autistic traits, 1 found a significant negative correlation, 3 did not find a correlation.
behavioral addiction	disease_to_anatomy	, 1	1	1.0	34325098	PMID:34325098; Original text:Results included 27 studies that found a positive correlation (15 of significance, 12 of unknown significance) between a behavioral addiction and either disorder or Autistic traits, 1 found a significant negative correlation, 3 did not find a correlation.
developmental disorders	disease_to_anatomy	groups	1	1.0	31501953	PMID:31501953; Original text:Compared with developmental disorders (developmental disorders) groups, effect size was significantly positive for sensory over-responsivity and Seeking; whereas compared with other clinical groups, only sensory over-responsivity was significant.
irritability	disease_to_anatomy	, somatic	1	1.713	15529462	PMID:15529462; Original text:Clinicians need to inquire about not only classic symptoms of depression such as anhedonia but also less obvious symptoms such as unprovoked irritability, unsubstantiated complaints of lack of love from family members, somatic complaints, and problems with concentration and poor school performance.
depression	disease_to_anatomy	, somatic	1	1.713	15529462	PMID:15529462; Original text:Clinicians need to inquire about not only classic symptoms of depression such as anhedonia but also less obvious symptoms such as unprovoked irritability, unsubstantiated complaints of lack of love from family members, somatic complaints, and problems with concentration and poor school performance.
anhedonia	disease_to_anatomy	, and	1	1.713	15529462	PMID:15529462; Original text:Clinicians need to inquire about not only classic symptoms of depression such as anhedonia but also less obvious symptoms such as unprovoked irritability, unsubstantiated complaints of lack of love from family members, somatic complaints, and problems with concentration and poor school performance.
anhedonia	disease_to_anatomy	, somatic	1	1.713	15529462	PMID:15529462; Original text:Clinicians need to inquire about not only classic symptoms of depression such as anhedonia but also less obvious symptoms such as unprovoked irritability, unsubstantiated complaints of lack of love from family members, somatic complaints, and problems with concentration and poor school performance.
somatic complaints	disease_to_anatomy	, and	1	1.713	15529462	PMID:15529462; Original text:Clinicians need to inquire about not only classic symptoms of depression such as anhedonia but also less obvious symptoms such as unprovoked irritability, unsubstantiated complaints of lack of love from family members, somatic complaints, and problems with concentration and poor school performance.
somatic complaints	disease_to_anatomy	, somatic	1	1.713	15529462	PMID:15529462; Original text:Clinicians need to inquire about not only classic symptoms of depression such as anhedonia but also less obvious symptoms such as unprovoked irritability, unsubstantiated complaints of lack of love from family members, somatic complaints, and problems with concentration and poor school performance.
asperger's disorder	disease_to_anatomy	of the	1	1.0	14959806	PMID:14959806; Original text:More consistent approaches to diagnosis and more rigorous assessment methods have significantly advanced research, although the boundaries of the 'broader phenotype' remain to be defined and the validity of Asperger's disorder as a discrete syndrome remains controversial.
autism	disease_to_anatomy	group (	3	3.713	25346345|16948927|8986845	PMID:25346345; Original text:Fifty-three children with autism and significant language delay between 2 and 6 years old were randomized to Pivotal Response TreatmentG (N = 27) or psychoeducation group (PEG;|PMID:16948927; Original text:In the risperidone group, 12 of 19 children showed improvement in the total Childhood Autism Rating Scale score and 17 of 19 children in the Children's Global Assessment Scale score compared with 0 of 20 children for the Childhood Autism Rating Scale score and 2 of 20 children for the Children's Global Assessment Scale score in the placebo group (P < .001 and P = .035, respectively).|PMID:8986845; Original text:13 (76%) of the Asperger syndrome patients were rated as pedantic compared to 4 (31%) of the high-functioning autism group (chi 2 = 6.3; p = .01).
language delay	disease_to_anatomy	group (	1	1.0	25346345	PMID:25346345; Original text:Fifty-three children with autism and significant language delay between 2 and 6 years old were randomized to Pivotal Response TreatmentG (N = 27) or psychoeducation group (PEG;
autistic	disease_to_anatomy	portion of	1	8.77	7854533	PMID:7854533; Original text:By contrast, measures of vermian lobules VI and VII and the posterior portion of the corpus callosum in these same autistic and normal volunteers differed significantly, by more than 9.9%.
autistic	disease_to_anatomy	portion of the	1	8.77	7854533	PMID:7854533; Original text:By contrast, measures of vermian lobules VI and VII and the posterior portion of the corpus callosum in these same autistic and normal volunteers differed significantly, by more than 9.9%.
autistic	disease_to_anatomy	corpus callosum	1	8.77	7854533	PMID:7854533; Original text:By contrast, measures of vermian lobules VI and VII and the posterior portion of the corpus callosum in these same autistic and normal volunteers differed significantly, by more than 9.9%.
bipolar disorder	disease_to_anatomy	of the	1	1.19	26276916	PMID:26276916; Original text:Previous studies have clearly indicated that in the group of patients with an early onset of the bipolar disorder the occurrence of suicidal thoughts and intentions were significantly increased.
suicidal thoughts	disease_to_anatomy	of the	1	1.19	26276916	PMID:26276916; Original text:Previous studies have clearly indicated that in the group of patients with an early onset of the bipolar disorder the occurrence of suicidal thoughts and intentions were significantly increased.
suicidal thoughts	disease_to_anatomy	group of	1	1.19	26276916	PMID:26276916; Original text:Previous studies have clearly indicated that in the group of patients with an early onset of the bipolar disorder the occurrence of suicidal thoughts and intentions were significantly increased.
hyperactivity	disease_to_anatomy	group (	1	6.936	24839884	PMID:24839884; Original text:Children in the omega-3 fatty acid group had a greater reduction in hyperactivity (-5.3 points) compared to the placebo group (-2.6 points), but the difference was not statistically significant (1.9-point greater improvement in the omega-3 group, 95% CI = -2.2 to 5.2).
hyperactivity	disease_to_anatomy	group	2	10.286999999999999	24839884|32347624	PMID:24839884; Original text:Children in the omega-3 fatty acid group had a greater reduction in hyperactivity (-5.3 points) compared to the placebo group (-2.6 points), but the difference was not statistically significant (1.9-point greater improvement in the omega-3 group, 95% CI = -2.2 to 5.2).|PMID:32347624; Original text:Compared to the placebo group, disorder patients in the sulforaphane group showed greater improvements in Irritability score (primary outcome measure; P = 0.001) and Hyperactivity/Noncompliance score (secondary outcome measure; P = 0.015), and significant Time × Treatment effect for Irritability (P = 0.007) and Hyperactivity/Noncompliance (P = 0.008).
depressive disorder	disease_to_anatomy	, and	1	12.384	33456050	PMID:33456050; Original text:The standardized mean differences were significantly correlated between SCZ and bipolar disorder, obsessive compulsive disorder, major depressive disorder, and ASD.
depressive disorder	disease_to_anatomy	, major	1	12.384	33456050	PMID:33456050; Original text:The standardized mean differences were significantly correlated between SCZ and bipolar disorder, obsessive compulsive disorder, major depressive disorder, and ASD.
asd	disease_to_anatomy	, major	1	12.384	33456050	PMID:33456050; Original text:The standardized mean differences were significantly correlated between SCZ and bipolar disorder, obsessive compulsive disorder, major depressive disorder, and ASD.
bipolar disorder	disease_to_anatomy	, and	1	12.384	33456050	PMID:33456050; Original text:The standardized mean differences were significantly correlated between SCZ and bipolar disorder, obsessive compulsive disorder, major depressive disorder, and ASD.
bipolar disorder	disease_to_anatomy	, major	1	12.384	33456050	PMID:33456050; Original text:The standardized mean differences were significantly correlated between SCZ and bipolar disorder, obsessive compulsive disorder, major depressive disorder, and ASD.
obsessive compulsive disorder	disease_to_anatomy	, and	1	12.384	33456050	PMID:33456050; Original text:The standardized mean differences were significantly correlated between SCZ and bipolar disorder, obsessive compulsive disorder, major depressive disorder, and ASD.
obsessive compulsive disorder	disease_to_anatomy	, major	1	12.384	33456050	PMID:33456050; Original text:The standardized mean differences were significantly correlated between SCZ and bipolar disorder, obsessive compulsive disorder, major depressive disorder, and ASD.
depressive	disease_to_anatomy	test	1	1.295	23503544	PMID:23503544; Original text:Significant, but modest, decreases in the severity of depressive symptoms (CDRS before vs after scores: 65.5 ± 10.8 vs 58.3 ± 8.2; paired t test, 3.1; df, 10; P =0.01) and attention-deficit/hyperactivity disorder symptoms (Attention Deficit/Hyperactivity Disorder Rating Scale before vs after: 36.4 ± 5 vs 32.8 ± 5; paired-t test, 2.94; df, 10; P = 0.015) were obtained after reboxetine treatment.
attention	disease_to_anatomy	test	1	1.295	23503544	PMID:23503544; Original text:Significant, but modest, decreases in the severity of depressive symptoms (CDRS before vs after scores: 65.5 ± 10.8 vs 58.3 ± 8.2; paired t test, 3.1; df, 10; P =0.01) and attention-deficit/hyperactivity disorder symptoms (Attention Deficit/Hyperactivity Disorder Rating Scale before vs after: 36.4 ± 5 vs 32.8 ± 5; paired-t test, 2.94; df, 10; P = 0.015) were obtained after reboxetine treatment.
depression	disease_to_anatomy	of the	2	2.295	23503544|24408892	PMID:23503544; Original text:A significant positive correlation was found between the changes in the total scores of the depression and the attention-deficit/hyperactivity disorder severity (Spearman correlation r = 0.65|PMID:24408892; Original text:Results for treatment outcome suggest that the a treatment group showed significant improvement in communication and social interaction domain scores on the Autism Diagnostic Observation Schedule, interpersonal relationship and play/leisure time on the subdomain scores of the Korean version of the Vineland Adaptive Behavior Scale (p's < 0.01), social skills knowledge total scores on the Test of Adolescent Social Skills Knowledge-Revised (p < 0.01), and decreased depressive symptoms on the Child Depression Inventory following treatment (p < 0.05).
neurological abnormalities	disease_to_anatomy	of the	1	4.84	21842186	PMID:21842186; Original text:Population heterogeneity and practical limitations inherent to the study of children currently limit a comprehensive understanding of the significance of specific neurological abnormalities in relation to observed deficits.
autism	disease_to_anatomy	cerebellum	1	1.0	22370873	PMID:22370873; Original text:There has been significant advancement in various aspects of scientific knowledge concerning the role of cerebellum in the etiopathogenesis of autism.
autism	disease_to_anatomy	of cerebellum	1	1.0	22370873	PMID:22370873; Original text:There has been significant advancement in various aspects of scientific knowledge concerning the role of cerebellum in the etiopathogenesis of autism.
n	disease_to_anatomy	, negative	1	1.0	16401163	PMID:16401163; Original text:We found a statistically significant improvement from baseline for last-observation-carried-forward (last-observation-carried-forward) analyses as well as for analyses of 12-week completers (N = 9) in our primary outcome measure, Negative Symptoms scores (F = 13.41, p < .0001 for 12-week completers; F = 9.64, p < .0001 for last-observation-carried-forward).
negative	disease_to_anatomy	, negative	1	1.0	16401163	PMID:16401163; Original text:We found a statistically significant improvement from baseline for last-observation-carried-forward (last-observation-carried-forward) analyses as well as for analyses of 12-week completers (N = 9) in our primary outcome measure, Negative Symptoms scores (F = 13.41, p < .0001 for 12-week completers; F = 9.64, p < .0001 for last-observation-carried-forward).
autism spectrum disorder	disease_to_anatomy	salivary	1	1.0	31931609	PMID:31931609; Original text:After a systematic search in the literature, we found that the salivary pH of individuals diagnosed with Autism Spectrum Disorder was significantly lower, but the results were not clinically significant that can increase their risks to tooth decay.
tooth decay	disease_to_anatomy	salivary	1	1.0	31931609	PMID:31931609; Original text:After a systematic search in the literature, we found that the salivary pH of individuals diagnosed with Autism Spectrum Disorder was significantly lower, but the results were not clinically significant that can increase their risks to tooth decay.
epilepsy	disease_to_anatomy	of gastrointestinal	1	4.207	20087181	PMID:20087181; Original text:There continues to be disagreement regarding the exact prevalence and etiological significance of gastrointestinal conditions, epilepsy and other abnormal electroencephalographic findings, and sleep problems.
sleep problems	disease_to_anatomy	of gastrointestinal	1	4.207	20087181	PMID:20087181; Original text:There continues to be disagreement regarding the exact prevalence and etiological significance of gastrointestinal conditions, epilepsy and other abnormal electroencephalographic findings, and sleep problems.
sleep problems	disease_to_anatomy	, and	1	4.207	20087181	PMID:20087181; Original text:There continues to be disagreement regarding the exact prevalence and etiological significance of gastrointestinal conditions, epilepsy and other abnormal electroencephalographic findings, and sleep problems.
gastrointestinal conditions	disease_to_anatomy	of gastrointestinal	1	4.207	20087181	PMID:20087181; Original text:There continues to be disagreement regarding the exact prevalence and etiological significance of gastrointestinal conditions, epilepsy and other abnormal electroencephalographic findings, and sleep problems.
gastrointestinal conditions	disease_to_anatomy	, and	1	4.207	20087181	PMID:20087181; Original text:There continues to be disagreement regarding the exact prevalence and etiological significance of gastrointestinal conditions, epilepsy and other abnormal electroencephalographic findings, and sleep problems.
negative affect	disease_to_anatomy	, and	1	1.0	34195911	PMID:34195911; Original text:Observed supportive parent emotion socialization behaviors were significantly associated with more observed adaptive emotion regulation strategies, and decreased observed and adolescent-reported negative affect, whereas non-supportive emotion socialization behaviors were associated with more observed negative affect and less observed adaptive emotion regulation strategies.
deviant behavior	disease_to_anatomy	of the	1	6.936	25617251	PMID:25617251; Original text:Caregivers of children with a history of institutionalization reported that these children had significantly more deviant behavior than never-institutionalized children on all subdomains of the the Social Communication Questionnaire (all p < 0.001).
cerebellar	disease_to_anatomy	hemispheres	1	5.359	2020537	PMID:2020537; Original text:Also, the only autopsy study to conduct statistical analyses of cerebellar cell loss found statistically significant Purkinje cell loss in both the vermis and hemispheres.
cerebellar	disease_to_anatomy	of cerebellar	1	5.359	2020537	PMID:2020537; Original text:Also, the only autopsy study to conduct statistical analyses of cerebellar cell loss found statistically significant Purkinje cell loss in both the vermis and hemispheres.
cerebellar	disease_to_anatomy	purkinje cell	1	5.359	2020537	PMID:2020537; Original text:Also, the only autopsy study to conduct statistical analyses of cerebellar cell loss found statistically significant Purkinje cell loss in both the vermis and hemispheres.
abnormal behavior	disease_to_anatomy	scale	1	9.412	25313065	PMID:25313065; Original text:On Clinical Global Impression Improvement Scale, a significantly greater number of participants receiving sulforaphane had improvement in social interaction, abnormal behavior, and verbal communication (P = 0.015-0.007).
abnormal behavior	disease_to_anatomy	, a	1	9.412	25313065	PMID:25313065; Original text:On Clinical Global Impression Improvement Scale, a significantly greater number of participants receiving sulforaphane had improvement in social interaction, abnormal behavior, and verbal communication (P = 0.015-0.007).
abnormal behavior	disease_to_anatomy	, and	1	9.412	25313065	PMID:25313065; Original text:On Clinical Global Impression Improvement Scale, a significantly greater number of participants receiving sulforaphane had improvement in social interaction, abnormal behavior, and verbal communication (P = 0.015-0.007).
abnormal behavior	disease_to_anatomy	(p	1	9.412	25313065	PMID:25313065; Original text:On Clinical Global Impression Improvement Scale, a significantly greater number of participants receiving sulforaphane had improvement in social interaction, abnormal behavior, and verbal communication (P = 0.015-0.007).
abnormal behavior	disease_to_anatomy	, abnormal	1	9.412	25313065	PMID:25313065; Original text:On Clinical Global Impression Improvement Scale, a significantly greater number of participants receiving sulforaphane had improvement in social interaction, abnormal behavior, and verbal communication (P = 0.015-0.007).
autism	disease_to_anatomy	(clinical	1	2.7	27043118	PMID:27043118; Original text:Treatment with memantine was associated with significant reduction on informant-rated (SRS-A, -28 ± 25; P < 0.001) and clinician-rated (Clinical Global Impression-Improvement subscale ≤2, 83%) measures of autism severity.
irritability	disease_to_anatomy	level of	1	2.118	26208985	PMID:26208985; Original text:Level of reduction and effect of time×treatment interaction in the treatment group were significant for irritability (P=0.03), lethargy/social withdrawal (P=0.04) and hyperactivity/non-compliance (P=0.03) but not for stereotypic behavior and inappropriate speech subscales compared with the placebo group.
stereotypic behavior	disease_to_anatomy	level of	1	2.118	26208985	PMID:26208985; Original text:Level of reduction and effect of time×treatment interaction in the treatment group were significant for irritability (P=0.03), lethargy/social withdrawal (P=0.04) and hyperactivity/non-compliance (P=0.03) but not for stereotypic behavior and inappropriate speech subscales compared with the placebo group.
social withdrawal	disease_to_anatomy	level of	1	2.118	26208985	PMID:26208985; Original text:Level of reduction and effect of time×treatment interaction in the treatment group were significant for irritability (P=0.03), lethargy/social withdrawal (P=0.04) and hyperactivity/non-compliance (P=0.03) but not for stereotypic behavior and inappropriate speech subscales compared with the placebo group.
lethargy	disease_to_anatomy	level of	1	2.118	26208985	PMID:26208985; Original text:Level of reduction and effect of time×treatment interaction in the treatment group were significant for irritability (P=0.03), lethargy/social withdrawal (P=0.04) and hyperactivity/non-compliance (P=0.03) but not for stereotypic behavior and inappropriate speech subscales compared with the placebo group.
inappropriate speech	disease_to_anatomy	level of	1	2.118	26208985	PMID:26208985; Original text:Level of reduction and effect of time×treatment interaction in the treatment group were significant for irritability (P=0.03), lethargy/social withdrawal (P=0.04) and hyperactivity/non-compliance (P=0.03) but not for stereotypic behavior and inappropriate speech subscales compared with the placebo group.
hyperactivity	disease_to_anatomy	level of	1	2.118	26208985	PMID:26208985; Original text:Level of reduction and effect of time×treatment interaction in the treatment group were significant for irritability (P=0.03), lethargy/social withdrawal (P=0.04) and hyperactivity/non-compliance (P=0.03) but not for stereotypic behavior and inappropriate speech subscales compared with the placebo group.
disrupted brain connectivity	disease_to_anatomy	of brain	1	1.0	27282107	PMID:27282107; Original text:Here, I review the extent and significance of brain somatic mutations and provide my perspective regarding these mutations as potential molecular lesions underlying relatively common conditions with disrupted brain connectivity.
molecular lesions	disease_to_anatomy	of brain	1	1.0	27282107	PMID:27282107; Original text:Here, I review the extent and significance of brain somatic mutations and provide my perspective regarding these mutations as potential molecular lesions underlying relatively common conditions with disrupted brain connectivity.
developmental disorder	disease_to_anatomy	, and	1	1.0	15749246	PMID:15749246; Original text:Autism is a complex developmental disorder without an established single etiology but with significant contributions from genetic studies, functional research, and neuropsychiatric and neuroradiologic investigations.
impressions	disease_to_anatomy	, and	1	6.936	19858761	PMID:19858761; Original text:Secondary: groups did not differ on Clinical Global Impressions-Improvement scores at endpoint; compared with MED, combined treatment showed significant reductions on Aberrant Behavior Checklist Irritability (d = 0.48; p = .01), Stereotypic Behavior (d = 0.23; p = .04), and Hyperactivity/Noncompliance subscales (d = 0.55; p = .04).
autistic symptoms	disease_to_anatomy	, and	2	4.743	18416666|8498878	PMID:18416666; Original text:However, recent studies indicate that co-occurrence of clinically significant disorder and autistic symptoms is common, and that some genes may influence both disorders.|PMID:8498878; Original text:Clomipramine was superior to both placebo and desipramine on ratings of autistic symptoms (including stereotypies), anger, and compulsive, ritualized behaviors (P < .05), with no differences between desipramine and placebo.
decrease of gray matter volume	disease_to_anatomy	of gray	1	5.902	23707581	PMID:23707581; Original text:Linear regression analysis of gray matter (gray matter) volume changes (known to occur with development) revealed a significant decrease of gray matter volume with Age for Motor (F(1,30)=17.92; p<0.001) and Visual F(1,16)=14.41; p<0.005 but not the Auditory ROI (p=0.55).
decrease of gray matter volume	disease_to_anatomy	gray matter	1	5.902	23707581	PMID:23707581; Original text:Linear regression analysis of gray matter (gray matter) volume changes (known to occur with development) revealed a significant decrease of gray matter volume with Age for Motor (F(1,30)=17.92; p<0.001) and Visual F(1,16)=14.41; p<0.005 but not the Auditory ROI (p=0.55).
decrease of gray matter volume	disease_to_anatomy	of gray matter	1	5.902	23707581	PMID:23707581; Original text:Linear regression analysis of gray matter (gray matter) volume changes (known to occur with development) revealed a significant decrease of gray matter volume with Age for Motor (F(1,30)=17.92; p<0.001) and Visual F(1,16)=14.41; p<0.005 but not the Auditory ROI (p=0.55).
mental retardation	disease_to_anatomy	, and	4	15.448	19319661|10425586|19736351|23471985	PMID:19319661; Original text:The most significant clinical features were mental retardation, epilepsy and autistic behaviour, and these symptoms did not worsen, in contrast to other reports.|PMID:10425586; Original text:Issues affecting differential diagnosis include the use of traditional diagnostic guidelines for preschoolers with developmental delays, developmental changes in behavioral characteristics, the involvement of cognitive factors in symptom expression, and the overlap between autism and mental retardation in individuals with significant cognitive impairment.|PMID:19736351; Original text:The collective frequency of rare copy number variations at these loci is significantly increased in cases with autism, in cases with schizophrenia, and in cases with mental retardation compared with controls (P < .001, P = .01, and P = .001, respectively, Fisher exact test).|PMID:23471985; Original text:As a posthoc analysis, we conducted genome-wide association scans on several organizational and topological network measures derived from the matrices to discover variants in and around genes associated with autism (autism), development (NEDD4), and mental retardation (UBE2A) significantly associated with connectivity.
autistic behaviour	disease_to_anatomy	, and	1	4.036	19319661	PMID:19319661; Original text:The most significant clinical features were mental retardation, epilepsy and autistic behaviour, and these symptoms did not worsen, in contrast to other reports.
sleep disturbance	disease_to_anatomy	, and	1	1.0	21570809	PMID:21570809; Original text:Sleep disturbance is a significant problem in the general pediatric population, and it occurs even more frequently in children with pervasive developmental disorders (pervasive developmental disorders).
pervasive developmental disorders	disease_to_anatomy	, and	1	1.0	21570809	PMID:21570809; Original text:Sleep disturbance is a significant problem in the general pediatric population, and it occurs even more frequently in children with pervasive developmental disorders (pervasive developmental disorders).
neuroinflammation	disease_to_anatomy	protein 1	1	1.0	32745763	PMID:32745763; Original text:Modulation of glutathione is also associated with regulation of redox-sensitive transcription factors nuclear factor kappa B (NF-κB) and activator protein 1 (AP-1) and downstream signaling (proinflammatory cytokines and inducible enzymes), thus providing a significant impact on neuroinflammation.
neuroinflammation	disease_to_anatomy	b (	1	1.0	32745763	PMID:32745763; Original text:Modulation of glutathione is also associated with regulation of redox-sensitive transcription factors nuclear factor kappa B (NF-κB) and activator protein 1 (AP-1) and downstream signaling (proinflammatory cytokines and inducible enzymes), thus providing a significant impact on neuroinflammation.
mitochondrial dysfunction	disease_to_anatomy	mitochondrial	2	6.893	32745763|33493659	PMID:32745763; Original text:Mitochondrial dysfunction, as well as neuronal apoptosis, may also provide a significant link between glutathione metabolism and disorder.|PMID:33493659; Original text:Neuronal apoptosis and mitochondrial dysfunction are recently outlined as significant factors linking glutathione impairments with the pathophysiology of disorder.
mitochondrial dysfunction	disease_to_anatomy	neuronal	2	6.893	32745763|33493659	PMID:32745763; Original text:Mitochondrial dysfunction, as well as neuronal apoptosis, may also provide a significant link between glutathione metabolism and disorder.|PMID:33493659; Original text:Neuronal apoptosis and mitochondrial dysfunction are recently outlined as significant factors linking glutathione impairments with the pathophysiology of disorder.
pervasive developmental disorder	disease_to_anatomy	26	1	3.351	16048456	PMID:16048456; Original text:At a cut-off of 26, the the Autism Spectrum Quotient-J had satisfactory sensitivity, specificity, and negative predictive value, but it had low positive predictive value (0.24) possibly due to the facts that the 25 mild 25 normally intelligent high-functioning pervasive developmental disorder patients scored lower and the controls scored higher on the the Autism Spectrum Quotient-J than British counterparts on the the Autism Spectrum Quotient.
pervasive developmental disorder	disease_to_anatomy	, and	2	4.351	16048456|11459079	PMID:16048456; Original text:At a cut-off of 26, the the Autism Spectrum Quotient-J had satisfactory sensitivity, specificity, and negative predictive value, but it had low positive predictive value (0.24) possibly due to the facts that the 25 mild 25 normally intelligent high-functioning pervasive developmental disorder patients scored lower and the controls scored higher on the the Autism Spectrum Quotient-J than British counterparts on the the Autism Spectrum Quotient.|PMID:11459079; Original text:We studied 9 Caucasian boys, 3.8-8.1 years old, with a DSM-IV diagnosis of a pervasive developmental disorder, living with their families, receiving no chronic medications, and without significant gastrointestinal symptoms.
substance abuse	disease_to_anatomy	(p	1	1.0	17574799	PMID:17574799; Original text:Female survivors of childhood abuse did not improve in treatment as much as their nonabused peers in psychological functioning (p < .001), substance abuse (p < .01), or continuing trauma exposure (p < .01) .
trauma	disease_to_anatomy	(p	1	1.0	17574799	PMID:17574799; Original text:Female survivors of childhood abuse did not improve in treatment as much as their nonabused peers in psychological functioning (p < .001), substance abuse (p < .01), or continuing trauma exposure (p < .01) .
autism	disease_to_anatomy	is	1	2.7	16160627	PMID:16160627; Original text:Post hoc analysis looking at the 3 core symptoms of autism, that is, social interaction, communication, and stereotyped behaviors, revealed a significant improvement of the social interaction score after 6 months of active treatment.
cognitive impairment	disease_to_anatomy	, and	1	1.0	10425586	PMID:10425586; Original text:Issues affecting differential diagnosis include the use of traditional diagnostic guidelines for preschoolers with developmental delays, developmental changes in behavioral characteristics, the involvement of cognitive factors in symptom expression, and the overlap between autism and mental retardation in individuals with significant cognitive impairment.
cognitive	disease_to_anatomy	, and	2	4.743	10425586|25161109	PMID:10425586; Original text:Issues affecting differential diagnosis include the use of traditional diagnostic guidelines for preschoolers with developmental delays, developmental changes in behavioral characteristics, the involvement of cognitive factors in symptom expression, and the overlap between autism and mental retardation in individuals with significant cognitive impairment.|PMID:25161109; Original text:Cognitive and behavioral disorders affect nearly 80% of all children with the neurofibromatosis type 1 inherited cancer syndrome, and are among the most significant clinical manifestations for patients and their families.
anxiety	disease_to_anatomy	2	1	1.026	24391123	PMID:24391123; Original text:Between visits 1 and 2, mean anxiety and behavior scores decreased significantly by 0.8 points (P = .03) for subjects within groups C and D. Significant changes were not observed within groups A and B. Mean anxiety and behavior scores did not differ significantly between groups over time, although group A versus C pairwise comparisons showed a trend toward significance (P = .06).
anxiety	disease_to_anatomy	group a	1	1.026	24391123	PMID:24391123; Original text:Between visits 1 and 2, mean anxiety and behavior scores decreased significantly by 0.8 points (P = .03) for subjects within groups C and D. Significant changes were not observed within groups A and B. Mean anxiety and behavior scores did not differ significantly between groups over time, although group A versus C pairwise comparisons showed a trend toward significance (P = .06).
anxiety	disease_to_anatomy	(p	3	3.026	24391123|20001837|24408892	PMID:24391123; Original text:Between visits 1 and 2, mean anxiety and behavior scores decreased significantly by 0.8 points (P = .03) for subjects within groups C and D. Significant changes were not observed within groups A and B. Mean anxiety and behavior scores did not differ significantly between groups over time, although group A versus C pairwise comparisons showed a trend toward significance (P = .06).|PMID:20001837; Original text:However, results from the Conners' Parent Questionnaire revealed an improvement only for anxiety (p = 0.04) in the massage group, whereas when both groups were compared, a significant improvement in conduct problem (p = 0.03) and anxiety (p = 0.01) was found.|PMID:24408892; Original text:Analyses of parental outcome reveal a significant decrease in maternal state anxiety in the a treatment group after controlling for potential confounding variables (p < 0.05).
anxiety	disease_to_anatomy	and 2	1	1.026	24391123	PMID:24391123; Original text:Between visits 1 and 2, mean anxiety and behavior scores decreased significantly by 0.8 points (P = .03) for subjects within groups C and D. Significant changes were not observed within groups A and B. Mean anxiety and behavior scores did not differ significantly between groups over time, although group A versus C pairwise comparisons showed a trend toward significance (P = .06).
autism spectrum disorder	disease_to_anatomy	risks	1	1.0	24231171	PMID:24231171; Original text:For children diagnosed with an autism spectrum disorder and/or intellectual disability, the co-occurrence of serious behavioral disturbance can pose significant health and safety risks, impede normal learning and development, and put great stress on family systems.
behavioral disturbance	disease_to_anatomy	, and	1	1.0	24231171	PMID:24231171; Original text:For children diagnosed with an autism spectrum disorder and/or intellectual disability, the co-occurrence of serious behavioral disturbance can pose significant health and safety risks, impede normal learning and development, and put great stress on family systems.
behavioral disturbance	disease_to_anatomy	risks	1	1.0	24231171	PMID:24231171; Original text:For children diagnosed with an autism spectrum disorder and/or intellectual disability, the co-occurrence of serious behavioral disturbance can pose significant health and safety risks, impede normal learning and development, and put great stress on family systems.
intellectual disability	disease_to_anatomy	risks	1	1.0	24231171	PMID:24231171; Original text:For children diagnosed with an autism spectrum disorder and/or intellectual disability, the co-occurrence of serious behavioral disturbance can pose significant health and safety risks, impede normal learning and development, and put great stress on family systems.
schizophrenia	disease_to_anatomy	body of	1	1.0	12457383	PMID:12457383; Original text:Although a growing body of evidence supports the hypothesis that exposure to obstetric complications (obstetric complications) increases the vulnerability for schizophrenia, some questions remain unanswered regarding the diagnostic specificity and the etiological significance of this association.
irritability	disease_to_anatomy	8	1	6.936	19797985	PMID:19797985; Original text:At week 8, all aripiprazole doses produced significantly greater improvement than placebo in mean Aberrant Behavior Checklist Irritability subscale scores (5 mg/day, -12.4; 10 mg/day, -13.2; 15 mg/day, -14.4; versus placebo, -8.4; all p < .05).
autistic	disease_to_anatomy	whole blood	2	2.0	24613076|24613076	PMID:24613076; Original text:Significantly higher 5-HT levels in autistic patients compared to controls were recorded both in whole blood (whole blood)|PMID:24613076; Original text:Altogether, elevated 5-HT blood levels were recorded in 28.3% in whole blood and 22.5% in platelet-rich plasma samples of autistic individuals, as reported in 15 and 4 studies, respectively.
autistic	disease_to_anatomy	rich plasma	1	1.0	24613076	PMID:24613076; Original text:Altogether, elevated 5-HT blood levels were recorded in 28.3% in whole blood and 22.5% in platelet-rich plasma samples of autistic individuals, as reported in 15 and 4 studies, respectively.
autistic	disease_to_anatomy	platelet-rich plasma	1	1.0	24613076	PMID:24613076; Original text:Altogether, elevated 5-HT blood levels were recorded in 28.3% in whole blood and 22.5% in platelet-rich plasma samples of autistic individuals, as reported in 15 and 4 studies, respectively.
anger	disease_to_anatomy	, and	2	3.7	8498878|9934941	PMID:8498878; Original text:Clomipramine was superior to both placebo and desipramine on ratings of autistic symptoms (including stereotypies), anger, and compulsive, ritualized behaviors (P < .05), with no differences between desipramine and placebo.|PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.
anger	disease_to_anatomy	(p	1	1.0	8498878	PMID:8498878; Original text:Clomipramine was superior to both placebo and desipramine on ratings of autistic symptoms (including stereotypies), anger, and compulsive, ritualized behaviors (P < .05), with no differences between desipramine and placebo.
autistic symptoms	disease_to_anatomy	(p	1	1.0	8498878	PMID:8498878; Original text:Clomipramine was superior to both placebo and desipramine on ratings of autistic symptoms (including stereotypies), anger, and compulsive, ritualized behaviors (P < .05), with no differences between desipramine and placebo.
irritability	disease_to_anatomy	, sensory	1	2.7	9934941	PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.
irritability	disease_to_anatomy	, motor	1	2.7	9934941	PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.
irritability	disease_to_anatomy	reactions	1	2.7	9934941	PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.
depression	disease_to_anatomy	, sensory	1	2.7	9934941	PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.
depression	disease_to_anatomy	, motor	1	2.7	9934941	PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.
depression	disease_to_anatomy	reactions	1	2.7	9934941	PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.
anxiety	disease_to_anatomy	, sensory	2	5.793	9934941|27721995	PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.|PMID:27721995; Original text:An intention-to-treat analysis showed significant overall gains for a wide range of symptoms in these children, including learning, memory, anxiety, attention span, motor skills, eating, sleeping, sensory processing, self-awareness, communication, social skills, and mood/autism behaviors.
anxiety	disease_to_anatomy	, motor	2	5.793	9934941|27721995	PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.|PMID:27721995; Original text:An intention-to-treat analysis showed significant overall gains for a wide range of symptoms in these children, including learning, memory, anxiety, attention span, motor skills, eating, sleeping, sensory processing, self-awareness, communication, social skills, and mood/autism behaviors.
anxiety	disease_to_anatomy	reactions	1	2.7	9934941	PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.
autism	disease_to_anatomy	, sensory	2	5.793	9934941|27721995	PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.|PMID:27721995; Original text:An intention-to-treat analysis showed significant overall gains for a wide range of symptoms in these children, including learning, memory, anxiety, attention span, motor skills, eating, sleeping, sensory processing, self-awareness, communication, social skills, and mood/autism behaviors.
autism	disease_to_anatomy	, motor	2	5.793	9934941|27721995	PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.|PMID:27721995; Original text:An intention-to-treat analysis showed significant overall gains for a wide range of symptoms in these children, including learning, memory, anxiety, attention span, motor skills, eating, sleeping, sensory processing, self-awareness, communication, social skills, and mood/autism behaviors.
autism	disease_to_anatomy	reactions	1	2.7	9934941	PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.
aggression	disease_to_anatomy	, sensory	1	2.7	9934941	PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.
aggression	disease_to_anatomy	, motor	1	2.7	9934941	PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.
aggression	disease_to_anatomy	reactions	1	2.7	9934941	PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.
anger	disease_to_anatomy	, sensory	1	2.7	9934941	PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.
anger	disease_to_anatomy	, motor	1	2.7	9934941	PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.
anger	disease_to_anatomy	reactions	1	2.7	9934941	PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.
hyperactivity	disease_to_anatomy	, sensory	1	2.7	9934941	PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.
hyperactivity	disease_to_anatomy	, motor	1	2.7	9934941	PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.
hyperactivity	disease_to_anatomy	reactions	1	2.7	9934941	PMID:9934941; Original text:Significant improvements in overall symptoms of autism, motor restlessness or hyperactivity, social relatedness, affectual reactions, sensory responses, language usage, self-injurious behavior, aggression, irritability or anger, anxiety, and depression were observed.
autism	disease_to_anatomy	component of	1	12.095	8879465	PMID:8879465; Original text:These preliminary results encourage our research on this chromosome, which could be considered as a significant genetic component of the multifactorial etiology of autism.
autism	disease_to_anatomy	chromosome	2	13.362	8879465|11525418	PMID:8879465; Original text:These preliminary results encourage our research on this chromosome, which could be considered as a significant genetic component of the multifactorial etiology of autism.|PMID:11525418; Original text:These data support the contribution of chromosomal abnormalities to a small but significant number of cases of autism, and highlight the involvement of chromosome 15 and the sex chromosomes.
nutritional deficiencies	disease_to_anatomy	level of	1	1.0	24676906	PMID:24676906; Original text:We investigated the status of redox and methylation metabolites, as well as the level of protein homocysteinylation and hair mercury levels, in autistic and neurotypical control Omani children, who were previously shown to exhibit significant nutritional deficiencies in serum folate and vitamin B₁₂.
psychiatric	disease_to_anatomy	, and	1	2.627	16697303	PMID:16697303; Original text:Catatonia should be assessed in any patient with spectrum disorders when there is an obvious and marked deterioration in movement, pattern of activities, self-care, and practical skills, compared with previous levels, through a comprehensive diagnostic evaluation of medical and psychiatric symptoms.
spectrum disorders	disease_to_anatomy	, and	3	8.89	16697303|28965590|33403915	PMID:16697303; Original text:Catatonia should be assessed in any patient with spectrum disorders when there is an obvious and marked deterioration in movement, pattern of activities, self-care, and practical skills, compared with previous levels, through a comprehensive diagnostic evaluation of medical and psychiatric symptoms.|PMID:28965590; Original text:The mercury level in whole blood (Hedges=0.43, 95% its 95% corresponding confidence interval: 0.12, 0.74, P=0.007), red blood cells (Hedges=1.61, 95% its 95% corresponding confidence interval: 0.83, 2.38, P<0.001), and brain (0.61ng/g, 95% its 95% corresponding confidence interval, 0.02, 1.19, P=0.043) was significantly higher in spectrum disorders patients than healthy subjects, whereas mercury level in hair (-0.14mg/g, 95% its 95% corresponding confidence interval: -0.28, -0.01, P=0.039) was significantly lower in spectrum disorders patients than healthy subjects.|PMID:33403915; Original text:Given the significant clinical and genetic overlap between spectrum disorders and attention deficit hyperactivity disorder, surprisingly, no reviews have compared the clinical, developmental, and genetic correlates of in particular, the default mode network in spectrum disorders and attention deficit hyperactivity disorder and here we address this knowledge gap.
mental health	disease_to_anatomy	2	1	6.936	16670650	PMID:16670650; Original text:Both treatments resulted in significant and progressive improvement in overall mental health at follow-up (F = 2, 97, p =.007) and mental health significantly improved over time in the 54% of principal caregivers who had the highest levels of mental health problems.
mental health	disease_to_anatomy	levels of	1	6.936	16670650	PMID:16670650; Original text:Both treatments resulted in significant and progressive improvement in overall mental health at follow-up (F = 2, 97, p =.007) and mental health significantly improved over time in the 54% of principal caregivers who had the highest levels of mental health problems.
mental health problems	disease_to_anatomy	2	1	6.936	16670650	PMID:16670650; Original text:Both treatments resulted in significant and progressive improvement in overall mental health at follow-up (F = 2, 97, p =.007) and mental health significantly improved over time in the 54% of principal caregivers who had the highest levels of mental health problems.
mental health problems	disease_to_anatomy	levels of	1	6.936	16670650	PMID:16670650; Original text:Both treatments resulted in significant and progressive improvement in overall mental health at follow-up (F = 2, 97, p =.007) and mental health significantly improved over time in the 54% of principal caregivers who had the highest levels of mental health problems.
brain overgrowth	disease_to_anatomy	(p	1	12.095	23706681	PMID:23706681; Original text:In systematic review, comparisons with locally recruited control subjects were significantly less likely to identify Early brain overgrowth in disorder than norm-based studies (p < .001).
spectrum disorders	disease_to_anatomy	group of	1	5.869	26770664	PMID:26770664; Original text:However, an overall significant improvement in SRS total raw score was observed from baseline to end of treatment for the entire group of children with spectrum disorders.
spectrum disorders	disease_to_anatomy	end of	1	5.869	26770664	PMID:26770664; Original text:However, an overall significant improvement in SRS total raw score was observed from baseline to end of treatment for the entire group of children with spectrum disorders.
cognitive and behavioral impairments	disease_to_anatomy	of the	1	3.093	21826280	PMID:21826280; Original text:We propose that alteration of the expression and/or timing of critical period circuit refinement in primary sensory brain areas may significantly contribute to autistic phenotypes, including cognitive and behavioral impairments.
autism spectrum disorder	disease_to_anatomy	(p	3	30.566000000000003	29146048|26792761|25149412	PMID:29146048; Original text:The meta-analysis of the literature suggested a weak but significant association between autism spectrum disorder diagnosis and increased cerebellar volume (p = .049, uncorrected), but the analysis of ABIDE did not show any relationship.|PMID:26792761; Original text:Greater T2DM incidence was associated with second-generation antipsychotic prescription (P ≤ .050) and less autism spectrum disorder diagnosis (P = .048)|PMID:25149412; Original text:In the case-control study, 17 males with autism spectrum disorder showed significant behavioural deficits in inferring others' social emotions (P = 0.018) but not in inferring others' beliefs (P = 0.064) compared with 17 typically developing demographically-matched male participants.
agitation	disease_to_anatomy	, and	1	2.195	23782127	PMID:23782127; Original text:The ABC irritability/agitation subscale (subscale 1) was significantly improved from 8 weeks, and the hyperactivity/noncompliance subscale (subscale 4) was significantly improved in 12 weeks.
stimulatory	disease_to_anatomy	, and	1	1.0	8463192	PMID:8463192; Original text:Asperger subjects tended to look less at the other person, to make more self-stimulatory gestures, and to look at the interviewer significantly less than normal subjects, and substantially less than schizoid subjects, during the periods when the interviewer was vocalizing although there were no such differences when the interviewer was listening.
schizoid	disease_to_anatomy	, and	1	1.0	8463192	PMID:8463192; Original text:Asperger subjects tended to look less at the other person, to make more self-stimulatory gestures, and to look at the interviewer significantly less than normal subjects, and substantially less than schizoid subjects, during the periods when the interviewer was vocalizing although there were no such differences when the interviewer was listening.
asd	disease_to_anatomy	the brain	2	7.540000000000001	23688533|21692142	PMID:23688533; Original text:Neurotensin is significantly increased in serum of children with ASD and stimulates mast cell secretion of mitochondrial adenosine triphosphate and DNA, which is increased in these children; these mitochondrial components are misconstrued as innate pathogens, triggering an autoallergic response in the brain.|PMID:21692142; Original text:We found six significant clusters of convergence indicating disturbances in the brain structure of ASD patients, including the lateral occipital lobe, the pericentral region, the medial temporal lobe, the basal ganglia, and proximate to the right parietal operculum.
asd	disease_to_anatomy	mast cell	1	3.119	23688533	PMID:23688533; Original text:Neurotensin is significantly increased in serum of children with ASD and stimulates mast cell secretion of mitochondrial adenosine triphosphate and DNA, which is increased in these children; these mitochondrial components are misconstrued as innate pathogens, triggering an autoallergic response in the brain.
asd	disease_to_anatomy	secretion of	1	3.119	23688533	PMID:23688533; Original text:Neurotensin is significantly increased in serum of children with ASD and stimulates mast cell secretion of mitochondrial adenosine triphosphate and DNA, which is increased in these children; these mitochondrial components are misconstrued as innate pathogens, triggering an autoallergic response in the brain.
asd	disease_to_anatomy	secretion	1	3.119	23688533	PMID:23688533; Original text:Neurotensin is significantly increased in serum of children with ASD and stimulates mast cell secretion of mitochondrial adenosine triphosphate and DNA, which is increased in these children; these mitochondrial components are misconstrued as innate pathogens, triggering an autoallergic response in the brain.
autistic	disease_to_anatomy	acids	1	2.974	21299356	PMID:21299356; Original text:Covering the literature from 1943 to the present in the PubMed and Ovid Medline databases, this review summarizes evidence of hormones, metabolites, amino acids, and other biomarkers present in significantly different quantities in autistic subjects compared to age- and sex-matched controls.
autistic	disease_to_anatomy	systems	1	2.849	20623006	PMID:20623006; Original text:Out of total of 48 acupuncture points present on ten fingertips of both hands and associated to organs/organ systems, autistic children differed significantly from controls (p < 0.05) in 36 (images without filter) and 12 (images with filter), siblings differed significantly from controls (p < 0.05) in 12 (images without filter) and seven (images with filter), autistic children differed significantly (p < 0.05) from siblings in eight (images without filter) and one (images with filter), fathers of autistic children differed significantly (p < 0.05) from controls in 14 (images without filter) and three (images with filter) and mothers of autistic children differed significantly (p < 0.05) from controls in five (images without filter) and nine (images with filter
autistic	disease_to_anatomy	fingertips	1	2.849	20623006	PMID:20623006; Original text:Out of total of 48 acupuncture points present on ten fingertips of both hands and associated to organs/organ systems, autistic children differed significantly from controls (p < 0.05) in 36 (images without filter) and 12 (images with filter), siblings differed significantly from controls (p < 0.05) in 12 (images without filter) and seven (images with filter), autistic children differed significantly (p < 0.05) from siblings in eight (images without filter) and one (images with filter), fathers of autistic children differed significantly (p < 0.05) from controls in 14 (images without filter) and three (images with filter) and mothers of autistic children differed significantly (p < 0.05) from controls in five (images without filter) and nine (images with filter
cognitive or psychiatric symptoms	disease_to_anatomy	of primary	1	1.0	31321675	PMID:31321675; Original text:While it is reasonable to consider that there may be a causal relationship between a posterior fossa arachnoid cyst and neurodevelopmental or psychiatric symptoms in some patients, there is also a nontrivial prevalence of a posterior fossa arachnoid cyst in the asymptomatic population and a significant possibility that many a posterior fossa arachnoid cyst are incidental findings in the context of primary cognitive or psychiatric symptoms.
cognitive or psychiatric symptoms	disease_to_anatomy	posterior fossa	1	1.0	31321675	PMID:31321675; Original text:While it is reasonable to consider that there may be a causal relationship between a posterior fossa arachnoid cyst and neurodevelopmental or psychiatric symptoms in some patients, there is also a nontrivial prevalence of a posterior fossa arachnoid cyst in the asymptomatic population and a significant possibility that many a posterior fossa arachnoid cyst are incidental findings in the context of primary cognitive or psychiatric symptoms.
cognitive or psychiatric symptoms	disease_to_anatomy	arachnoid	1	1.0	31321675	PMID:31321675; Original text:While it is reasonable to consider that there may be a causal relationship between a posterior fossa arachnoid cyst and neurodevelopmental or psychiatric symptoms in some patients, there is also a nontrivial prevalence of a posterior fossa arachnoid cyst in the asymptomatic population and a significant possibility that many a posterior fossa arachnoid cyst are incidental findings in the context of primary cognitive or psychiatric symptoms.
posterior fossa arachnoid cyst	disease_to_anatomy	of primary	1	1.0	31321675	PMID:31321675; Original text:While it is reasonable to consider that there may be a causal relationship between a posterior fossa arachnoid cyst and neurodevelopmental or psychiatric symptoms in some patients, there is also a nontrivial prevalence of a posterior fossa arachnoid cyst in the asymptomatic population and a significant possibility that many a posterior fossa arachnoid cyst are incidental findings in the context of primary cognitive or psychiatric symptoms.
posterior fossa arachnoid cyst	disease_to_anatomy	posterior fossa	1	1.0	31321675	PMID:31321675; Original text:While it is reasonable to consider that there may be a causal relationship between a posterior fossa arachnoid cyst and neurodevelopmental or psychiatric symptoms in some patients, there is also a nontrivial prevalence of a posterior fossa arachnoid cyst in the asymptomatic population and a significant possibility that many a posterior fossa arachnoid cyst are incidental findings in the context of primary cognitive or psychiatric symptoms.
posterior fossa arachnoid cyst	disease_to_anatomy	arachnoid	1	1.0	31321675	PMID:31321675; Original text:While it is reasonable to consider that there may be a causal relationship between a posterior fossa arachnoid cyst and neurodevelopmental or psychiatric symptoms in some patients, there is also a nontrivial prevalence of a posterior fossa arachnoid cyst in the asymptomatic population and a significant possibility that many a posterior fossa arachnoid cyst are incidental findings in the context of primary cognitive or psychiatric symptoms.
neurodevelopmental or psychiatric symptoms	disease_to_anatomy	of primary	1	1.0	31321675	PMID:31321675; Original text:While it is reasonable to consider that there may be a causal relationship between a posterior fossa arachnoid cyst and neurodevelopmental or psychiatric symptoms in some patients, there is also a nontrivial prevalence of a posterior fossa arachnoid cyst in the asymptomatic population and a significant possibility that many a posterior fossa arachnoid cyst are incidental findings in the context of primary cognitive or psychiatric symptoms.
neurodevelopmental or psychiatric symptoms	disease_to_anatomy	posterior fossa	1	1.0	31321675	PMID:31321675; Original text:While it is reasonable to consider that there may be a causal relationship between a posterior fossa arachnoid cyst and neurodevelopmental or psychiatric symptoms in some patients, there is also a nontrivial prevalence of a posterior fossa arachnoid cyst in the asymptomatic population and a significant possibility that many a posterior fossa arachnoid cyst are incidental findings in the context of primary cognitive or psychiatric symptoms.
neurodevelopmental or psychiatric symptoms	disease_to_anatomy	arachnoid	1	1.0	31321675	PMID:31321675; Original text:While it is reasonable to consider that there may be a causal relationship between a posterior fossa arachnoid cyst and neurodevelopmental or psychiatric symptoms in some patients, there is also a nontrivial prevalence of a posterior fossa arachnoid cyst in the asymptomatic population and a significant possibility that many a posterior fossa arachnoid cyst are incidental findings in the context of primary cognitive or psychiatric symptoms.
autism-spectrum disorders	disease_to_anatomy	default mode network	1	1.0	29688876	PMID:29688876; Original text:Specifically, cortical thickness showed significant enrichment between patients with if autism-spectrum disorders and those with attention-deficit/hyperactivity disorder in the default mode network, between patients with if autism-spectrum disorders and those with schizophrenia in the frontoparietal and limbic networks, and between patients with attention-deficit/hyperactivity disorder and those with schizophrenia in the ventral attention network.
autism-spectrum disorders	disease_to_anatomy	network	1	1.0	29688876	PMID:29688876; Original text:Specifically, cortical thickness showed significant enrichment between patients with if autism-spectrum disorders and those with attention-deficit/hyperactivity disorder in the default mode network, between patients with if autism-spectrum disorders and those with schizophrenia in the frontoparietal and limbic networks, and between patients with attention-deficit/hyperactivity disorder and those with schizophrenia in the ventral attention network.
autism-spectrum disorders	disease_to_anatomy	the ventral	1	1.0	29688876	PMID:29688876; Original text:Specifically, cortical thickness showed significant enrichment between patients with if autism-spectrum disorders and those with attention-deficit/hyperactivity disorder in the default mode network, between patients with if autism-spectrum disorders and those with schizophrenia in the frontoparietal and limbic networks, and between patients with attention-deficit/hyperactivity disorder and those with schizophrenia in the ventral attention network.
autism-spectrum disorders	disease_to_anatomy	default mode	1	1.0	29688876	PMID:29688876; Original text:Specifically, cortical thickness showed significant enrichment between patients with if autism-spectrum disorders and those with attention-deficit/hyperactivity disorder in the default mode network, between patients with if autism-spectrum disorders and those with schizophrenia in the frontoparietal and limbic networks, and between patients with attention-deficit/hyperactivity disorder and those with schizophrenia in the ventral attention network.
autism-spectrum disorders	disease_to_anatomy	, and	1	1.0	29688876	PMID:29688876; Original text:Specifically, cortical thickness showed significant enrichment between patients with if autism-spectrum disorders and those with attention-deficit/hyperactivity disorder in the default mode network, between patients with if autism-spectrum disorders and those with schizophrenia in the frontoparietal and limbic networks, and between patients with attention-deficit/hyperactivity disorder and those with schizophrenia in the ventral attention network.
autism-spectrum disorders	disease_to_anatomy	, cortical	1	1.0	29688876	PMID:29688876; Original text:Specifically, cortical thickness showed significant enrichment between patients with if autism-spectrum disorders and those with attention-deficit/hyperactivity disorder in the default mode network, between patients with if autism-spectrum disorders and those with schizophrenia in the frontoparietal and limbic networks, and between patients with attention-deficit/hyperactivity disorder and those with schizophrenia in the ventral attention network.
autism-spectrum disorders	disease_to_anatomy	mode network	1	1.0	29688876	PMID:29688876; Original text:Specifically, cortical thickness showed significant enrichment between patients with if autism-spectrum disorders and those with attention-deficit/hyperactivity disorder in the default mode network, between patients with if autism-spectrum disorders and those with schizophrenia in the frontoparietal and limbic networks, and between patients with attention-deficit/hyperactivity disorder and those with schizophrenia in the ventral attention network.
autism-spectrum disorders	disease_to_anatomy	networks	1	1.0	29688876	PMID:29688876; Original text:Specifically, cortical thickness showed significant enrichment between patients with if autism-spectrum disorders and those with attention-deficit/hyperactivity disorder in the default mode network, between patients with if autism-spectrum disorders and those with schizophrenia in the frontoparietal and limbic networks, and between patients with attention-deficit/hyperactivity disorder and those with schizophrenia in the ventral attention network.
schizophrenia	disease_to_anatomy	default mode network	1	1.0	29688876	PMID:29688876; Original text:Specifically, cortical thickness showed significant enrichment between patients with if autism-spectrum disorders and those with attention-deficit/hyperactivity disorder in the default mode network, between patients with if autism-spectrum disorders and those with schizophrenia in the frontoparietal and limbic networks, and between patients with attention-deficit/hyperactivity disorder and those with schizophrenia in the ventral attention network.
schizophrenia	disease_to_anatomy	network	1	1.0	29688876	PMID:29688876; Original text:Specifically, cortical thickness showed significant enrichment between patients with if autism-spectrum disorders and those with attention-deficit/hyperactivity disorder in the default mode network, between patients with if autism-spectrum disorders and those with schizophrenia in the frontoparietal and limbic networks, and between patients with attention-deficit/hyperactivity disorder and those with schizophrenia in the ventral attention network.
schizophrenia	disease_to_anatomy	the ventral	1	1.0	29688876	PMID:29688876; Original text:Specifically, cortical thickness showed significant enrichment between patients with if autism-spectrum disorders and those with attention-deficit/hyperactivity disorder in the default mode network, between patients with if autism-spectrum disorders and those with schizophrenia in the frontoparietal and limbic networks, and between patients with attention-deficit/hyperactivity disorder and those with schizophrenia in the ventral attention network.
schizophrenia	disease_to_anatomy	default mode	1	1.0	29688876	PMID:29688876; Original text:Specifically, cortical thickness showed significant enrichment between patients with if autism-spectrum disorders and those with attention-deficit/hyperactivity disorder in the default mode network, between patients with if autism-spectrum disorders and those with schizophrenia in the frontoparietal and limbic networks, and between patients with attention-deficit/hyperactivity disorder and those with schizophrenia in the ventral attention network.
schizophrenia	disease_to_anatomy	, cortical	1	1.0	29688876	PMID:29688876; Original text:Specifically, cortical thickness showed significant enrichment between patients with if autism-spectrum disorders and those with attention-deficit/hyperactivity disorder in the default mode network, between patients with if autism-spectrum disorders and those with schizophrenia in the frontoparietal and limbic networks, and between patients with attention-deficit/hyperactivity disorder and those with schizophrenia in the ventral attention network.
schizophrenia	disease_to_anatomy	mode network	1	1.0	29688876	PMID:29688876; Original text:Specifically, cortical thickness showed significant enrichment between patients with if autism-spectrum disorders and those with attention-deficit/hyperactivity disorder in the default mode network, between patients with if autism-spectrum disorders and those with schizophrenia in the frontoparietal and limbic networks, and between patients with attention-deficit/hyperactivity disorder and those with schizophrenia in the ventral attention network.
schizophrenia	disease_to_anatomy	networks	1	1.0	29688876	PMID:29688876; Original text:Specifically, cortical thickness showed significant enrichment between patients with if autism-spectrum disorders and those with attention-deficit/hyperactivity disorder in the default mode network, between patients with if autism-spectrum disorders and those with schizophrenia in the frontoparietal and limbic networks, and between patients with attention-deficit/hyperactivity disorder and those with schizophrenia in the ventral attention network.
asperger's syndrome	disease_to_anatomy	volume)	1	1.0	12077008	PMID:12077008; Original text:We found significant age-related differences in volume of cerebral hemispheres and caudate nuclei (controls, but not people with Asperger's syndrome, had age-related reductions in volume).
asperger's syndrome	disease_to_anatomy	hemispheres	1	1.0	12077008	PMID:12077008; Original text:We found significant age-related differences in volume of cerebral hemispheres and caudate nuclei (controls, but not people with Asperger's syndrome, had age-related reductions in volume).
asperger's syndrome	disease_to_anatomy	nuclei (	1	1.0	12077008	PMID:12077008; Original text:We found significant age-related differences in volume of cerebral hemispheres and caudate nuclei (controls, but not people with Asperger's syndrome, had age-related reductions in volume).
asperger's syndrome	disease_to_anatomy	cerebral hemispheres	1	1.0	12077008	PMID:12077008; Original text:We found significant age-related differences in volume of cerebral hemispheres and caudate nuclei (controls, but not people with Asperger's syndrome, had age-related reductions in volume).
asperger's syndrome	disease_to_anatomy	of cerebral	1	1.0	12077008	PMID:12077008; Original text:We found significant age-related differences in volume of cerebral hemispheres and caudate nuclei (controls, but not people with Asperger's syndrome, had age-related reductions in volume).
asperger's syndrome	disease_to_anatomy	white matter	1	1.0	12077008	PMID:12077008; Original text:Also, people with Asperger's syndrome had significantly less grey matter in fronto-striatal and cerebellar regions than controls, and widespread differences in white matter.
asperger's syndrome	disease_to_anatomy	, and	1	1.0	12077008	PMID:12077008; Original text:Also, people with Asperger's syndrome had significantly less grey matter in fronto-striatal and cerebellar regions than controls, and widespread differences in white matter.
asperger's syndrome	disease_to_anatomy	grey matter	1	1.0	12077008	PMID:12077008; Original text:Also, people with Asperger's syndrome had significantly less grey matter in fronto-striatal and cerebellar regions than controls, and widespread differences in white matter.
asperger's syndrome	disease_to_anatomy	, sensorimotor	1	1.0	12077008	PMID:12077008; Original text:Moreover, sensorimotor gating was significantly impaired in Asperger's syndrome.
autism	disease_to_anatomy	groups	1	1.5	22987458	PMID:22987458; Original text:There were no statistically significant differences in average percentage changes of total the Autism Treatment Evaluation Checklist score score and all subscales scores when comparing the hyperbaric oxygen therapy and sham air groups, either by parents or clinicians.
social anxiety	disease_to_anatomy	, and	1	1.0	12462859	PMID:12462859; Original text:Social anxiety disorder is well suited to the spectrum concept because it has trait-like qualities of early onset, chronicity, and no empirically derived threshold that demarcates normal from clinically significant trait social anxiety.
social anxiety disorder	disease_to_anatomy	, and	1	1.0	12462859	PMID:12462859; Original text:Social anxiety disorder is well suited to the spectrum concept because it has trait-like qualities of early onset, chronicity, and no empirically derived threshold that demarcates normal from clinically significant trait social anxiety.
stereotyped behavior	disease_to_anatomy	(p	1	1.0	18685284	PMID:18685284; Original text:Paired comparison of baseline and 13-week endpoint scores showed significant reductions in Aberrant Behavior Checklist subscale scores for irritability (p < 0.0001), lethargy (p < 0.0001), stereotyped behavior (p < 0.005), hyperactivity (p < 0.0001) and inappropriate speech (p < 0.005).
lethargy	disease_to_anatomy	(p	2	2.0	18685284|24849255	PMID:18685284; Original text:Paired comparison of baseline and 13-week endpoint scores showed significant reductions in Aberrant Behavior Checklist subscale scores for irritability (p < 0.0001), lethargy (p < 0.0001), stereotyped behavior (p < 0.005), hyperactivity (p < 0.0001) and inappropriate speech (p < 0.005).|PMID:24849255; Original text:Secondary measures were not statistically significant with the exception of ABC-lethargy (p = 0.046) and total Short Sensory Profile score (p = 0.009).
inappropriate speech	disease_to_anatomy	(p	1	1.0	18685284	PMID:18685284; Original text:Paired comparison of baseline and 13-week endpoint scores showed significant reductions in Aberrant Behavior Checklist subscale scores for irritability (p < 0.0001), lethargy (p < 0.0001), stereotyped behavior (p < 0.005), hyperactivity (p < 0.0001) and inappropriate speech (p < 0.005).
mental handicap	disease_to_anatomy	field of	1	1.0	1544010	PMID:1544010; Original text:The disorder has considerable significance for psychiatrists, particularly, but by no means exclusively, those working in the field of mental handicap and with children.
extrapyramidal symptoms	disease_to_anatomy	(p	1	1.833	15068403	PMID:15068403; Original text:No significant difference was observed between the two groups in terms of extrapyramidal symptoms (P = 0.23).
neuronal apoptosis	disease_to_anatomy	mitochondrial	1	5.893	33493659	PMID:33493659; Original text:Neuronal apoptosis and mitochondrial dysfunction are recently outlined as significant factors linking glutathione impairments with the pathophysiology of disorder.
neuronal apoptosis	disease_to_anatomy	neuronal	1	5.893	33493659	PMID:33493659; Original text:Neuronal apoptosis and mitochondrial dysfunction are recently outlined as significant factors linking glutathione impairments with the pathophysiology of disorder.
t2dm	disease_to_anatomy	, and	1	17.471	26792761	PMID:26792761; Original text:In multivariable meta-regression analyses of 10 studies, greater cumulative T2DM risk was associated with longer follow-up (P < .001), olanzapine prescription (P < .001), and male sex (P = .002)
t2dm	disease_to_anatomy	(p	2	34.942	26792761|26792761	PMID:26792761; Original text:In multivariable meta-regression analyses of 10 studies, greater cumulative T2DM risk was associated with longer follow-up (P < .001), olanzapine prescription (P < .001), and male sex (P = .002)|PMID:26792761; Original text:Greater T2DM incidence was associated with second-generation antipsychotic prescription (P ≤ .050) and less autism spectrum disorder diagnosis (P = .048)
t2dm	disease_to_anatomy	, greater	1	17.471	26792761	PMID:26792761; Original text:In multivariable meta-regression analyses of 10 studies, greater cumulative T2DM risk was associated with longer follow-up (P < .001), olanzapine prescription (P < .001), and male sex (P = .002)
asperger	disease_to_anatomy	of the	1	1.0	9690938	PMID:9690938; Original text:The autistic group's performance on the false belief, belief term comprehension, and belief term expression tasks was significantly poorer than that of the Asperger, language impaired, and normal groups.
klinefelter syndrome	disease_to_anatomy	x	1	1.0	29972105	PMID:29972105; Original text:Moreover, given that Klinefelter Syndrome subjects have an additional X, genes on the extra-chromosome could also exert a significant impact.
klinefelter syndrome	disease_to_anatomy	chromosome	1	1.0	29972105	PMID:29972105; Original text:Moreover, given that Klinefelter Syndrome subjects have an additional X, genes on the extra-chromosome could also exert a significant impact.
autism spectrum disorders	disease_to_anatomy	of blood	1	1.0	28138831	PMID:28138831; Original text:A meta-analysis of blood Brain-derived neurotrophic factor in 887 patients with autism spectrum disorders and 901 control subjects demonstrated significantly higher Brain-derived neurotrophic factor levels in autism spectrum disorders compared to controls with the SMD of 0.47 (95% CI 0.07-0.86, p = 0.02).
autism spectrum disorders	disease_to_anatomy	blood brain	1	1.0	28138831	PMID:28138831; Original text:A meta-analysis of blood Brain-derived neurotrophic factor in 887 patients with autism spectrum disorders and 901 control subjects demonstrated significantly higher Brain-derived neurotrophic factor levels in autism spectrum disorders compared to controls with the SMD of 0.47 (95% CI 0.07-0.86, p = 0.02).
echolalia	disease_to_anatomy	, and	1	1.486	26161804	PMID:26161804; Original text:Recent contributions to the literature reflect significant disagreement regarding how echolalia should be defined, understood, and managed.
autism spectrum disorders	disease_to_anatomy	of all	1	3.041	15863467	PMID:15863467; Original text:Diagnostic criteria, age of the sample, and urban or rural location were associated with estimated prevalence of all all autism spectrum disorders.
autism	disease_to_anatomy	field of	1	2.74	28715464	PMID:28715464; Original text:A significant increase in overall adaptation and social skills (median 8 and 7.7 points) in the the Social-Emotional Profile was demonstrated in addition to a significant reduction in the the Childhood Autism Rating Scale score (median: 4 points), including in the field of social relationships.
anxiety	disease_to_anatomy	of the	4	4.0	22588377|22588377|31351241|11466160	PMID:22588377; Original text:Twenty-two children (ages 8-14; IQ ≥ 70) with disorder and clinically significant anxiety were randomly assigned to 16 sessions of the Coping Cat program (cognitive-behavioral therapy; CBT) or a 16-week waitlist.|PMID:22588377; Original text:Results provide preliminary evidence that a modified version of the Coping Cat program may be a feasible and effective program for reducing clinically significant levels of anxiety in children with high-functioning disorder.|PMID:31351241; Original text:Statistically significant and large improvements were also found in post-treatment teacher and parent reports of child anxiety as well as a behavioral measure of the child speaking to an unknown adult.|PMID:11466160; Original text:After treatment, the patients showed significant improvement on the scores of the Yale--Brown Obsessive--Compulsive Scale -- Obsessions subscale and the Hamilton Anxiety Scale; Clinical Global Impressions -- Autism scores showed 3 of the patients much improved and 3 unchanged.
anxiety	disease_to_anatomy	levels of	2	2.0	22588377|21660428	"PMID:22588377; Original text:Results provide preliminary evidence that a modified version of the Coping Cat program may be a feasible and effective program for reducing clinically significant levels of anxiety in children with high-functioning disorder.|PMID:21660428; Original text:Children in both programs showed significantly lower levels of generalized anxiety and total anxiety symptoms at 6-month follow-up on SCAS-C. Clinician ratings on the CGI-S demonstrated an increase in the percentage of participants rated as ""Normal"" and ""Borderline"" for both programs."
attention deficit hyperactivity disorder	disease_to_anatomy	(p	1	2.747	25760553	PMID:25760553; Original text:At the age of 13 y, attention deficit hyperactivity disorder or Asperger syndrome was diagnosed in 6/35 (17.1%) children in the placebo and none in the probiotic group (P = 0.008).
asperger syndrome	disease_to_anatomy	(p	1	2.747	25760553	PMID:25760553; Original text:At the age of 13 y, attention deficit hyperactivity disorder or Asperger syndrome was diagnosed in 6/35 (17.1%) children in the placebo and none in the probiotic group (P = 0.008).
pain	disease_to_anatomy	nervous system	1	5.359	28562301	PMID:28562301; Original text:Pain is a frequent and significant problem for children with impairment of the central nervous system, with the highest frequency and severity occurring in children with the greatest impairment.
pain	disease_to_anatomy	of the	2	10.718	28562301|28562301	PMID:28562301; Original text:Pain is a frequent and significant problem for children with impairment of the central nervous system, with the highest frequency and severity occurring in children with the greatest impairment.|PMID:28562301; Original text:Despite the significance of the problem, this population remains vulnerable to underrecognition and undertreatment of pain.
pain	disease_to_anatomy	central nervous	1	5.359	28562301	PMID:28562301; Original text:Pain is a frequent and significant problem for children with impairment of the central nervous system, with the highest frequency and severity occurring in children with the greatest impairment.
pain	disease_to_anatomy	system	1	5.359	28562301	PMID:28562301; Original text:Pain is a frequent and significant problem for children with impairment of the central nervous system, with the highest frequency and severity occurring in children with the greatest impairment.
pain	disease_to_anatomy	central nervous system	1	5.359	28562301	PMID:28562301; Original text:Pain is a frequent and significant problem for children with impairment of the central nervous system, with the highest frequency and severity occurring in children with the greatest impairment.
mental disorders	disease_to_anatomy	of the	1	2.097	31914909	PMID:31914909; Original text:Pro and their nutrient sources can improve mental health and psychological function and can be offered as new medicines for common mental disorders, however, more clinical studies are necessary to conduct regarding the clinical significance of the effects and their bioequivalence or superiority against current treatments.
mental	disease_to_anatomy	of the	1	2.097	31914909	PMID:31914909; Original text:Pro and their nutrient sources can improve mental health and psychological function and can be offered as new medicines for common mental disorders, however, more clinical studies are necessary to conduct regarding the clinical significance of the effects and their bioequivalence or superiority against current treatments.
focal epilepsy	disease_to_anatomy	, focal	1	2.368	23727450	PMID:23727450; Original text:Our subject displays severely deficient expressive language, stereotypic and repetitive behaviours, mild intellectual disability (mild intellectual disability), focal epilepsy, short stature and absence of significant dysmorphic features.
dysmorphic features	disease_to_anatomy	, focal	1	2.368	23727450	PMID:23727450; Original text:Our subject displays severely deficient expressive language, stereotypic and repetitive behaviours, mild intellectual disability (mild intellectual disability), focal epilepsy, short stature and absence of significant dysmorphic features.
repetitive behaviours	disease_to_anatomy	, focal	1	2.368	23727450	PMID:23727450; Original text:Our subject displays severely deficient expressive language, stereotypic and repetitive behaviours, mild intellectual disability (mild intellectual disability), focal epilepsy, short stature and absence of significant dysmorphic features.
deficient expressive language	disease_to_anatomy	, focal	1	2.368	23727450	PMID:23727450; Original text:Our subject displays severely deficient expressive language, stereotypic and repetitive behaviours, mild intellectual disability (mild intellectual disability), focal epilepsy, short stature and absence of significant dysmorphic features.
intellectual disability	disease_to_anatomy	, focal	1	2.368	23727450	PMID:23727450; Original text:Our subject displays severely deficient expressive language, stereotypic and repetitive behaviours, mild intellectual disability (mild intellectual disability), focal epilepsy, short stature and absence of significant dysmorphic features.
constipation	disease_to_anatomy	, and	2	15.120999999999999	28122648|31665947	PMID:28122648; Original text:The Gastrointestinal Symptom Rating Scale revealed an approximately 80% reduction of GI symptoms at the end of treatment, including significant improvements in symptoms of constipation, diarrhea, indigestion, and abdominal pain.|PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.
constipation	disease_to_anatomy	end of	1	11.607	28122648	PMID:28122648; Original text:The Gastrointestinal Symptom Rating Scale revealed an approximately 80% reduction of GI symptoms at the end of treatment, including significant improvements in symptoms of constipation, diarrhea, indigestion, and abdominal pain.
diarrhea	disease_to_anatomy	, and	1	11.607	28122648	PMID:28122648; Original text:The Gastrointestinal Symptom Rating Scale revealed an approximately 80% reduction of GI symptoms at the end of treatment, including significant improvements in symptoms of constipation, diarrhea, indigestion, and abdominal pain.
diarrhea	disease_to_anatomy	end of	1	11.607	28122648	PMID:28122648; Original text:The Gastrointestinal Symptom Rating Scale revealed an approximately 80% reduction of GI symptoms at the end of treatment, including significant improvements in symptoms of constipation, diarrhea, indigestion, and abdominal pain.
indigestion	disease_to_anatomy	, and	1	11.607	28122648	PMID:28122648; Original text:The Gastrointestinal Symptom Rating Scale revealed an approximately 80% reduction of GI symptoms at the end of treatment, including significant improvements in symptoms of constipation, diarrhea, indigestion, and abdominal pain.
indigestion	disease_to_anatomy	end of	1	11.607	28122648	PMID:28122648; Original text:The Gastrointestinal Symptom Rating Scale revealed an approximately 80% reduction of GI symptoms at the end of treatment, including significant improvements in symptoms of constipation, diarrhea, indigestion, and abdominal pain.
in	disease_to_anatomy	, and	1	11.607	28122648	PMID:28122648; Original text:The Gastrointestinal Symptom Rating Scale revealed an approximately 80% reduction of GI symptoms at the end of treatment, including significant improvements in symptoms of constipation, diarrhea, indigestion, and abdominal pain.
in	disease_to_anatomy	end of	1	11.607	28122648	PMID:28122648; Original text:The Gastrointestinal Symptom Rating Scale revealed an approximately 80% reduction of GI symptoms at the end of treatment, including significant improvements in symptoms of constipation, diarrhea, indigestion, and abdominal pain.
abdominal pain	disease_to_anatomy	, and	1	11.607	28122648	PMID:28122648; Original text:The Gastrointestinal Symptom Rating Scale revealed an approximately 80% reduction of GI symptoms at the end of treatment, including significant improvements in symptoms of constipation, diarrhea, indigestion, and abdominal pain.
abdominal pain	disease_to_anatomy	end of	1	11.607	28122648	PMID:28122648; Original text:The Gastrointestinal Symptom Rating Scale revealed an approximately 80% reduction of GI symptoms at the end of treatment, including significant improvements in symptoms of constipation, diarrhea, indigestion, and abdominal pain.
autism spectrum disorder	disease_to_anatomy	brainstem	1	1.0	25248666	PMID:25248666; Original text:Such reduced noise, perhaps a function of atypical brainstem activation, would enhance detection and discrimination in autism spectrum disorder but at significant cost, foregoing the widespread benefits of noise in neural networks.
autism spectrum disorder	disease_to_anatomy	neural networks	1	1.0	25248666	PMID:25248666; Original text:Such reduced noise, perhaps a function of atypical brainstem activation, would enhance detection and discrimination in autism spectrum disorder but at significant cost, foregoing the widespread benefits of noise in neural networks.
ptsd	disease_to_anatomy	, and	1	1.0	34499230	PMID:34499230; Original text:In ASD, bulimia nervosa, and PTSD samples, significantly increased rates of Polycystic ovary syndrome were reported compared with healthy control samples, although studies were relatively small.
bulimia nervosa	disease_to_anatomy	, and	1	1.0	34499230	PMID:34499230; Original text:In ASD, bulimia nervosa, and PTSD samples, significantly increased rates of Polycystic ovary syndrome were reported compared with healthy control samples, although studies were relatively small.
polycystic ovary syndrome	disease_to_anatomy	, and	1	1.0	34499230	PMID:34499230; Original text:In ASD, bulimia nervosa, and PTSD samples, significantly increased rates of Polycystic ovary syndrome were reported compared with healthy control samples, although studies were relatively small.
constipation	disease_to_anatomy	transplant	1	3.514	31665947	PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.
constipation	disease_to_anatomy	, gastrointestinal	1	3.514	31665947	PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.
constipation	disease_to_anatomy	, a	1	3.514	31665947	PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.
constipation	disease_to_anatomy	transplantation	1	3.514	31665947	PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.
autism	disease_to_anatomy	transplant	1	3.514	31665947	PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.
autism	disease_to_anatomy	, gastrointestinal	1	3.514	31665947	PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.
autism	disease_to_anatomy	, a	5	12.706	31665947|28217829|9648034|9648034|12010627	PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.|PMID:28217829; Original text:In terms of prevention, a recent small study showed vitamin D supplementation during pregnancy (5000 IU/day) and during infancy and early childhood (1000 IU/day) significantly reduced the expected incidence of autism in mothers who already had one autistic child from 20% to 5%.|PMID:9648034; Original text:Describes treatment of autism, a severe, chronic developmental disorder that results in significant lifelong disability for most persons, with few persons ever functioning in an independent and typical lifestyle.|PMID:9648034; Original text:Within the past decade, a number of studies have reported significant changes in the outcomes of very young children with autism following intensive comprehensive treatment.|PMID:12010627; Original text:Over the past decade, a significant upswing in research has occurred to examine the biologic basis of autism.
autism	disease_to_anatomy	transplantation	1	3.514	31665947	PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.
diarrhea).areas	disease_to_anatomy	transplant	1	3.514	31665947	PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.
diarrhea).areas	disease_to_anatomy	, gastrointestinal	1	3.514	31665947	PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.
diarrhea).areas	disease_to_anatomy	, a	1	3.514	31665947	PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.
diarrhea).areas	disease_to_anatomy	, and	1	3.514	31665947	PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.
diarrhea).areas	disease_to_anatomy	transplantation	1	3.514	31665947	PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.
asd	disease_to_anatomy	transplant	1	3.514	31665947	PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.
asd	disease_to_anatomy	, gastrointestinal	2	15.898	31665947|21263444	PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.|PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
asd	disease_to_anatomy	, a	1	3.514	31665947	PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.
asd	disease_to_anatomy	transplantation	1	3.514	31665947	PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.
autism spectrum disorders	disease_to_anatomy	transplant	1	3.514	31665947	PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.
autism spectrum disorders	disease_to_anatomy	, gastrointestinal	1	3.514	31665947	PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.
autism spectrum disorders	disease_to_anatomy	transplantation	1	3.514	31665947	PMID:31665947; Original text:Introduction: The purpose of this review is to discuss Microbiota Transplant Therapy (Microbiota Transplant Therapy), a type of intensive intestinal microbiota transplantation (intensive intestinal microbiota transplantation), for people with autism spectrum disorders (ASD) and chronic gastrointestinal disorders (constipation and/or diarrhea).Areas covered: This paper briefly reviews intensive intestinal microbiota transplantation, gastrointestinal symptoms and gastrointestinal bacteria in children with ASD, and results and lessons learned from intensive Microbiota Transplant Therapy for autism.
asperger syndrome	disease_to_anatomy	, a	1	1.694	15292669	PMID:15292669; Original text:In spectral power analysis, a statistically nonsignificant trend towards decreased relative delta power and increased theta power in slow-wave sleep was found in the Asperger syndrome group.
genetic diseases	disease_to_anatomy	part of	1	1.0	22805709	PMID:22805709; Original text:These mutations, although individually rare, may capture a significant part of the heritability for complex genetic diseases that is not detectable by genome-wide association studies.
genetic diseases	disease_to_anatomy	of the	1	1.0	22805709	PMID:22805709; Original text:These mutations, although individually rare, may capture a significant part of the heritability for complex genetic diseases that is not detectable by genome-wide association studies.
genetic diseases	disease_to_anatomy	part of the	1	1.0	22805709	PMID:22805709; Original text:These mutations, although individually rare, may capture a significant part of the heritability for complex genetic diseases that is not detectable by genome-wide association studies.
autism	disease_to_anatomy	positive	1	5.869	34034808	PMID:34034808; Original text:The effect sizes on the the Ohio Autism Clinical Impressions Scale were non-statistically significant but positive, suggesting a possible trend toward greater improvement in those on treatment with Sulforaphane (Cohen's d 0.21; 95% CI - 0.46, 0.88 and 0.10; 95% CI - 0.52, 0.72, respectively).
neurocognitive disturbances	disease_to_anatomy	, and	1	2.704	34273950	PMID:34273950; Original text:This phenotype is therefore associated with neurocognitive disturbances and social cognition, indicating potential functional maladjustment in the affected subjects, and a potentially significant impact on quality of life.
asd	disease_to_anatomy	prefrontal cortex	2	6.813	25292351|30758329	PMID:25292351; Original text:Fluoxetine significantly normalized the the right dorsolateral prefrontal cortex underactivation in ASD relative to controls whereas it increased posterior cingulate cortex (PCC) deactivation in disorder relative to control boys.|PMID:30758329; Original text:Across regions, its major non-intoxicating component cannabidiol increased GABA+ in controls, but decreased GABA+ in ASD; the group difference in change in GABA + in the the dorsomedial prefrontal cortex was significant.
asd	disease_to_anatomy	posterior cingulate cortex	1	5.813	25292351	PMID:25292351; Original text:Fluoxetine significantly normalized the the right dorsolateral prefrontal cortex underactivation in ASD relative to controls whereas it increased posterior cingulate cortex (PCC) deactivation in disorder relative to control boys.
asd	disease_to_anatomy	dorsolateral prefrontal cortex	1	5.813	25292351	PMID:25292351; Original text:Fluoxetine significantly normalized the the right dorsolateral prefrontal cortex underactivation in ASD relative to controls whereas it increased posterior cingulate cortex (PCC) deactivation in disorder relative to control boys.
asd	disease_to_anatomy	cingulate cortex	1	5.813	25292351	PMID:25292351; Original text:Fluoxetine significantly normalized the the right dorsolateral prefrontal cortex underactivation in ASD relative to controls whereas it increased posterior cingulate cortex (PCC) deactivation in disorder relative to control boys.
asd	disease_to_anatomy	cortex (	1	5.813	25292351	PMID:25292351; Original text:Fluoxetine significantly normalized the the right dorsolateral prefrontal cortex underactivation in ASD relative to controls whereas it increased posterior cingulate cortex (PCC) deactivation in disorder relative to control boys.
asd	disease_to_anatomy	posterior cingulate	1	5.813	25292351	PMID:25292351; Original text:Fluoxetine significantly normalized the the right dorsolateral prefrontal cortex underactivation in ASD relative to controls whereas it increased posterior cingulate cortex (PCC) deactivation in disorder relative to control boys.
asd	disease_to_anatomy	dorsolateral prefrontal	1	5.813	25292351	PMID:25292351; Original text:Fluoxetine significantly normalized the the right dorsolateral prefrontal cortex underactivation in ASD relative to controls whereas it increased posterior cingulate cortex (PCC) deactivation in disorder relative to control boys.
asthma	disease_to_anatomy	of the	1	1.0	32997856	PMID:32997856; Original text:We performed a meta-analysis of 23 of the studies, which showed a significant association between asthma and disorder: odds ratio (odds ratio) 1.52 (1.42-1.63)
asthma	disease_to_anatomy	and 3	1	1.0	32997856	PMID:32997856; Original text:Seventeen asthma-ASD studies were included, whereof 7 showed a positive association and 3 a negative association; 8/17 were population-based with a cross-sectional study design and 4/17 had a low risk of bias.
attention	disease_to_anatomy	, and	1	1.0	27278054	PMID:27278054; Original text:Both groups showed a significant improvement in attention-deficit/hyperactivity disorder symptoms after 24 weeks of treatment (attention-deficit/hyperactivity disorder Rating Scale, Conners Parent Rating Scale-Hyperactivity, and Clinical Global Improvement-Severity Scale).
attention	disease_to_anatomy	scale	1	1.0	27278054	PMID:27278054; Original text:Both groups showed a significant improvement in attention-deficit/hyperactivity disorder symptoms after 24 weeks of treatment (attention-deficit/hyperactivity disorder Rating Scale, Conners Parent Rating Scale-Hyperactivity, and Clinical Global Improvement-Severity Scale).
hyperactivity	disease_to_anatomy	scale	1	1.0	27278054	PMID:27278054; Original text:Both groups showed a significant improvement in attention-deficit/hyperactivity disorder symptoms after 24 weeks of treatment (attention-deficit/hyperactivity disorder Rating Scale, Conners Parent Rating Scale-Hyperactivity, and Clinical Global Improvement-Severity Scale).
attention-deficit hyperactivity disorder	disease_to_anatomy	of the	1	1.315	23123089	PMID:23123089; Original text:Use of the a frequency modulation system resulted in significant average improvements in speech recognition in noise for the children with autism spectrum disorders and attention-deficit hyperactivity disorder as well as large effect sizes.
attention-deficit hyperactivity disorder	disease_to_anatomy	system	1	1.315	23123089	PMID:23123089; Original text:Given the significantly better speech recognition in noise, increased on-task behaviors, and improved teacher ratings of listening behaviors with the a frequency modulation system, these devices may be a viable option for children who have autism spectrum disorders and attention-deficit hyperactivity disorder in the classroom.
attention-deficit hyperactivity disorder	disease_to_anatomy	, and	2	5.313000000000001	23123089|33376247	PMID:23123089; Original text:Given the significantly better speech recognition in noise, increased on-task behaviors, and improved teacher ratings of listening behaviors with the a frequency modulation system, these devices may be a viable option for children who have autism spectrum disorders and attention-deficit hyperactivity disorder in the classroom.|PMID:33376247; Original text:When combining the presence of magnetic resonance imaging findings, facial morphological variants, and genetic copy number variants, statistically significant relationships were found with disorder and attention-deficit hyperactivity disorder diagnoses (p = 0.0006 and p = 0.002, respectively).
autism spectrum disorders	disease_to_anatomy	system	1	1.315	23123089	PMID:23123089; Original text:Given the significantly better speech recognition in noise, increased on-task behaviors, and improved teacher ratings of listening behaviors with the a frequency modulation system, these devices may be a viable option for children who have autism spectrum disorders and attention-deficit hyperactivity disorder in the classroom.
autism	disease_to_anatomy	9	1	1.0	15590241	PMID:15590241; Original text:Journal of the Association of the Academy of Minority Physicians, 9, 9-15] reported an uncontrolled trial of secretin with three participants with autism, which apparently resulted in significant behavioral improvement.
autism	disease_to_anatomy	and 3	2	6.359	15121991|11466160	PMID:15121991; Original text:There are 3 main approaches to identifying genetic loci, chromosomal regions likely to contain relevant genes: 1) whole genome screens, searching for linkage of autism to shared genetic markers in populations of multiplex families (families with >1 affected family member; 2) cytogenetic studies that may guide molecular studies by pointing to relevant inherited or de novo chromosomal abnormalities in affected individuals and their families; and 3) evaluation of candidate genes known to affect brain development in these significantly linked regions or, alternatively, linkage of candidate genes selected a priori because of their presumptive contribution to the pathogenesis of autism.|PMID:11466160; Original text:After treatment, the patients showed significant improvement on the scores of the Yale--Brown Obsessive--Compulsive Scale -- Obsessions subscale and the Hamilton Anxiety Scale; Clinical Global Impressions -- Autism scores showed 3 of the patients much improved and 3 unchanged.
autism	disease_to_anatomy	, chromosomal	1	5.359	15121991	PMID:15121991; Original text:There are 3 main approaches to identifying genetic loci, chromosomal regions likely to contain relevant genes: 1) whole genome screens, searching for linkage of autism to shared genetic markers in populations of multiplex families (families with >1 affected family member; 2) cytogenetic studies that may guide molecular studies by pointing to relevant inherited or de novo chromosomal abnormalities in affected individuals and their families; and 3) evaluation of candidate genes known to affect brain development in these significantly linked regions or, alternatively, linkage of candidate genes selected a priori because of their presumptive contribution to the pathogenesis of autism.
chromosomal abnormalities	disease_to_anatomy	and 3	1	5.359	15121991	PMID:15121991; Original text:There are 3 main approaches to identifying genetic loci, chromosomal regions likely to contain relevant genes: 1) whole genome screens, searching for linkage of autism to shared genetic markers in populations of multiplex families (families with >1 affected family member; 2) cytogenetic studies that may guide molecular studies by pointing to relevant inherited or de novo chromosomal abnormalities in affected individuals and their families; and 3) evaluation of candidate genes known to affect brain development in these significantly linked regions or, alternatively, linkage of candidate genes selected a priori because of their presumptive contribution to the pathogenesis of autism.
chromosomal abnormalities	disease_to_anatomy	, chromosomal	1	5.359	15121991	PMID:15121991; Original text:There are 3 main approaches to identifying genetic loci, chromosomal regions likely to contain relevant genes: 1) whole genome screens, searching for linkage of autism to shared genetic markers in populations of multiplex families (families with >1 affected family member; 2) cytogenetic studies that may guide molecular studies by pointing to relevant inherited or de novo chromosomal abnormalities in affected individuals and their families; and 3) evaluation of candidate genes known to affect brain development in these significantly linked regions or, alternatively, linkage of candidate genes selected a priori because of their presumptive contribution to the pathogenesis of autism.
chromosomal	disease_to_anatomy	and 3	1	5.359	15121991	PMID:15121991; Original text:There are 3 main approaches to identifying genetic loci, chromosomal regions likely to contain relevant genes: 1) whole genome screens, searching for linkage of autism to shared genetic markers in populations of multiplex families (families with >1 affected family member; 2) cytogenetic studies that may guide molecular studies by pointing to relevant inherited or de novo chromosomal abnormalities in affected individuals and their families; and 3) evaluation of candidate genes known to affect brain development in these significantly linked regions or, alternatively, linkage of candidate genes selected a priori because of their presumptive contribution to the pathogenesis of autism.
chromosomal	disease_to_anatomy	, chromosomal	1	5.359	15121991	PMID:15121991; Original text:There are 3 main approaches to identifying genetic loci, chromosomal regions likely to contain relevant genes: 1) whole genome screens, searching for linkage of autism to shared genetic markers in populations of multiplex families (families with >1 affected family member; 2) cytogenetic studies that may guide molecular studies by pointing to relevant inherited or de novo chromosomal abnormalities in affected individuals and their families; and 3) evaluation of candidate genes known to affect brain development in these significantly linked regions or, alternatively, linkage of candidate genes selected a priori because of their presumptive contribution to the pathogenesis of autism.
tri	disease_to_anatomy	, and	1	1.549	31018221	PMID:31018221; Original text:Type of spasticity (hemiplegia > diplegia > tri/quadriplegia; OR [odds ratio] = 1.76, SE [standard error] = 0.2785, p = 0.04), communication disorders (OR = 7.442, SE = 0.59, p < 0.001), intellectual disability (OR = 2.27, SE = 0.43, p = 0.05), feeding abilities (OR = 0.35, SE = 0.35, p = 0.002), and motor function (OR = 0.59, SE = 0.22, p = 0.01) were significantly associated with disorder.
hemiplegia	disease_to_anatomy	, and	1	1.549	31018221	PMID:31018221; Original text:Type of spasticity (hemiplegia > diplegia > tri/quadriplegia; OR [odds ratio] = 1.76, SE [standard error] = 0.2785, p = 0.04), communication disorders (OR = 7.442, SE = 0.59, p < 0.001), intellectual disability (OR = 2.27, SE = 0.43, p = 0.05), feeding abilities (OR = 0.35, SE = 0.35, p = 0.002), and motor function (OR = 0.59, SE = 0.22, p = 0.01) were significantly associated with disorder.
diplegia	disease_to_anatomy	, and	1	1.549	31018221	PMID:31018221; Original text:Type of spasticity (hemiplegia > diplegia > tri/quadriplegia; OR [odds ratio] = 1.76, SE [standard error] = 0.2785, p = 0.04), communication disorders (OR = 7.442, SE = 0.59, p < 0.001), intellectual disability (OR = 2.27, SE = 0.43, p = 0.05), feeding abilities (OR = 0.35, SE = 0.35, p = 0.002), and motor function (OR = 0.59, SE = 0.22, p = 0.01) were significantly associated with disorder.
spasticity	disease_to_anatomy	, and	1	1.549	31018221	PMID:31018221; Original text:Type of spasticity (hemiplegia > diplegia > tri/quadriplegia; OR [odds ratio] = 1.76, SE [standard error] = 0.2785, p = 0.04), communication disorders (OR = 7.442, SE = 0.59, p < 0.001), intellectual disability (OR = 2.27, SE = 0.43, p = 0.05), feeding abilities (OR = 0.35, SE = 0.35, p = 0.002), and motor function (OR = 0.59, SE = 0.22, p = 0.01) were significantly associated with disorder.
communication disorders	disease_to_anatomy	, and	1	1.549	31018221	PMID:31018221; Original text:Type of spasticity (hemiplegia > diplegia > tri/quadriplegia; OR [odds ratio] = 1.76, SE [standard error] = 0.2785, p = 0.04), communication disorders (OR = 7.442, SE = 0.59, p < 0.001), intellectual disability (OR = 2.27, SE = 0.43, p = 0.05), feeding abilities (OR = 0.35, SE = 0.35, p = 0.002), and motor function (OR = 0.59, SE = 0.22, p = 0.01) were significantly associated with disorder.
quadriplegia	disease_to_anatomy	, and	1	1.549	31018221	PMID:31018221; Original text:Type of spasticity (hemiplegia > diplegia > tri/quadriplegia; OR [odds ratio] = 1.76, SE [standard error] = 0.2785, p = 0.04), communication disorders (OR = 7.442, SE = 0.59, p < 0.001), intellectual disability (OR = 2.27, SE = 0.43, p = 0.05), feeding abilities (OR = 0.35, SE = 0.35, p = 0.002), and motor function (OR = 0.59, SE = 0.22, p = 0.01) were significantly associated with disorder.
autistic	disease_to_anatomy	superior parietal	1	1.0	14561452	PMID:14561452; Original text:Within the task condition, a region-of-interest comparison of attend-left versus attend-right conditions indicated that modulation of activation in the autistic brain as a function of the lateral focus of spatial attention was abnormally decreased in the left ventral occipital cortex (P<0.03), abnormally increased in the left intraparietal sulcus (P<0.01), and abnormally variable in the superior parietal lobe (P<0.03).
autistic	disease_to_anatomy	parietal	1	1.0	14561452	PMID:14561452; Original text:Within the task condition, a region-of-interest comparison of attend-left versus attend-right conditions indicated that modulation of activation in the autistic brain as a function of the lateral focus of spatial attention was abnormally decreased in the left ventral occipital cortex (P<0.03), abnormally increased in the left intraparietal sulcus (P<0.01), and abnormally variable in the superior parietal lobe (P<0.03).
autistic	disease_to_anatomy	of the lateral	1	1.0	14561452	PMID:14561452; Original text:Within the task condition, a region-of-interest comparison of attend-left versus attend-right conditions indicated that modulation of activation in the autistic brain as a function of the lateral focus of spatial attention was abnormally decreased in the left ventral occipital cortex (P<0.03), abnormally increased in the left intraparietal sulcus (P<0.01), and abnormally variable in the superior parietal lobe (P<0.03).
autistic	disease_to_anatomy	the lateral	1	1.0	14561452	PMID:14561452; Original text:Within the task condition, a region-of-interest comparison of attend-left versus attend-right conditions indicated that modulation of activation in the autistic brain as a function of the lateral focus of spatial attention was abnormally decreased in the left ventral occipital cortex (P<0.03), abnormally increased in the left intraparietal sulcus (P<0.01), and abnormally variable in the superior parietal lobe (P<0.03).
autistic	disease_to_anatomy	intraparietal sulcus	1	1.0	14561452	PMID:14561452; Original text:Within the task condition, a region-of-interest comparison of attend-left versus attend-right conditions indicated that modulation of activation in the autistic brain as a function of the lateral focus of spatial attention was abnormally decreased in the left ventral occipital cortex (P<0.03), abnormally increased in the left intraparietal sulcus (P<0.01), and abnormally variable in the superior parietal lobe (P<0.03).
autistic	disease_to_anatomy	lobe (	1	1.0	14561452	PMID:14561452; Original text:Within the task condition, a region-of-interest comparison of attend-left versus attend-right conditions indicated that modulation of activation in the autistic brain as a function of the lateral focus of spatial attention was abnormally decreased in the left ventral occipital cortex (P<0.03), abnormally increased in the left intraparietal sulcus (P<0.01), and abnormally variable in the superior parietal lobe (P<0.03).
autistic	disease_to_anatomy	parietal lobe	1	1.0	14561452	PMID:14561452; Original text:Within the task condition, a region-of-interest comparison of attend-left versus attend-right conditions indicated that modulation of activation in the autistic brain as a function of the lateral focus of spatial attention was abnormally decreased in the left ventral occipital cortex (P<0.03), abnormally increased in the left intraparietal sulcus (P<0.01), and abnormally variable in the superior parietal lobe (P<0.03).
autistic	disease_to_anatomy	cortex (	1	1.0	14561452	PMID:14561452; Original text:Within the task condition, a region-of-interest comparison of attend-left versus attend-right conditions indicated that modulation of activation in the autistic brain as a function of the lateral focus of spatial attention was abnormally decreased in the left ventral occipital cortex (P<0.03), abnormally increased in the left intraparietal sulcus (P<0.01), and abnormally variable in the superior parietal lobe (P<0.03).
autistic	disease_to_anatomy	occipital cortex	1	1.0	14561452	PMID:14561452; Original text:Within the task condition, a region-of-interest comparison of attend-left versus attend-right conditions indicated that modulation of activation in the autistic brain as a function of the lateral focus of spatial attention was abnormally decreased in the left ventral occipital cortex (P<0.03), abnormally increased in the left intraparietal sulcus (P<0.01), and abnormally variable in the superior parietal lobe (P<0.03).
autistic	disease_to_anatomy	group of	1	1.0	15673999	PMID:15673999; Original text:An evaluation of vitamin B(6) levels prior to the study found that the autistic children had substantially elevated levels of B6 compared to a control group of typical children (75% higher, p < 0.0000001).
ear-occlusion	disease_to_anatomy	of ear	1	1.0	10755175	PMID:10755175; Original text:Significant differences tended to show that the control condition was superior on parent-rated measures of hyperactivity and on direct observational measures of ear-occlusion.
hyperactivity	disease_to_anatomy	of ear	1	1.0	10755175	PMID:10755175; Original text:Significant differences tended to show that the control condition was superior on parent-rated measures of hyperactivity and on direct observational measures of ear-occlusion.
mitochondrial disease	disease_to_anatomy	mitochondrial	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
mitochondrial disease	disease_to_anatomy	, motor	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
mitochondrial disease	disease_to_anatomy	, gastrointestinal	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
mitochondrial disease	disease_to_anatomy	, and	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
mitochondrial disease	disease_to_anatomy	, female	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
seizures	disease_to_anatomy	mitochondrial	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
seizures	disease_to_anatomy	, motor	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
seizures	disease_to_anatomy	, gastrointestinal	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
seizures	disease_to_anatomy	, and	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
seizures	disease_to_anatomy	, female	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
developmental regression	disease_to_anatomy	mitochondrial	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
developmental regression	disease_to_anatomy	, motor	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
developmental regression	disease_to_anatomy	, gastrointestinal	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
developmental regression	disease_to_anatomy	, and	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
developmental regression	disease_to_anatomy	, female	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
motor delay	disease_to_anatomy	mitochondrial	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
motor delay	disease_to_anatomy	, motor	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
motor delay	disease_to_anatomy	, gastrointestinal	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
motor delay	disease_to_anatomy	, and	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
motor delay	disease_to_anatomy	, female	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
asd	disease_to_anatomy	, motor	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
asd	disease_to_anatomy	, female	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
gastrointestinal abnormalities	disease_to_anatomy	mitochondrial	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
gastrointestinal abnormalities	disease_to_anatomy	, motor	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
gastrointestinal abnormalities	disease_to_anatomy	, gastrointestinal	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
gastrointestinal abnormalities	disease_to_anatomy	, and	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
gastrointestinal abnormalities	disease_to_anatomy	, female	1	12.384	21263444	PMID:21263444; Original text:The prevalence of developmental regression (52%), seizures (41%), motor delay (51%), gastrointestinal abnormalities (74%), female gender (39%), and elevated lactate (78%) and pyruvate (45%) was significantly higher in ASD/concomitant mitochondrial disease compared with the general ASD population.
asperger syndrome	disease_to_anatomy	the hippocampus	1	1.0	21948742	PMID:21948742; Original text:We compared, using magnetic resonance imaging, the in vivo anatomy of the hippocampus in 32 healthy individuals with Asperger syndrome (12-47 years) and 32 healthy controls who did not differ significantly in age or IQ.
asperger syndrome	disease_to_anatomy	hippocampus	1	1.0	21948742	PMID:21948742; Original text:We compared, using magnetic resonance imaging, the in vivo anatomy of the hippocampus in 32 healthy individuals with Asperger syndrome (12-47 years) and 32 healthy controls who did not differ significantly in age or IQ.
asperger syndrome	disease_to_anatomy	of the	3	3.0	21948742|21948742|8986845	PMID:21948742; Original text:We compared, using magnetic resonance imaging, the in vivo anatomy of the hippocampus in 32 healthy individuals with Asperger syndrome (12-47 years) and 32 healthy controls who did not differ significantly in age or IQ.|PMID:21948742; Original text:Individuals with Asperger syndrome have significant differences from controls in bulk volume and aging of the amygdala.|PMID:8986845; Original text:13 (76%) of the Asperger syndrome patients were rated as pedantic compared to 4 (31%) of the high-functioning autism group (chi 2 = 6.3; p = .01).
asperger syndrome	disease_to_anatomy	of the hippocampus	1	1.0	21948742	PMID:21948742; Original text:We compared, using magnetic resonance imaging, the in vivo anatomy of the hippocampus in 32 healthy individuals with Asperger syndrome (12-47 years) and 32 healthy controls who did not differ significantly in age or IQ.
asperger syndrome	disease_to_anatomy	and left	1	1.0	21948742	PMID:21948742; Original text:However, individuals with Asperger syndrome had a significantly larger raw bulk volume of total (P<0.01), right (P<0.01), and left amygdala (P<0.05); and when corrected for overall brain size, total (P<0.05), and right amygdala (P<0.01).
asperger syndrome	disease_to_anatomy	, and	2	2.0	21948742|21948742	PMID:21948742; Original text:However, individuals with Asperger syndrome had a significantly larger raw bulk volume of total (P<0.01), right (P<0.01), and left amygdala (P<0.05); and when corrected for overall brain size, total (P<0.05), and right amygdala (P<0.01).|PMID:21948742; Original text:There was a significant group difference in aging of left amygdala; controls, but not individuals with Asperger syndrome, had a significant age-related increase in volume (r = 0.486, P<0.01, and r = 0.007, P = 0.97, z = 1.995).
asperger syndrome	disease_to_anatomy	amygdala	3	3.0	21948742|21948742|21948742	PMID:21948742; Original text:However, individuals with Asperger syndrome had a significantly larger raw bulk volume of total (P<0.01), right (P<0.01), and left amygdala (P<0.05); and when corrected for overall brain size, total (P<0.05), and right amygdala (P<0.01).|PMID:21948742; Original text:There was a significant group difference in aging of left amygdala; controls, but not individuals with Asperger syndrome, had a significant age-related increase in volume (r = 0.486, P<0.01, and r = 0.007, P = 0.97, z = 1.995).|PMID:21948742; Original text:Individuals with Asperger syndrome have significant differences from controls in bulk volume and aging of the amygdala.
asperger syndrome	disease_to_anatomy	, right	1	1.0	21948742	PMID:21948742; Original text:However, individuals with Asperger syndrome had a significantly larger raw bulk volume of total (P<0.01), right (P<0.01), and left amygdala (P<0.05); and when corrected for overall brain size, total (P<0.05), and right amygdala (P<0.01).
asperger syndrome	disease_to_anatomy	, z	1	1.0	21948742	PMID:21948742; Original text:There was a significant group difference in aging of left amygdala; controls, but not individuals with Asperger syndrome, had a significant age-related increase in volume (r = 0.486, P<0.01, and r = 0.007, P = 0.97, z = 1.995).
asperger syndrome	disease_to_anatomy	the amygdala	1	1.0	21948742	PMID:21948742; Original text:Individuals with Asperger syndrome have significant differences from controls in bulk volume and aging of the amygdala.
asperger syndrome	disease_to_anatomy	of the amygdala	1	1.0	21948742	PMID:21948742; Original text:Individuals with Asperger syndrome have significant differences from controls in bulk volume and aging of the amygdala.
dietdos	disease_to_anatomy	point	1	4.028	20406576	PMID:20406576; Original text:diett this point, there was a significant improvement to mean diet group scores (time*treatment interaction) on sub-domains of dietDOS, GdietRS and dietDHD-IV measures.
dietdhd	disease_to_anatomy	point	1	4.028	20406576	PMID:20406576; Original text:diett this point, there was a significant improvement to mean diet group scores (time*treatment interaction) on sub-domains of dietDOS, GdietRS and dietDHD-IV measures.
spectrum disorders	disease_to_anatomy	, red	1	1.0	28965590	PMID:28965590; Original text:The mercury level in whole blood (Hedges=0.43, 95% its 95% corresponding confidence interval: 0.12, 0.74, P=0.007), red blood cells (Hedges=1.61, 95% its 95% corresponding confidence interval: 0.83, 2.38, P<0.001), and brain (0.61ng/g, 95% its 95% corresponding confidence interval, 0.02, 1.19, P=0.043) was significantly higher in spectrum disorders patients than healthy subjects, whereas mercury level in hair (-0.14mg/g, 95% its 95% corresponding confidence interval: -0.28, -0.01, P=0.039) was significantly lower in spectrum disorders patients than healthy subjects.
spectrum disorders	disease_to_anatomy	whole blood	1	1.0	28965590	PMID:28965590; Original text:The mercury level in whole blood (Hedges=0.43, 95% its 95% corresponding confidence interval: 0.12, 0.74, P=0.007), red blood cells (Hedges=1.61, 95% its 95% corresponding confidence interval: 0.83, 2.38, P<0.001), and brain (0.61ng/g, 95% its 95% corresponding confidence interval, 0.02, 1.19, P=0.043) was significantly higher in spectrum disorders patients than healthy subjects, whereas mercury level in hair (-0.14mg/g, 95% its 95% corresponding confidence interval: -0.28, -0.01, P=0.039) was significantly lower in spectrum disorders patients than healthy subjects.
spectrum disorders	disease_to_anatomy	red blood cells	1	1.0	28965590	PMID:28965590; Original text:The mercury level in whole blood (Hedges=0.43, 95% its 95% corresponding confidence interval: 0.12, 0.74, P=0.007), red blood cells (Hedges=1.61, 95% its 95% corresponding confidence interval: 0.83, 2.38, P<0.001), and brain (0.61ng/g, 95% its 95% corresponding confidence interval, 0.02, 1.19, P=0.043) was significantly higher in spectrum disorders patients than healthy subjects, whereas mercury level in hair (-0.14mg/g, 95% its 95% corresponding confidence interval: -0.28, -0.01, P=0.039) was significantly lower in spectrum disorders patients than healthy subjects.
spectrum disorders	disease_to_anatomy	cells (	1	1.0	28965590	PMID:28965590; Original text:The mercury level in whole blood (Hedges=0.43, 95% its 95% corresponding confidence interval: 0.12, 0.74, P=0.007), red blood cells (Hedges=1.61, 95% its 95% corresponding confidence interval: 0.83, 2.38, P<0.001), and brain (0.61ng/g, 95% its 95% corresponding confidence interval, 0.02, 1.19, P=0.043) was significantly higher in spectrum disorders patients than healthy subjects, whereas mercury level in hair (-0.14mg/g, 95% its 95% corresponding confidence interval: -0.28, -0.01, P=0.039) was significantly lower in spectrum disorders patients than healthy subjects.
spectrum disorders	disease_to_anatomy	blood cells	1	1.0	28965590	PMID:28965590; Original text:The mercury level in whole blood (Hedges=0.43, 95% its 95% corresponding confidence interval: 0.12, 0.74, P=0.007), red blood cells (Hedges=1.61, 95% its 95% corresponding confidence interval: 0.83, 2.38, P<0.001), and brain (0.61ng/g, 95% its 95% corresponding confidence interval, 0.02, 1.19, P=0.043) was significantly higher in spectrum disorders patients than healthy subjects, whereas mercury level in hair (-0.14mg/g, 95% its 95% corresponding confidence interval: -0.28, -0.01, P=0.039) was significantly lower in spectrum disorders patients than healthy subjects.
spectrum disorders	disease_to_anatomy	red blood	1	1.0	28965590	PMID:28965590; Original text:The mercury level in whole blood (Hedges=0.43, 95% its 95% corresponding confidence interval: 0.12, 0.74, P=0.007), red blood cells (Hedges=1.61, 95% its 95% corresponding confidence interval: 0.83, 2.38, P<0.001), and brain (0.61ng/g, 95% its 95% corresponding confidence interval, 0.02, 1.19, P=0.043) was significantly higher in spectrum disorders patients than healthy subjects, whereas mercury level in hair (-0.14mg/g, 95% its 95% corresponding confidence interval: -0.28, -0.01, P=0.039) was significantly lower in spectrum disorders patients than healthy subjects.
spectrum disorders	disease_to_anatomy	, red blood	1	1.0	28965590	PMID:28965590; Original text:The mercury level in whole blood (Hedges=0.43, 95% its 95% corresponding confidence interval: 0.12, 0.74, P=0.007), red blood cells (Hedges=1.61, 95% its 95% corresponding confidence interval: 0.83, 2.38, P<0.001), and brain (0.61ng/g, 95% its 95% corresponding confidence interval, 0.02, 1.19, P=0.043) was significantly higher in spectrum disorders patients than healthy subjects, whereas mercury level in hair (-0.14mg/g, 95% its 95% corresponding confidence interval: -0.28, -0.01, P=0.039) was significantly lower in spectrum disorders patients than healthy subjects.
asd	disease_to_anatomy	monocyte	1	12.384	24934179	PMID:24934179; Original text:Concentrations of interleukin (interleukin)-1beta (P<0.001), interleukin-6 (P=0.03), interleukin-8 (P=0.04), interferon-gamma (P=0.02), eotaxin (P=0.01) and monocyte chemotactic protein-1 (P<0.05) were significantly higher in the participants with ASD compared with the HC group, while concentrations of transforming growth factor-β1 were significantly lower (P<0.001).
asd	disease_to_anatomy	group	2	18.277	24934179|32305492	PMID:24934179; Original text:Concentrations of interleukin (interleukin)-1beta (P<0.001), interleukin-6 (P=0.03), interleukin-8 (P=0.04), interferon-gamma (P=0.02), eotaxin (P=0.01) and monocyte chemotactic protein-1 (P<0.05) were significantly higher in the participants with ASD compared with the HC group, while concentrations of transforming growth factor-β1 were significantly lower (P<0.001).|PMID:32305492; Original text:Compared to children in the control group, significantly lower levels of acetic acid, propionic acid and butyric acid were found, and a hyperserotonergic state (increased serotonin) and dopamine metabolism disorder (decreased homovanillic acid) were observed in children with ASD.
asd	disease_to_anatomy	of superficial	1	1.0	19708861	PMID:19708861; Original text:There is a need for caution in interpreting the significance of superficial similarities between ASD and the behavioural phenotypes of certain genetically determined syndromes.
autistic	disease_to_anatomy	medial prefrontal	1	1.0	26336909	PMID:26336909; Original text:Moreover, using the same social-judgement task as used in our previous single-dose oxytocin trial, we confirmed that the current continual administration also significantly mitigated behavioural and neural responses during the task, both of which were originally impaired in autistic individuals (judgement tendency: P = 0.019, d = 0.62; eye-gaze effect: P = 0.03, d = 0.56; anterior cingulate activity: P = 0.00069, d = 0.97; dorso-medial prefrontal activity: P = 0.0014, d = 0.92; all, PFDR < 0.05).
autistic	disease_to_anatomy	anterior cingulate	1	1.0	26336909	PMID:26336909; Original text:Moreover, using the same social-judgement task as used in our previous single-dose oxytocin trial, we confirmed that the current continual administration also significantly mitigated behavioural and neural responses during the task, both of which were originally impaired in autistic individuals (judgement tendency: P = 0.019, d = 0.62; eye-gaze effect: P = 0.03, d = 0.56; anterior cingulate activity: P = 0.00069, d = 0.97; dorso-medial prefrontal activity: P = 0.0014, d = 0.92; all, PFDR < 0.05).
asd	disease_to_anatomy	(ci	1	1.0	27120988	PMID:27120988; Original text:This random-effects meta-analysis of spoken-language outcomes for children with ASD who received early intervention as compared with usual treatments yielded a significant overall mean effect size of g = 0.26 (CI = 0.11 to 0.42).
neurodevelopmental disorders	disease_to_anatomy	of the	1	12.891	30563709	PMID:30563709; Original text:Advances in sequencing technology have significantly expanded our understanding of the genetics of autism and neurodevelopmental disorders (neurodevelopmental disorders).
autism	disease_to_anatomy	white matter	1	1.0	17531541	PMID:17531541; Original text:One final point is the initial overgrowth of white matter in the first 2 years of life in autistic children, followed later by arrested growth, resulting in aberrant connectivity; myelination of white matter will likely be significant in the etiology of autism.
autism	disease_to_anatomy	myelination	1	1.0	17531541	PMID:17531541; Original text:One final point is the initial overgrowth of white matter in the first 2 years of life in autistic children, followed later by arrested growth, resulting in aberrant connectivity; myelination of white matter will likely be significant in the etiology of autism.
autistic	disease_to_anatomy	white matter	1	1.0	17531541	PMID:17531541; Original text:One final point is the initial overgrowth of white matter in the first 2 years of life in autistic children, followed later by arrested growth, resulting in aberrant connectivity; myelination of white matter will likely be significant in the etiology of autism.
autistic	disease_to_anatomy	myelination	1	1.0	17531541	PMID:17531541; Original text:One final point is the initial overgrowth of white matter in the first 2 years of life in autistic children, followed later by arrested growth, resulting in aberrant connectivity; myelination of white matter will likely be significant in the etiology of autism.
disruptive behavior	disease_to_anatomy	, and	1	13.946	24061784	PMID:24061784; Original text:Several baseline predictors of response were identified, and a principal component analysis yielded 3 composite measures (disruptive behavior, autism/mood, and caregiver strain) that significantly predicted response at week 12.
mood	disease_to_anatomy	, and	1	13.946	24061784	PMID:24061784; Original text:Several baseline predictors of response were identified, and a principal component analysis yielded 3 composite measures (disruptive behavior, autism/mood, and caregiver strain) that significantly predicted response at week 12.
autism	disease_to_anatomy	complex	1	2.89	32563542	PMID:32563542; Original text:Recently, significant progress has been possible with the prospective calculation of the prevalence of autism in Tuberous sclerosis complex, identification of early clinical and neurophysiological biomarkers to predict autism, and investigation of different therapies to prevent autism in this high-risk population.
tuberous sclerosis	disease_to_anatomy	of the	1	2.89	32563542	PMID:32563542; Original text:Recently, significant progress has been possible with the prospective calculation of the prevalence of autism in Tuberous sclerosis complex, identification of early clinical and neurophysiological biomarkers to predict autism, and investigation of different therapies to prevent autism in this high-risk population.
autistic symptoms	disease_to_anatomy	of the	1	1.713	9512308	PMID:9512308; Original text:Only in one child was there a very significant improvement, with almost total amelioration of autistic symptoms over the time period of the four infusions.
irritability	disease_to_anatomy	1	1	1.295	32168067	PMID:32168067; Original text:Repeated-measures analysis demonstrated significant effect for time-treatment interaction in the Childhood Autism Rating Scale (F (1, 2.23) = 13.22, P < 0.001), as well as 4 subscales of the ABC-C including: irritability (F (1, 2.12) = 3.84, P = 0.026), hyperactivity (F (1, 2.09) = 3.56, P = 0.039), lethargy (F (1, 2.18) = 31.50, P < 0.001), and stereotypy (F (1, 1.89) = 4.04, P = 0.026).
stereotypy	disease_to_anatomy	of the	2	2.59	32168067|32947424	PMID:32168067; Original text:Repeated-measures analysis demonstrated significant effect for time-treatment interaction in the Childhood Autism Rating Scale (F (1, 2.23) = 13.22, P < 0.001), as well as 4 subscales of the ABC-C including: irritability (F (1, 2.12) = 3.84, P = 0.026), hyperactivity (F (1, 2.09) = 3.56, P = 0.039), lethargy (F (1, 2.18) = 31.50, P < 0.001), and stereotypy (F (1, 1.89) = 4.04, P = 0.026).|PMID:32947424; Original text:Repeated measures analysis was suggestive of greater exhibited improvement for the pregnenolone group on irritability, stereotypy, and hyperactivity subscales of the Aberrant Behavior Checklist-Community Edition over the trial period (F = 3.84, df = 1.96, P = 0.025; F = 4.29, df = 1.39, P = 0.029; F = 6.55, df = 1.67, P = 0.004, respectively).
stereotypy	disease_to_anatomy	1	1	1.295	32168067	PMID:32168067; Original text:Repeated-measures analysis demonstrated significant effect for time-treatment interaction in the Childhood Autism Rating Scale (F (1, 2.23) = 13.22, P < 0.001), as well as 4 subscales of the ABC-C including: irritability (F (1, 2.12) = 3.84, P = 0.026), hyperactivity (F (1, 2.09) = 3.56, P = 0.039), lethargy (F (1, 2.18) = 31.50, P < 0.001), and stereotypy (F (1, 1.89) = 4.04, P = 0.026).
stereotypy	disease_to_anatomy	, and	3	4.499	32168067|19284641|32947424	PMID:32168067; Original text:Repeated-measures analysis demonstrated significant effect for time-treatment interaction in the Childhood Autism Rating Scale (F (1, 2.23) = 13.22, P < 0.001), as well as 4 subscales of the ABC-C including: irritability (F (1, 2.12) = 3.84, P = 0.026), hyperactivity (F (1, 2.09) = 3.56, P = 0.039), lethargy (F (1, 2.18) = 31.50, P < 0.001), and stereotypy (F (1, 1.89) = 4.04, P = 0.026).|PMID:19284641; Original text:On the Aberrant Behavior Checklist, significant improvements were observed in the tre1.3 atmosphereent group in total score, irritability, stereotypy, hyperactivity, and speech (p < 0.03 for each), but not in the control group.|PMID:32947424; Original text:Repeated measures analysis was suggestive of greater exhibited improvement for the pregnenolone group on irritability, stereotypy, and hyperactivity subscales of the Aberrant Behavior Checklist-Community Edition over the trial period (F = 3.84, df = 1.96, P = 0.025; F = 4.29, df = 1.39, P = 0.029; F = 6.55, df = 1.67, P = 0.004, respectively).
autism	disease_to_anatomy	1	1	1.295	32168067	PMID:32168067; Original text:Repeated-measures analysis demonstrated significant effect for time-treatment interaction in the Childhood Autism Rating Scale (F (1, 2.23) = 13.22, P < 0.001), as well as 4 subscales of the ABC-C including: irritability (F (1, 2.12) = 3.84, P = 0.026), hyperactivity (F (1, 2.09) = 3.56, P = 0.039), lethargy (F (1, 2.18) = 31.50, P < 0.001), and stereotypy (F (1, 1.89) = 4.04, P = 0.026).
lethargy	disease_to_anatomy	of the	2	5.236	32168067|30980177	PMID:32168067; Original text:Repeated-measures analysis demonstrated significant effect for time-treatment interaction in the Childhood Autism Rating Scale (F (1, 2.23) = 13.22, P < 0.001), as well as 4 subscales of the ABC-C including: irritability (F (1, 2.12) = 3.84, P = 0.026), hyperactivity (F (1, 2.09) = 3.56, P = 0.039), lethargy (F (1, 2.18) = 31.50, P < 0.001), and stereotypy (F (1, 1.89) = 4.04, P = 0.026).|PMID:30980177; Original text:Analysis of the combined data revealed significant improvement for all the ABC subscales (irritability: F = 51.644, df = 1.66, p < 0.001, lethargy: F = 39.734, df = 1.38, p < 0.001, stereotypic behavior: F = 25.495, df = 1.56, p < 0.001, hyperactivity: F = 54.135, df = 1.35, p < 0.001, and inappropriate speech: F = 19.277, df = 1.47, p = 0.004).
lethargy	disease_to_anatomy	1	1	1.295	32168067	PMID:32168067; Original text:Repeated-measures analysis demonstrated significant effect for time-treatment interaction in the Childhood Autism Rating Scale (F (1, 2.23) = 13.22, P < 0.001), as well as 4 subscales of the ABC-C including: irritability (F (1, 2.12) = 3.84, P = 0.026), hyperactivity (F (1, 2.09) = 3.56, P = 0.039), lethargy (F (1, 2.18) = 31.50, P < 0.001), and stereotypy (F (1, 1.89) = 4.04, P = 0.026).
lethargy	disease_to_anatomy	, and	3	7.430999999999999	32168067|30980177|29027815	PMID:32168067; Original text:Repeated-measures analysis demonstrated significant effect for time-treatment interaction in the Childhood Autism Rating Scale (F (1, 2.23) = 13.22, P < 0.001), as well as 4 subscales of the ABC-C including: irritability (F (1, 2.12) = 3.84, P = 0.026), hyperactivity (F (1, 2.09) = 3.56, P = 0.039), lethargy (F (1, 2.18) = 31.50, P < 0.001), and stereotypy (F (1, 1.89) = 4.04, P = 0.026).|PMID:30980177; Original text:Analysis of the combined data revealed significant improvement for all the ABC subscales (irritability: F = 51.644, df = 1.66, p < 0.001, lethargy: F = 39.734, df = 1.38, p < 0.001, stereotypic behavior: F = 25.495, df = 1.56, p < 0.001, hyperactivity: F = 54.135, df = 1.35, p < 0.001, and inappropriate speech: F = 19.277, df = 1.47, p = 0.004).|PMID:29027815; Original text:No significant improvements were obtained on the lethargy/social withdrawal, stereotypic behavior, and inappropriate speech subscale scores.
hyperactivity	disease_to_anatomy	1	1	1.295	32168067	PMID:32168067; Original text:Repeated-measures analysis demonstrated significant effect for time-treatment interaction in the Childhood Autism Rating Scale (F (1, 2.23) = 13.22, P < 0.001), as well as 4 subscales of the ABC-C including: irritability (F (1, 2.12) = 3.84, P = 0.026), hyperactivity (F (1, 2.09) = 3.56, P = 0.039), lethargy (F (1, 2.18) = 31.50, P < 0.001), and stereotypy (F (1, 1.89) = 4.04, P = 0.026).
attention-deficit/hyperactivity disorder	disease_to_anatomy	, and	3	7.401999999999999	23782128|15090875|30446273	PMID:23782128; Original text:(DSM-IV-TR) criteria for an autism spectrum disorder (disorder) on the Autism Diagnostic Interview-Revised (-Revised) and the Autism Diagnostic Observation Schedule (the Autism Diagnostic Observation Schedule), and had significant symptoms of attention-deficit/hyperactivity disorder (attention-deficit/hyperactivity disorder).|PMID:15090875; Original text:Recent oculomotor studies have made significant contributions to the understanding of neurodevelopmental disorders, most notably in autism, attention-deficit/hyperactivity disorder, and Tourette's syndrome.|PMID:30446273; Original text:Assessing the occurrence of ASD and Attention-Deficit/Hyperactivity Disorder would improve the significant cost of healthcare, therapies, and overall daily living for families with children affected by Cerebral Palsy.
conduct problem	disease_to_anatomy	, a	1	1.0	20001837	PMID:20001837; Original text:However, results from the Conners' Parent Questionnaire revealed an improvement only for anxiety (p = 0.04) in the massage group, whereas when both groups were compared, a significant improvement in conduct problem (p = 0.03) and anxiety (p = 0.01) was found.
conduct problem	disease_to_anatomy	(p	1	1.0	20001837	PMID:20001837; Original text:However, results from the Conners' Parent Questionnaire revealed an improvement only for anxiety (p = 0.04) in the massage group, whereas when both groups were compared, a significant improvement in conduct problem (p = 0.03) and anxiety (p = 0.01) was found.
conduct problem	disease_to_anatomy	group	1	1.0	20001837	PMID:20001837; Original text:However, results from the Conners' Parent Questionnaire revealed an improvement only for anxiety (p = 0.04) in the massage group, whereas when both groups were compared, a significant improvement in conduct problem (p = 0.03) and anxiety (p = 0.01) was found.
anxiety	disease_to_anatomy	, a	1	1.0	20001837	PMID:20001837; Original text:However, results from the Conners' Parent Questionnaire revealed an improvement only for anxiety (p = 0.04) in the massage group, whereas when both groups were compared, a significant improvement in conduct problem (p = 0.03) and anxiety (p = 0.01) was found.
attention deficit hyperactivity disorder	disease_to_anatomy	default mode network	1	5.263	33403915	PMID:33403915; Original text:Given the significant clinical and genetic overlap between spectrum disorders and attention deficit hyperactivity disorder, surprisingly, no reviews have compared the clinical, developmental, and genetic correlates of in particular, the default mode network in spectrum disorders and attention deficit hyperactivity disorder and here we address this knowledge gap.
attention deficit hyperactivity disorder	disease_to_anatomy	, and	2	7.688	33403915|32840005	PMID:33403915; Original text:Given the significant clinical and genetic overlap between spectrum disorders and attention deficit hyperactivity disorder, surprisingly, no reviews have compared the clinical, developmental, and genetic correlates of in particular, the default mode network in spectrum disorders and attention deficit hyperactivity disorder and here we address this knowledge gap.|PMID:32840005; Original text:Most of the meta-analyses reported that compared to non-users, the risks of preterm birth, low birth weight, spontaneous abortion, persistent pulmonary hypertension, autism spectrum disorders, and attention deficit hyperactivity disorder in offspring of antidepressant users were significantly higher.
attention deficit hyperactivity disorder	disease_to_anatomy	default mode	1	5.263	33403915	PMID:33403915; Original text:Given the significant clinical and genetic overlap between spectrum disorders and attention deficit hyperactivity disorder, surprisingly, no reviews have compared the clinical, developmental, and genetic correlates of in particular, the default mode network in spectrum disorders and attention deficit hyperactivity disorder and here we address this knowledge gap.
attention deficit hyperactivity disorder	disease_to_anatomy	mode network	1	5.263	33403915	PMID:33403915; Original text:Given the significant clinical and genetic overlap between spectrum disorders and attention deficit hyperactivity disorder, surprisingly, no reviews have compared the clinical, developmental, and genetic correlates of in particular, the default mode network in spectrum disorders and attention deficit hyperactivity disorder and here we address this knowledge gap.
spectrum disorders	disease_to_anatomy	default mode network	1	5.263	33403915	PMID:33403915; Original text:Given the significant clinical and genetic overlap between spectrum disorders and attention deficit hyperactivity disorder, surprisingly, no reviews have compared the clinical, developmental, and genetic correlates of in particular, the default mode network in spectrum disorders and attention deficit hyperactivity disorder and here we address this knowledge gap.
spectrum disorders	disease_to_anatomy	default mode	1	5.263	33403915	PMID:33403915; Original text:Given the significant clinical and genetic overlap between spectrum disorders and attention deficit hyperactivity disorder, surprisingly, no reviews have compared the clinical, developmental, and genetic correlates of in particular, the default mode network in spectrum disorders and attention deficit hyperactivity disorder and here we address this knowledge gap.
spectrum disorders	disease_to_anatomy	mode network	1	5.263	33403915	PMID:33403915; Original text:Given the significant clinical and genetic overlap between spectrum disorders and attention deficit hyperactivity disorder, surprisingly, no reviews have compared the clinical, developmental, and genetic correlates of in particular, the default mode network in spectrum disorders and attention deficit hyperactivity disorder and here we address this knowledge gap.
social and attention problems	disease_to_anatomy	of the	1	3.291	25804268	PMID:25804268; Original text:At post-treatment, participants showed significant improvements on all subscales of the Social Responsiveness Scale (P < 0.01) and the Social and Attention Problems syndrome scales of the Child Behavior Checklist (P < 0.05).
social and attention problems	disease_to_anatomy	(p	1	3.291	25804268	PMID:25804268; Original text:At post-treatment, participants showed significant improvements on all subscales of the Social Responsiveness Scale (P < 0.01) and the Social and Attention Problems syndrome scales of the Child Behavior Checklist (P < 0.05).
social	disease_to_anatomy	(p	1	3.291	25804268	PMID:25804268; Original text:At post-treatment, participants showed significant improvements on all subscales of the Social Responsiveness Scale (P < 0.01) and the Social and Attention Problems syndrome scales of the Child Behavior Checklist (P < 0.05).
stereotypic behavior	disease_to_anatomy	of the	1	3.941	30980177	PMID:30980177; Original text:Analysis of the combined data revealed significant improvement for all the ABC subscales (irritability: F = 51.644, df = 1.66, p < 0.001, lethargy: F = 39.734, df = 1.38, p < 0.001, stereotypic behavior: F = 25.495, df = 1.56, p < 0.001, hyperactivity: F = 54.135, df = 1.35, p < 0.001, and inappropriate speech: F = 19.277, df = 1.47, p = 0.004).
stereotypic behavior	disease_to_anatomy	, and	1	3.941	30980177	PMID:30980177; Original text:Analysis of the combined data revealed significant improvement for all the ABC subscales (irritability: F = 51.644, df = 1.66, p < 0.001, lethargy: F = 39.734, df = 1.38, p < 0.001, stereotypic behavior: F = 25.495, df = 1.56, p < 0.001, hyperactivity: F = 54.135, df = 1.35, p < 0.001, and inappropriate speech: F = 19.277, df = 1.47, p = 0.004).
inappropriate speech	disease_to_anatomy	of the	1	3.941	30980177	PMID:30980177; Original text:Analysis of the combined data revealed significant improvement for all the ABC subscales (irritability: F = 51.644, df = 1.66, p < 0.001, lethargy: F = 39.734, df = 1.38, p < 0.001, stereotypic behavior: F = 25.495, df = 1.56, p < 0.001, hyperactivity: F = 54.135, df = 1.35, p < 0.001, and inappropriate speech: F = 19.277, df = 1.47, p = 0.004).
inappropriate speech	disease_to_anatomy	, and	3	7.135999999999999	30980177|29027815|33029705	PMID:30980177; Original text:Analysis of the combined data revealed significant improvement for all the ABC subscales (irritability: F = 51.644, df = 1.66, p < 0.001, lethargy: F = 39.734, df = 1.38, p < 0.001, stereotypic behavior: F = 25.495, df = 1.56, p < 0.001, hyperactivity: F = 54.135, df = 1.35, p < 0.001, and inappropriate speech: F = 19.277, df = 1.47, p = 0.004).|PMID:29027815; Original text:No significant improvements were obtained on the lethargy/social withdrawal, stereotypic behavior, and inappropriate speech subscale scores.|PMID:33029705; Original text:The repeated measures analysis showed significant effect for time × treatment interaction on inappropriate speech (F = 3.51; df = 1.61; P = 0.044), stereotypic behavior (F = 4.02; df = 1.37; P = 0.036), and hyperactivity/noncompliance (F = 6.79; df = 1.66; P = 0.003) subscale scores.
depression	disease_to_anatomy	(p	1	1.0	24408892	PMID:24408892; Original text:Results for treatment outcome suggest that the a treatment group showed significant improvement in communication and social interaction domain scores on the Autism Diagnostic Observation Schedule, interpersonal relationship and play/leisure time on the subdomain scores of the Korean version of the Vineland Adaptive Behavior Scale (p's < 0.01), social skills knowledge total scores on the Test of Adolescent Social Skills Knowledge-Revised (p < 0.01), and decreased depressive symptoms on the Child Depression Inventory following treatment (p < 0.05).
depressive symptoms	disease_to_anatomy	of the	1	1.0	24408892	PMID:24408892; Original text:Results for treatment outcome suggest that the a treatment group showed significant improvement in communication and social interaction domain scores on the Autism Diagnostic Observation Schedule, interpersonal relationship and play/leisure time on the subdomain scores of the Korean version of the Vineland Adaptive Behavior Scale (p's < 0.01), social skills knowledge total scores on the Test of Adolescent Social Skills Knowledge-Revised (p < 0.01), and decreased depressive symptoms on the Child Depression Inventory following treatment (p < 0.05).
depressive symptoms	disease_to_anatomy	(p	1	1.0	24408892	PMID:24408892; Original text:Results for treatment outcome suggest that the a treatment group showed significant improvement in communication and social interaction domain scores on the Autism Diagnostic Observation Schedule, interpersonal relationship and play/leisure time on the subdomain scores of the Korean version of the Vineland Adaptive Behavior Scale (p's < 0.01), social skills knowledge total scores on the Test of Adolescent Social Skills Knowledge-Revised (p < 0.01), and decreased depressive symptoms on the Child Depression Inventory following treatment (p < 0.05).
depressive symptoms	disease_to_anatomy	, and	1	1.0	24408892	PMID:24408892; Original text:Results for treatment outcome suggest that the a treatment group showed significant improvement in communication and social interaction domain scores on the Autism Diagnostic Observation Schedule, interpersonal relationship and play/leisure time on the subdomain scores of the Korean version of the Vineland Adaptive Behavior Scale (p's < 0.01), social skills knowledge total scores on the Test of Adolescent Social Skills Knowledge-Revised (p < 0.01), and decreased depressive symptoms on the Child Depression Inventory following treatment (p < 0.05).
depressive	disease_to_anatomy	, and	1	1.0	24408892	PMID:24408892; Original text:In an a randomized controlled trial, participants receiving the PEERS(®) treatment showed significant improvement in social skills knowledge, interpersonal skills, and play/leisure skills, as well as a decrease in depressive symptoms and disorder symptoms.
asd	disease_to_anatomy	system	1	1.0	22638012	PMID:22638012; Original text:While some individuals with ASD have significant differences in the serotonin system, to our knowledge, no one has investigated its role during facial emotion processing in adults with ASD and control subjects using acute tryptophan depletion (acute tryptophan depletion) and functional magnetic resonance imaging.
asd	disease_to_anatomy	of facial	1	1.0	22638012	PMID:22638012; Original text:Modulation of the processing of facial expressions of emotion by serotonin significantly differs in people with ASD compared with control subjects.
respiratory distress	disease_to_anatomy	of respiratory	1	5.524	25004304	PMID:25004304; Original text:Low-strength evidence suggested neonates of pregnant women with depression taking selective serotonin reuptake inhibitors had higher risk of respiratory distress than did neonates of untreated women (13.9% compared with 7.8%; P<.001) but no difference in risk of neonatal convulsions (0.14% compared with 0.11%; P=.64) or preterm birth (17% compared with 10%; P=.07).
depression	disease_to_anatomy	of respiratory	1	5.524	25004304	PMID:25004304; Original text:Low-strength evidence suggested neonates of pregnant women with depression taking selective serotonin reuptake inhibitors had higher risk of respiratory distress than did neonates of untreated women (13.9% compared with 7.8%; P<.001) but no difference in risk of neonatal convulsions (0.14% compared with 0.11%; P=.64) or preterm birth (17% compared with 10%; P=.07).
preterm birth	disease_to_anatomy	of respiratory	1	5.524	25004304	PMID:25004304; Original text:Low-strength evidence suggested neonates of pregnant women with depression taking selective serotonin reuptake inhibitors had higher risk of respiratory distress than did neonates of untreated women (13.9% compared with 7.8%; P<.001) but no difference in risk of neonatal convulsions (0.14% compared with 0.11%; P=.64) or preterm birth (17% compared with 10%; P=.07).
convulsions	disease_to_anatomy	of respiratory	1	5.524	25004304	PMID:25004304; Original text:Low-strength evidence suggested neonates of pregnant women with depression taking selective serotonin reuptake inhibitors had higher risk of respiratory distress than did neonates of untreated women (13.9% compared with 7.8%; P<.001) but no difference in risk of neonatal convulsions (0.14% compared with 0.11%; P=.64) or preterm birth (17% compared with 10%; P=.07).
autism spectrum disorders	disease_to_anatomy	hippocampus	1	6.936	23452684	PMID:23452684; Original text:activation likelihood estimation meta-analyses of social tasks showed that children and adolescents with autism spectrum disorders versus adults had significantly greater hyperactivation in the left post-central gyrus, and greater hypoactivation in the right hippocampus and right superior temporal gyrus.
autism spectrum disorders	disease_to_anatomy	central gyrus	1	6.936	23452684	PMID:23452684; Original text:activation likelihood estimation meta-analyses of social tasks showed that children and adolescents with autism spectrum disorders versus adults had significantly greater hyperactivation in the left post-central gyrus, and greater hypoactivation in the right hippocampus and right superior temporal gyrus.
autism spectrum disorders	disease_to_anatomy	superior temporal	1	6.936	23452684	PMID:23452684; Original text:activation likelihood estimation meta-analyses of social tasks showed that children and adolescents with autism spectrum disorders versus adults had significantly greater hyperactivation in the left post-central gyrus, and greater hypoactivation in the right hippocampus and right superior temporal gyrus.
autism spectrum disorders	disease_to_anatomy	temporal gyrus	1	6.936	23452684	PMID:23452684; Original text:activation likelihood estimation meta-analyses of social tasks showed that children and adolescents with autism spectrum disorders versus adults had significantly greater hyperactivation in the left post-central gyrus, and greater hypoactivation in the right hippocampus and right superior temporal gyrus.
autism spectrum disorders	disease_to_anatomy	superior temporal gyrus	1	6.936	23452684	PMID:23452684; Original text:activation likelihood estimation meta-analyses of social tasks showed that children and adolescents with autism spectrum disorders versus adults had significantly greater hyperactivation in the left post-central gyrus, and greater hypoactivation in the right hippocampus and right superior temporal gyrus.
autism spectrum disorders	disease_to_anatomy	temporal	1	6.936	23452684	PMID:23452684; Original text:activation likelihood estimation meta-analyses of social tasks showed that children and adolescents with autism spectrum disorders versus adults had significantly greater hyperactivation in the left post-central gyrus, and greater hypoactivation in the right hippocampus and right superior temporal gyrus.
autism spectrum disorders	disease_to_anatomy	gyrus	2	13.872	23452684|23452684	PMID:23452684; Original text:activation likelihood estimation meta-analyses of social tasks showed that children and adolescents with autism spectrum disorders versus adults had significantly greater hyperactivation in the left post-central gyrus, and greater hypoactivation in the right hippocampus and right superior temporal gyrus.|PMID:23452684; Original text:activation likelihood estimation meta-analyses of nonsocial tasks showed that children with autism spectrum disorders versus adults had significantly greater hyperactivation in the right insula and left cingulate gyrus, and hypoactivation in the right middle frontal gyrus.
autism spectrum disorders	disease_to_anatomy	and left	1	6.936	23452684	PMID:23452684; Original text:activation likelihood estimation meta-analyses of nonsocial tasks showed that children with autism spectrum disorders versus adults had significantly greater hyperactivation in the right insula and left cingulate gyrus, and hypoactivation in the right middle frontal gyrus.
autism spectrum disorders	disease_to_anatomy	cingulate gyrus	1	6.936	23452684	PMID:23452684; Original text:activation likelihood estimation meta-analyses of nonsocial tasks showed that children with autism spectrum disorders versus adults had significantly greater hyperactivation in the right insula and left cingulate gyrus, and hypoactivation in the right middle frontal gyrus.
autism spectrum disorders	disease_to_anatomy	frontal gyrus	1	6.936	23452684	PMID:23452684; Original text:activation likelihood estimation meta-analyses of nonsocial tasks showed that children with autism spectrum disorders versus adults had significantly greater hyperactivation in the right insula and left cingulate gyrus, and hypoactivation in the right middle frontal gyrus.
hyperactivity	disease_to_anatomy	points	1	1.0	29159857	PMID:29159857; Original text:-1.13 to -0.43; 4 studies, 73 participants; P < 0.001; low-quality evidence) and parents (mean difference (mean difference) -6.61 points, 95% 95% confidence interval -12.19 to -1.03, rated on the hyperactivity subscale of the Aberrant Behviour Checklist, range 0 to 48; 2 studies, 71 participants; P = 0.02; low-quality evidence).
intellectual disability	disease_to_anatomy	, allogeneic	1	1.0	32444220	PMID:32444220; Original text:In a subanalysis of children without intellectual disability (intellectual disability), allogeneic, but not autologous, CB was associated with improvement in a larger percentage of children on the clinician-rated Clinical Global Impression-Improvement scale, but the OR for improvement was not significant.
intellectual disability	disease_to_anatomy	scale	1	1.0	32444220	PMID:32444220; Original text:In a subanalysis of children without intellectual disability (intellectual disability), allogeneic, but not autologous, CB was associated with improvement in a larger percentage of children on the clinician-rated Clinical Global Impression-Improvement scale, but the OR for improvement was not significant.
autism spectrum disorder	disease_to_anatomy	of frontal	1	1.0	22200338	PMID:22200338; Original text:functional MRI showed recruitment of frontal areas, including the insula, that have significantly different patterns in children (7 to 14 years of age) with autism spectrum disorder compared to typically developing children, indicating that successful performance implicated differing strategies in these two groups of children.
autism spectrum disorder	disease_to_anatomy	areas	1	1.0	22200338	PMID:22200338; Original text:functional MRI showed recruitment of frontal areas, including the insula, that have significantly different patterns in children (7 to 14 years of age) with autism spectrum disorder compared to typically developing children, indicating that successful performance implicated differing strategies in these two groups of children.
weight loss	disease_to_anatomy	of the	1	1.0	30305689	PMID:30305689; Original text:Of the included studies, half (n = 6) demonstrated significant weight loss; including comprehensive (n = 3), pharmaceutical (n = 2), and exercise (n = 1) interventions.
weight loss	disease_to_anatomy	, and	1	1.0	30305689	PMID:30305689; Original text:Of the included studies, half (n = 6) demonstrated significant weight loss; including comprehensive (n = 3), pharmaceutical (n = 2), and exercise (n = 1) interventions.
maladaptive behavior	disease_to_anatomy	, and	1	1.0	8911223	PMID:8911223; Original text:Fluvoxamine was superior to placebo in reducing repetitive thoughts and behavior (P < .001), maladaptive behavior (P < .001), and aggression (P < .03), and in improving some aspects of social relatedness (P < .04), especially language usage (P < .008).
maladaptive behavior	disease_to_anatomy	(p	1	1.0	8911223	PMID:8911223; Original text:Fluvoxamine was superior to placebo in reducing repetitive thoughts and behavior (P < .001), maladaptive behavior (P < .001), and aggression (P < .03), and in improving some aspects of social relatedness (P < .04), especially language usage (P < .008).
repetitive thoughts	disease_to_anatomy	, and	1	1.0	8911223	PMID:8911223; Original text:Fluvoxamine was superior to placebo in reducing repetitive thoughts and behavior (P < .001), maladaptive behavior (P < .001), and aggression (P < .03), and in improving some aspects of social relatedness (P < .04), especially language usage (P < .008).
repetitive thoughts	disease_to_anatomy	(p	1	1.0	8911223	PMID:8911223; Original text:Fluvoxamine was superior to placebo in reducing repetitive thoughts and behavior (P < .001), maladaptive behavior (P < .001), and aggression (P < .03), and in improving some aspects of social relatedness (P < .04), especially language usage (P < .008).
aggression	disease_to_anatomy	(p	1	1.0	8911223	PMID:8911223; Original text:Fluvoxamine was superior to placebo in reducing repetitive thoughts and behavior (P < .001), maladaptive behavior (P < .001), and aggression (P < .03), and in improving some aspects of social relatedness (P < .04), especially language usage (P < .008).
autism spectrum disorder	disease_to_anatomy	brain	1	2.208	32294031	PMID:32294031; Original text:Therefore, its deficiency during pregnancy and early childhood may significantly impact on a developing brain, leading to possible adverse neuropsychological outcomes including Autism Spectrum Disorder (Autism Spectrum Disorder).
self	disease_to_anatomy	, and	1	2.195	19519261	PMID:19519261; Original text:Twenty-two (88%) of 25 subjects were responders in regard to interfering symptoms of irritability, including aggression, self-injury, and tantrums, with a final the Clinical Global Impressions-Improvement of 1 or 2 (very much or much improved) and a 25% or greater improvement on the the Aberrant Behavior Checklist.
tantrums	disease_to_anatomy	, and	2	5.324999999999999	19519261|22549762	PMID:19519261; Original text:Twenty-two (88%) of 25 subjects were responders in regard to interfering symptoms of irritability, including aggression, self-injury, and tantrums, with a final the Clinical Global Impressions-Improvement of 1 or 2 (very much or much improved) and a 25% or greater improvement on the the Aberrant Behavior Checklist.|PMID:22549762; Original text:Individuals with autistic disorder (autistic disorder) frequently exhibit significant irritability marked by severe tantrums, aggression, and self-injury.
asd	disease_to_anatomy	(p	2	2.0	34618724|31595678	PMID:34618724; Original text:The Enhanced training did not have a significant effect on provider-endorsed ASD concerns (p = 0.615) or accuracy of endorsing concerns (p = 0.619).|PMID:31595678; Original text:Children with ASD had a 41.1% greater risk (P = .018) of development of obesity.
developmental disorder	disease_to_anatomy	, a	1	1.0	9648034	PMID:9648034; Original text:Describes treatment of autism, a severe, chronic developmental disorder that results in significant lifelong disability for most persons, with few persons ever functioning in an independent and typical lifestyle.
disability	disease_to_anatomy	, a	1	1.0	9648034	PMID:9648034; Original text:Describes treatment of autism, a severe, chronic developmental disorder that results in significant lifelong disability for most persons, with few persons ever functioning in an independent and typical lifestyle.
autism spectrum disorders	disease_to_anatomy	of heart	1	8.33	32818581	PMID:32818581; Original text:The reactivity of Heart rate variability in situations of social stress (g=-0.4647, p = 0.0033) and social debriefing (g=-0.5001, p = 0.0007) was also significantly lower in subjects with autism spectrum disorders.
spectrum disorders	disease_to_anatomy	brodmann area 10	1	2.652	18485420	PMID:18485420; Original text:However, on a new test of executive function (selection between stimulus-oriented and stimulus-independent thought), the spectrum disorders group exhibited significantly greater signal-change in medial rostral prefrontal cortex (especially Brodmann Area 10) in the comparison of stimulus-oriented versus stimulus-independent attention.
spectrum disorders	disease_to_anatomy	prefrontal cortex	1	2.652	18485420	PMID:18485420; Original text:However, on a new test of executive function (selection between stimulus-oriented and stimulus-independent thought), the spectrum disorders group exhibited significantly greater signal-change in medial rostral prefrontal cortex (especially Brodmann Area 10) in the comparison of stimulus-oriented versus stimulus-independent attention.
spectrum disorders	disease_to_anatomy	brodmann area	1	2.652	18485420	PMID:18485420; Original text:However, on a new test of executive function (selection between stimulus-oriented and stimulus-independent thought), the spectrum disorders group exhibited significantly greater signal-change in medial rostral prefrontal cortex (especially Brodmann Area 10) in the comparison of stimulus-oriented versus stimulus-independent attention.
spectrum disorders	disease_to_anatomy	cortex (	1	2.652	18485420	PMID:18485420; Original text:However, on a new test of executive function (selection between stimulus-oriented and stimulus-independent thought), the spectrum disorders group exhibited significantly greater signal-change in medial rostral prefrontal cortex (especially Brodmann Area 10) in the comparison of stimulus-oriented versus stimulus-independent attention.
spectrum disorders	disease_to_anatomy	area 10	1	2.652	18485420	PMID:18485420; Original text:However, on a new test of executive function (selection between stimulus-oriented and stimulus-independent thought), the spectrum disorders group exhibited significantly greater signal-change in medial rostral prefrontal cortex (especially Brodmann Area 10) in the comparison of stimulus-oriented versus stimulus-independent attention.
schz	disease_to_anatomy	of the	1	4.943	28314733	PMID:28314733; Original text:The poor understanding of the genetics of ASD and SCHZ is a significant hurdle to developing effective treatments for these costly conditions.
autistic disorder	disease_to_anatomy	, and	1	3.13	22549762	PMID:22549762; Original text:Individuals with autistic disorder (autistic disorder) frequently exhibit significant irritability marked by severe tantrums, aggression, and self-injury.
self-injury	disease_to_anatomy	, and	1	3.13	22549762	PMID:22549762; Original text:Individuals with autistic disorder (autistic disorder) frequently exhibit significant irritability marked by severe tantrums, aggression, and self-injury.
autistic disorders	disease_to_anatomy	growth hormone	1	1.0	10649829	PMID:10649829; Original text:In adult autistic disorders, severity of repetitive behaviors at baseline, as measured by YBOCS-compulsion score, significantly positively correlated with both peak delta growth hormone response and area under the curve growth hormone response to sumatriptan.
repetitive behaviors	disease_to_anatomy	growth hormone	1	1.0	10649829	PMID:10649829; Original text:In adult autistic disorders, severity of repetitive behaviors at baseline, as measured by YBOCS-compulsion score, significantly positively correlated with both peak delta growth hormone response and area under the curve growth hormone response to sumatriptan.
neurological disorder	disease_to_anatomy	of the	1	2.849	23965928	PMID:23965928; Original text:Autism spectrum disorder (disorder) is a neurological disorder in which a significant number of the children experience a developmental regression characterized by a loss of previously acquired skills and abilities.
developmental regression	disease_to_anatomy	of the	1	2.849	23965928	PMID:23965928; Original text:Autism spectrum disorder (disorder) is a neurological disorder in which a significant number of the children experience a developmental regression characterized by a loss of previously acquired skills and abilities.
wlc	disease_to_anatomy	(i	1	2.339	28869842	PMID:28869842; Original text:The main results are as follows: (I) the spectrum disorders-EXP group showed significant improvement, compared to the spectrum disorders-WLC group, in their reading comprehension ability evidenced from change in comprehension scores; (II) the spectrum disorders-EXP group showed increased local brain connectivity in Reading Network regions compared to the spectrum disorders-WLC group post-intervention; (III) intervention-related changes in local brain connectivity were observed in the spectrum disorders-EXP from pre to post-intervention; and (IV) improvement in language comprehension significantly predicted changes in local connectivity.
wlc	disease_to_anatomy	(i)	1	2.339	28869842	PMID:28869842; Original text:The main results are as follows: (I) the spectrum disorders-EXP group showed significant improvement, compared to the spectrum disorders-WLC group, in their reading comprehension ability evidenced from change in comprehension scores; (II) the spectrum disorders-EXP group showed increased local brain connectivity in Reading Network regions compared to the spectrum disorders-WLC group post-intervention; (III) intervention-related changes in local brain connectivity were observed in the spectrum disorders-EXP from pre to post-intervention; and (IV) improvement in language comprehension significantly predicted changes in local connectivity.
wlc	disease_to_anatomy	i)	1	2.339	28869842	PMID:28869842; Original text:The main results are as follows: (I) the spectrum disorders-EXP group showed significant improvement, compared to the spectrum disorders-WLC group, in their reading comprehension ability evidenced from change in comprehension scores; (II) the spectrum disorders-EXP group showed increased local brain connectivity in Reading Network regions compared to the spectrum disorders-WLC group post-intervention; (III) intervention-related changes in local brain connectivity were observed in the spectrum disorders-EXP from pre to post-intervention; and (IV) improvement in language comprehension significantly predicted changes in local connectivity.
wlc	disease_to_anatomy	group	1	2.339	28869842	PMID:28869842; Original text:The main results are as follows: (I) the spectrum disorders-EXP group showed significant improvement, compared to the spectrum disorders-WLC group, in their reading comprehension ability evidenced from change in comprehension scores; (II) the spectrum disorders-EXP group showed increased local brain connectivity in Reading Network regions compared to the spectrum disorders-WLC group post-intervention; (III) intervention-related changes in local brain connectivity were observed in the spectrum disorders-EXP from pre to post-intervention; and (IV) improvement in language comprehension significantly predicted changes in local connectivity.
spectrum disorders	disease_to_anatomy	(i	1	2.339	28869842	PMID:28869842; Original text:The main results are as follows: (I) the spectrum disorders-EXP group showed significant improvement, compared to the spectrum disorders-WLC group, in their reading comprehension ability evidenced from change in comprehension scores; (II) the spectrum disorders-EXP group showed increased local brain connectivity in Reading Network regions compared to the spectrum disorders-WLC group post-intervention; (III) intervention-related changes in local brain connectivity were observed in the spectrum disorders-EXP from pre to post-intervention; and (IV) improvement in language comprehension significantly predicted changes in local connectivity.
spectrum disorders	disease_to_anatomy	(i)	1	2.339	28869842	PMID:28869842; Original text:The main results are as follows: (I) the spectrum disorders-EXP group showed significant improvement, compared to the spectrum disorders-WLC group, in their reading comprehension ability evidenced from change in comprehension scores; (II) the spectrum disorders-EXP group showed increased local brain connectivity in Reading Network regions compared to the spectrum disorders-WLC group post-intervention; (III) intervention-related changes in local brain connectivity were observed in the spectrum disorders-EXP from pre to post-intervention; and (IV) improvement in language comprehension significantly predicted changes in local connectivity.
spectrum disorders	disease_to_anatomy	i)	1	2.339	28869842	PMID:28869842; Original text:The main results are as follows: (I) the spectrum disorders-EXP group showed significant improvement, compared to the spectrum disorders-WLC group, in their reading comprehension ability evidenced from change in comprehension scores; (II) the spectrum disorders-EXP group showed increased local brain connectivity in Reading Network regions compared to the spectrum disorders-WLC group post-intervention; (III) intervention-related changes in local brain connectivity were observed in the spectrum disorders-EXP from pre to post-intervention; and (IV) improvement in language comprehension significantly predicted changes in local connectivity.
spectrum disorders	disease_to_anatomy	group	1	2.339	28869842	PMID:28869842; Original text:The main results are as follows: (I) the spectrum disorders-EXP group showed significant improvement, compared to the spectrum disorders-WLC group, in their reading comprehension ability evidenced from change in comprehension scores; (II) the spectrum disorders-EXP group showed increased local brain connectivity in Reading Network regions compared to the spectrum disorders-WLC group post-intervention; (III) intervention-related changes in local brain connectivity were observed in the spectrum disorders-EXP from pre to post-intervention; and (IV) improvement in language comprehension significantly predicted changes in local connectivity.
autism spectrum disorder	disease_to_anatomy	postcentral gyrus	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism spectrum disorder	disease_to_anatomy	anterior cingulate	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism spectrum disorder	disease_to_anatomy	, superior temporal	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism spectrum disorder	disease_to_anatomy	gyrus, postcentral	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism spectrum disorder	disease_to_anatomy	superior temporal	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism spectrum disorder	disease_to_anatomy	middle temporal	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism spectrum disorder	disease_to_anatomy	gyrus	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism spectrum disorder	disease_to_anatomy	cortex and	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism spectrum disorder	disease_to_anatomy	, postcentral	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism spectrum disorder	disease_to_anatomy	temporal gyrus, superior	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism spectrum disorder	disease_to_anatomy	middle temporal gyrus	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism spectrum disorder	disease_to_anatomy	temporal gyrus	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism spectrum disorder	disease_to_anatomy	temporal	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism spectrum disorder	disease_to_anatomy	parahippocampal gyrus	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism spectrum disorder	disease_to_anatomy	, superior	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism spectrum disorder	disease_to_anatomy	anterior cingulate cortex	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism spectrum disorder	disease_to_anatomy	cingulate cortex	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism spectrum disorder	disease_to_anatomy	superior temporal gyrus	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism spectrum disorder	disease_to_anatomy	cerebellum	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism spectrum disorder	disease_to_anatomy	gyrus, superior	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism spectrum disorder	disease_to_anatomy	gyrus, superior temporal	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism spectrum disorder	disease_to_anatomy	gray matter	1	1.0	26769980	PMID:26769980; Original text:The voxel-wise meta-analysis revealed that relative to controls, adults with autism spectrum disorder had significantly increased gray matter volume in the middle temporal gyrus, superior temporal gyrus, postcentral gyrus and parahippocampal gyrus, and reduced gray matter volume in the anterior cingulate cortex and cerebellum.
autism	disease_to_anatomy	of male	1	1.0	26769980	PMID:26769980; Original text:Variations in gray matter volume were significantly associated with the mean age and mean total IQ score of the patients, as well as with the percentage of male patients with autism.
autism	disease_to_anatomy	gray matter	1	1.0	26769980	PMID:26769980; Original text:Variations in gray matter volume were significantly associated with the mean age and mean total IQ score of the patients, as well as with the percentage of male patients with autism.
autism spectrum disorders	disease_to_anatomy	neural stem	1	4.326	24136242	PMID:24136242; Original text:Particularly, accumulated data suggest that the effect of PTEN on neural stem-cell development contributes significantly to the pathophysiology of autism spectrum disorders.
smith-lemli-opitz syndrome	disease_to_anatomy	of the	1	1.0	10959439	PMID:10959439; Original text:Most significant clinically has been the realization that many of the postnatal clinical problems of patients with Smith-Lemli-Opitz syndrome are direct consequences of the inability to synthesize the large amounts of cholesterol needed for growth and for the synthesis of compounds derived from cholesterol, such as steroid hormones.
behavioural deficits	disease_to_anatomy	(p	1	1.0	25149412	PMID:25149412; Original text:In the case-control study, 17 males with autism spectrum disorder showed significant behavioural deficits in inferring others' social emotions (P = 0.018) but not in inferring others' beliefs (P = 0.064) compared with 17 typically developing demographically-matched male participants.
asd	disease_to_anatomy	levels of	2	11.786	32305492|32305492	PMID:32305492; Original text:We found that gut microbiota was in a state of dysbiosis and significantly lower levels of Bifidobacteriales and Bifidobacterium longum were observed at the discovery stage in children with ASD.|PMID:32305492; Original text:Compared to children in the control group, significantly lower levels of acetic acid, propionic acid and butyric acid were found, and a hyperserotonergic state (increased serotonin) and dopamine metabolism disorder (decreased homovanillic acid) were observed in children with ASD.
dopamine metabolism disorder	disease_to_anatomy	levels of	1	5.893	32305492	PMID:32305492; Original text:Compared to children in the control group, significantly lower levels of acetic acid, propionic acid and butyric acid were found, and a hyperserotonergic state (increased serotonin) and dopamine metabolism disorder (decreased homovanillic acid) were observed in children with ASD.
dopamine metabolism disorder	disease_to_anatomy	, and	1	5.893	32305492	PMID:32305492; Original text:Compared to children in the control group, significantly lower levels of acetic acid, propionic acid and butyric acid were found, and a hyperserotonergic state (increased serotonin) and dopamine metabolism disorder (decreased homovanillic acid) were observed in children with ASD.
dopamine metabolism disorder	disease_to_anatomy	acid	1	5.893	32305492	PMID:32305492; Original text:Compared to children in the control group, significantly lower levels of acetic acid, propionic acid and butyric acid were found, and a hyperserotonergic state (increased serotonin) and dopamine metabolism disorder (decreased homovanillic acid) were observed in children with ASD.
dopamine metabolism disorder	disease_to_anatomy	group	1	5.893	32305492	PMID:32305492; Original text:Compared to children in the control group, significantly lower levels of acetic acid, propionic acid and butyric acid were found, and a hyperserotonergic state (increased serotonin) and dopamine metabolism disorder (decreased homovanillic acid) were observed in children with ASD.
hyperserotonergic	disease_to_anatomy	levels of	1	5.893	32305492	PMID:32305492; Original text:Compared to children in the control group, significantly lower levels of acetic acid, propionic acid and butyric acid were found, and a hyperserotonergic state (increased serotonin) and dopamine metabolism disorder (decreased homovanillic acid) were observed in children with ASD.
hyperserotonergic	disease_to_anatomy	, and	1	5.893	32305492	PMID:32305492; Original text:Compared to children in the control group, significantly lower levels of acetic acid, propionic acid and butyric acid were found, and a hyperserotonergic state (increased serotonin) and dopamine metabolism disorder (decreased homovanillic acid) were observed in children with ASD.
hyperserotonergic	disease_to_anatomy	acid	1	5.893	32305492	PMID:32305492; Original text:Compared to children in the control group, significantly lower levels of acetic acid, propionic acid and butyric acid were found, and a hyperserotonergic state (increased serotonin) and dopamine metabolism disorder (decreased homovanillic acid) were observed in children with ASD.
hyperserotonergic	disease_to_anatomy	group	1	5.893	32305492	PMID:32305492; Original text:Compared to children in the control group, significantly lower levels of acetic acid, propionic acid and butyric acid were found, and a hyperserotonergic state (increased serotonin) and dopamine metabolism disorder (decreased homovanillic acid) were observed in children with ASD.
asd	disease_to_anatomy	acid	1	5.893	32305492	PMID:32305492; Original text:Compared to children in the control group, significantly lower levels of acetic acid, propionic acid and butyric acid were found, and a hyperserotonergic state (increased serotonin) and dopamine metabolism disorder (decreased homovanillic acid) were observed in children with ASD.
restricted or repetitive behaviors	disease_to_anatomy	levels of	1	1.0	26331980	PMID:26331980; Original text:Individuals with Prader-Willi syndrome demonstrate significant levels of restricted or repetitive behaviors and social-communication impairment, in some reports reaching similar levels to those of non-Prader-Willi syndrome disorder comparison groups.
prader-willi syndrome disorder	disease_to_anatomy	levels of	1	1.0	26331980	PMID:26331980; Original text:Individuals with Prader-Willi syndrome demonstrate significant levels of restricted or repetitive behaviors and social-communication impairment, in some reports reaching similar levels to those of non-Prader-Willi syndrome disorder comparison groups.
prader-willi syndrome	disease_to_anatomy	levels of	1	1.0	26331980	PMID:26331980; Original text:Individuals with Prader-Willi syndrome demonstrate significant levels of restricted or repetitive behaviors and social-communication impairment, in some reports reaching similar levels to those of non-Prader-Willi syndrome disorder comparison groups.
social-communication impairment	disease_to_anatomy	levels of	1	1.0	26331980	PMID:26331980; Original text:Individuals with Prader-Willi syndrome demonstrate significant levels of restricted or repetitive behaviors and social-communication impairment, in some reports reaching similar levels to those of non-Prader-Willi syndrome disorder comparison groups.
developmental delay/	disease_to_anatomy	, and	1	5.512	33434711	PMID:33434711; Original text:Advances in laboratory testing have significantly increased the detection of rare genetic etiologies of neurodevelopmental psychiatric disorders (neurodevelopmental psychiatric disorders), particularly developmental delay/ intellectual disability, autism spectrum disorder, and schizophrenia.
neurodevelopmental psychiatric disorders	disease_to_anatomy	, and	1	5.512	33434711	PMID:33434711; Original text:Advances in laboratory testing have significantly increased the detection of rare genetic etiologies of neurodevelopmental psychiatric disorders (neurodevelopmental psychiatric disorders), particularly developmental delay/ intellectual disability, autism spectrum disorder, and schizophrenia.
autistic disorders	disease_to_anatomy	-v	1	0.142	22650115	PMID:22650115; Original text:For this reason, the term spectrum points out the significance of the dimensional assessment of autistic disorders, which will most likely be the basis of the new diagnostic classification of the disorders belonging to the current group of pervasive developmental disorders in the new DSM-V classification.
autistic disorders	disease_to_anatomy	of the	1	0.142	22650115	PMID:22650115; Original text:For this reason, the term spectrum points out the significance of the dimensional assessment of autistic disorders, which will most likely be the basis of the new diagnostic classification of the disorders belonging to the current group of pervasive developmental disorders in the new DSM-V classification.
autistic disorders	disease_to_anatomy	group of	1	0.142	22650115	PMID:22650115; Original text:For this reason, the term spectrum points out the significance of the dimensional assessment of autistic disorders, which will most likely be the basis of the new diagnostic classification of the disorders belonging to the current group of pervasive developmental disorders in the new DSM-V classification.
pervasive developmental disorders	disease_to_anatomy	-v	1	0.142	22650115	PMID:22650115; Original text:For this reason, the term spectrum points out the significance of the dimensional assessment of autistic disorders, which will most likely be the basis of the new diagnostic classification of the disorders belonging to the current group of pervasive developmental disorders in the new DSM-V classification.
pervasive developmental disorders	disease_to_anatomy	of the	1	0.142	22650115	PMID:22650115; Original text:For this reason, the term spectrum points out the significance of the dimensional assessment of autistic disorders, which will most likely be the basis of the new diagnostic classification of the disorders belonging to the current group of pervasive developmental disorders in the new DSM-V classification.
pervasive developmental disorders	disease_to_anatomy	group of	1	0.142	22650115	PMID:22650115; Original text:For this reason, the term spectrum points out the significance of the dimensional assessment of autistic disorders, which will most likely be the basis of the new diagnostic classification of the disorders belonging to the current group of pervasive developmental disorders in the new DSM-V classification.
tourette's syndrome	disease_to_anatomy	, and	1	4.207	15090875	PMID:15090875; Original text:Recent oculomotor studies have made significant contributions to the understanding of neurodevelopmental disorders, most notably in autism, attention-deficit/hyperactivity disorder, and Tourette's syndrome.
pervasive developmental disorder	disease_to_anatomy	(p	1	3.941	18080171	PMID:18080171; Original text:Compared to haloperidol, risperidone led to a significantly greater reduction in the Aberrant Behavior Checklist (the Aberrant Behavior Checklist) and Turgay DSM-IV Pervasive Developmental Disorder (Turgay DSM-IV Pervasive Developmental Disorder) scale scores (P < 0.05 and P < 0.01).
ep	disease_to_anatomy	, and	1	12.095	3886023	PMID:3886023; Original text:The behavioral improvement observed with the combination vitamin B6-magnesium was associated with significant modifications of both biochemical and electrophysiological parameters: the urinary homovanillic acid excretion decreased, and EP amplitude and morphology seemed to be normalized.
pain	disease_to_anatomy	, and	1	2.174	25336035	PMID:25336035; Original text:low-dose naltrexone improved pain tolerance as shown by a significant increase on Cold pressor times for post detoxification patients from 16 seconds to 55 seconds and in fibromyalgia patients from 21 seconds to 42 seconds, and improved relatedness.
fibromyalgia	disease_to_anatomy	, and	1	2.174	25336035	PMID:25336035; Original text:low-dose naltrexone improved pain tolerance as shown by a significant increase on Cold pressor times for post detoxification patients from 16 seconds to 55 seconds and in fibromyalgia patients from 21 seconds to 42 seconds, and improved relatedness.
psychiatric	disease_to_anatomy	of the	1	1.765	19780345	"PMID:19780345; Original text:The current view of the psychiatric significance of inter-ictal spike discharges (inter-ictal spike discharges) in nonepileptic, psychiatric patients is that the discharges are ""incidental"" and are of no clinical significance."
autistic	disease_to_anatomy	cortex	1	1.0	15730889	"PMID:15730889; Original text:In published reports, these animals have been found to have a significant loss of serotonin terminals, decreased metabolic activity in cortex, changes in columnar development in cortex, changes in serotonin receptors, and ""autistic-like"" behaviors."
autistic	disease_to_anatomy	receptors	1	1.0	15730889	"PMID:15730889; Original text:In published reports, these animals have been found to have a significant loss of serotonin terminals, decreased metabolic activity in cortex, changes in columnar development in cortex, changes in serotonin receptors, and ""autistic-like"" behaviors."
autistic	disease_to_anatomy	terminals	1	1.0	15730889	"PMID:15730889; Original text:In published reports, these animals have been found to have a significant loss of serotonin terminals, decreased metabolic activity in cortex, changes in columnar development in cortex, changes in serotonin receptors, and ""autistic-like"" behaviors."
antidepressants	disease_to_anatomy	, 3	1	1.0	33222504	PMID:33222504; Original text:Most interesting results for response were reported for 2 sets of candidate gene studies, namely: (1) The DRD3 Ser9Gly (rs6280) polymorphism was examined in patients treated with risperidone in 3 studies, 2 of which reported an association with risperidone treatment response and (2) the SLC6A4 5-HTTLPR polymorphism and treatment response to antidepressants which was investigated in 4 studies, 3 of which reported significant associations.
antidepressants	disease_to_anatomy	3 of	1	1.0	33222504	PMID:33222504; Original text:Most interesting results for response were reported for 2 sets of candidate gene studies, namely: (1) The DRD3 Ser9Gly (rs6280) polymorphism was examined in patients treated with risperidone in 3 studies, 2 of which reported an association with risperidone treatment response and (2) the SLC6A4 5-HTTLPR polymorphism and treatment response to antidepressants which was investigated in 4 studies, 3 of which reported significant associations.
antidepressants	disease_to_anatomy	, 2	1	1.0	33222504	PMID:33222504; Original text:Most interesting results for response were reported for 2 sets of candidate gene studies, namely: (1) The DRD3 Ser9Gly (rs6280) polymorphism was examined in patients treated with risperidone in 3 studies, 2 of which reported an association with risperidone treatment response and (2) the SLC6A4 5-HTTLPR polymorphism and treatment response to antidepressants which was investigated in 4 studies, 3 of which reported significant associations.
antidepressants	disease_to_anatomy	2 of	1	1.0	33222504	PMID:33222504; Original text:Most interesting results for response were reported for 2 sets of candidate gene studies, namely: (1) The DRD3 Ser9Gly (rs6280) polymorphism was examined in patients treated with risperidone in 3 studies, 2 of which reported an association with risperidone treatment response and (2) the SLC6A4 5-HTTLPR polymorphism and treatment response to antidepressants which was investigated in 4 studies, 3 of which reported significant associations.
autism	disease_to_anatomy	area of	1	1.0	11408327	PMID:11408327; Original text:The cross-sectional area of the AD was significantly smaller than normal in autism, the largest deviation from normal size (-13.5%) being found in autistic children aged 29 months to 4 years.
autism	disease_to_anatomy	area of the	1	1.0	11408327	PMID:11408327; Original text:The cross-sectional area of the AD was significantly smaller than normal in autism, the largest deviation from normal size (-13.5%) being found in autistic children aged 29 months to 4 years.
autistic	disease_to_anatomy	area of	1	1.0	11408327	PMID:11408327; Original text:The cross-sectional area of the AD was significantly smaller than normal in autism, the largest deviation from normal size (-13.5%) being found in autistic children aged 29 months to 4 years.
autistic	disease_to_anatomy	area of the	1	1.0	11408327	PMID:11408327; Original text:The cross-sectional area of the AD was significantly smaller than normal in autism, the largest deviation from normal size (-13.5%) being found in autistic children aged 29 months to 4 years.
alexithymia	disease_to_anatomy	group (	1	1.0	30399531	PMID:30399531; Original text:There was also a higher prevalence of alexithymia in the disorder group (49.93% compared to 4.89%), with a significantly increased risk of alexithymia in autistic participants.
psychiatric disorders	disease_to_anatomy	, and	1	3.288	21863344	PMID:21863344; Original text:Empathy, for instance, is a rather elaborated human ability, and several recent studies point to significant impairments in patients suffering from psychiatric disorders, such as schizophrenia or autism.
inherited cancer syndrome	disease_to_anatomy	of all	1	3.743	25161109	PMID:25161109; Original text:Cognitive and behavioral disorders affect nearly 80% of all children with the neurofibromatosis type 1 inherited cancer syndrome, and are among the most significant clinical manifestations for patients and their families.
inherited cancer syndrome	disease_to_anatomy	type 1	1	3.743	25161109	PMID:25161109; Original text:Cognitive and behavioral disorders affect nearly 80% of all children with the neurofibromatosis type 1 inherited cancer syndrome, and are among the most significant clinical manifestations for patients and their families.
inherited cancer syndrome	disease_to_anatomy	, and	1	3.743	25161109	PMID:25161109; Original text:Cognitive and behavioral disorders affect nearly 80% of all children with the neurofibromatosis type 1 inherited cancer syndrome, and are among the most significant clinical manifestations for patients and their families.
neurofibromatosis type	disease_to_anatomy	of all	1	3.743	25161109	PMID:25161109; Original text:Cognitive and behavioral disorders affect nearly 80% of all children with the neurofibromatosis type 1 inherited cancer syndrome, and are among the most significant clinical manifestations for patients and their families.
neurofibromatosis type	disease_to_anatomy	type 1	1	3.743	25161109	PMID:25161109; Original text:Cognitive and behavioral disorders affect nearly 80% of all children with the neurofibromatosis type 1 inherited cancer syndrome, and are among the most significant clinical manifestations for patients and their families.
neurofibromatosis type	disease_to_anatomy	, and	1	3.743	25161109	PMID:25161109; Original text:Cognitive and behavioral disorders affect nearly 80% of all children with the neurofibromatosis type 1 inherited cancer syndrome, and are among the most significant clinical manifestations for patients and their families.
cognitive	disease_to_anatomy	of all	1	3.743	25161109	PMID:25161109; Original text:Cognitive and behavioral disorders affect nearly 80% of all children with the neurofibromatosis type 1 inherited cancer syndrome, and are among the most significant clinical manifestations for patients and their families.
cognitive	disease_to_anatomy	type 1	1	3.743	25161109	PMID:25161109; Original text:Cognitive and behavioral disorders affect nearly 80% of all children with the neurofibromatosis type 1 inherited cancer syndrome, and are among the most significant clinical manifestations for patients and their families.
autism spectrum disorders	disease_to_anatomy	peripheral blood	1	1.0	32272227	PMID:32272227; Original text:Significantly elevated C-reactive protein levels in peripheral blood were found in Autism Spectrum Disorders children compared with healthy controls (Hedges' g = 0.527, 95% CI: 0.224-0.830, p = 0.001).
autistic	disease_to_anatomy	, peripheral	1	1.0	32272227	PMID:32272227; Original text:In our study, peripheral C-reactive protein levels were significantly elevated in autistic children compared with healthy children.
obesity	disease_to_anatomy	(p	1	1.0	31595678	PMID:31595678; Original text:Children with ASD had a 41.1% greater risk (P = .018) of development of obesity.
autistic	disease_to_anatomy	process of	1	1.0	30517284	PMID:30517284; Original text:The results of the identified studies confirm the significant importance of these instruments in improving the communicative process of autistic children.
generalized	disease_to_anatomy	levels of	1	1.0	21660428	"PMID:21660428; Original text:Children in both programs showed significantly lower levels of generalized anxiety and total anxiety symptoms at 6-month follow-up on SCAS-C. Clinician ratings on the CGI-S demonstrated an increase in the percentage of participants rated as ""Normal"" and ""Borderline"" for both programs."
autism	disease_to_anatomy	, memory	1	3.093	27721995	PMID:27721995; Original text:An intention-to-treat analysis showed significant overall gains for a wide range of symptoms in these children, including learning, memory, anxiety, attention span, motor skills, eating, sleeping, sensory processing, self-awareness, communication, social skills, and mood/autism behaviors.
anxiety	disease_to_anatomy	, memory	1	3.093	27721995	PMID:27721995; Original text:An intention-to-treat analysis showed significant overall gains for a wide range of symptoms in these children, including learning, memory, anxiety, attention span, motor skills, eating, sleeping, sensory processing, self-awareness, communication, social skills, and mood/autism behaviors.
autism spectrum disorders	disease_to_anatomy	trabecular bone	1	1.0	28342168	PMID:28342168; Original text:After adjusting for potential covariates, having autism spectrum disorders was associated with significantly lower trabecular bone mineral density and bone strength at the radius, and with marginally lower total body less head bone mineral content (p < 0.09).
autism spectrum disorders	disease_to_anatomy	and bone	1	1.0	28342168	PMID:28342168; Original text:After adjusting for potential covariates, having autism spectrum disorders was associated with significantly lower trabecular bone mineral density and bone strength at the radius, and with marginally lower total body less head bone mineral content (p < 0.09).
infantile spasms	disease_to_anatomy	(p	1	6.04	25944453	PMID:25944453; Original text:Only patients with symptomatic Infantile spasms developed autism spectrum disorders (p = 0.003).
hypsarrhythmia	disease_to_anatomy	(p	1	6.04	25944453	PMID:25944453; Original text:Other risk factors were identified such as having chronic epileptic discharges in the frontotemporal areas after disappearance of hypsarrhythmia (p = 0.005 and p = 0.007) and being of nonwhite origin (p = 0.009).
epileptic	disease_to_anatomy	(p	1	6.04	25944453	PMID:25944453; Original text:Other risk factors were identified such as having chronic epileptic discharges in the frontotemporal areas after disappearance of hypsarrhythmia (p = 0.005 and p = 0.007) and being of nonwhite origin (p = 0.009).
autism	disease_to_anatomy	3 of	1	1.0	11466160	PMID:11466160; Original text:After treatment, the patients showed significant improvement on the scores of the Yale--Brown Obsessive--Compulsive Scale -- Obsessions subscale and the Hamilton Anxiety Scale; Clinical Global Impressions -- Autism scores showed 3 of the patients much improved and 3 unchanged.
anxiety	disease_to_anatomy	3 of	1	1.0	11466160	PMID:11466160; Original text:After treatment, the patients showed significant improvement on the scores of the Yale--Brown Obsessive--Compulsive Scale -- Obsessions subscale and the Hamilton Anxiety Scale; Clinical Global Impressions -- Autism scores showed 3 of the patients much improved and 3 unchanged.
anxiety	disease_to_anatomy	and 3	1	1.0	11466160	PMID:11466160; Original text:After treatment, the patients showed significant improvement on the scores of the Yale--Brown Obsessive--Compulsive Scale -- Obsessions subscale and the Hamilton Anxiety Scale; Clinical Global Impressions -- Autism scores showed 3 of the patients much improved and 3 unchanged.
autism	disease_to_anatomy	of all	1	4.17	32122747	PMID:32122747; Original text:Furthermore, metabolism represent a significant percentage of all autism cases.
social impairments	disease_to_anatomy	of the	1	1.0	27651096	PMID:27651096; Original text:Despite these limitations in the field to date, there remains significant potential for oxytocin to ameliorate aspects of the persistent and debilitating social impairments in individuals with disorder.
developmental disabilities	disease_to_anatomy	, and	1	1.0	24757919	PMID:24757919; Original text:Autism spectrum disorders (disorders) are a group of developmental disabilities that can cause significant social, communication, and behavioral challenges for children and families.
disorders	disease_to_anatomy	, and	1	1.0	24757919	PMID:24757919; Original text:Autism spectrum disorders (disorders) are a group of developmental disabilities that can cause significant social, communication, and behavioral challenges for children and families.
neurodevelopmental psychiatric disorders	disease_to_anatomy	of large	1	5.512	33773394	PMID:33773394; Original text:Many rare genomic variants of large effect size have been identified; all of them together can explain a significant proportion of neurodevelopmental psychiatric disorders.
attention-	disease_to_anatomy	, and	1	4.539	20694583	PMID:20694583; Original text:Individuals with co-occurring ASD and attention-deficit/hyperactivity disorder symptoms are more severely impaired, with significant deficits seen in social processing, adaptive functioning, and executive control.
autistic	disease_to_anatomy	inferior frontal gyrus	1	1.0	25817280	PMID:25817280; Original text:The increments in the concentration of oxygenated hemoglobin in the pars opercularis of the inferior frontal gyrus in autistic subjects were significantly lower than those in the controls.
autistic	disease_to_anatomy	pars opercularis	1	1.0	25817280	PMID:25817280; Original text:The increments in the concentration of oxygenated hemoglobin in the pars opercularis of the inferior frontal gyrus in autistic subjects were significantly lower than those in the controls.
autistic	disease_to_anatomy	frontal gyrus	1	1.0	25817280	PMID:25817280; Original text:The increments in the concentration of oxygenated hemoglobin in the pars opercularis of the inferior frontal gyrus in autistic subjects were significantly lower than those in the controls.
autistic	disease_to_anatomy	of the inferior	1	1.0	25817280	PMID:25817280; Original text:The increments in the concentration of oxygenated hemoglobin in the pars opercularis of the inferior frontal gyrus in autistic subjects were significantly lower than those in the controls.
autistic	disease_to_anatomy	the inferior	1	1.0	25817280	PMID:25817280; Original text:The increments in the concentration of oxygenated hemoglobin in the pars opercularis of the inferior frontal gyrus in autistic subjects were significantly lower than those in the controls.
autistic	disease_to_anatomy	, main	1	5.869	29796237	PMID:29796237; Original text:In social relatedness and circumscribed interests, main effects of Diagnosis revealed that as expected, autistic adults reported significantly greater lifetime prevalence of symptoms in these domains; an effect of Sex, in circumscribed interests, also suggested that males generally reported more prevalent symptoms than females.
macrocephaly	disease_to_anatomy	, a	1	1.0	10382131	PMID:10382131; Original text:Macrocephaly (head circumference > 97th centile) was observed in 16.7% of the sample, a significantly higher proportion than that expected.
macrocephaly	disease_to_anatomy	of the	1	1.0	10382131	PMID:10382131; Original text:Macrocephaly (head circumference > 97th centile) was observed in 16.7% of the sample, a significantly higher proportion than that expected.
microcephaly	disease_to_anatomy	of the	1	1.0	10382131	PMID:10382131; Original text:Microcephaly (head circumference < 3rd centile) was also significantly raised and found in 15.1% of the sample.
asperger's syndromed.	disease_to_anatomy	of the	1	1.541	22508080	PMID:22508080; Original text:Data from multiple animals and human clinical trials suggest that antiandrogen medications have the ability to significantly reduce traits in patients diagnosed with an Asperger's syndromeD. In light of the robust association between hyperandrogenism and Asperger's syndromeD, it is recommended subjects diagnosed with an Asperger's syndromeD should undergo routine screening for elevated androgens, and appropriate treatment should be initiated for those with elevated androgens.
asperger's syndromed.	disease_to_anatomy	, and	1	1.541	22508080	PMID:22508080; Original text:Data from multiple animals and human clinical trials suggest that antiandrogen medications have the ability to significantly reduce traits in patients diagnosed with an Asperger's syndromeD. In light of the robust association between hyperandrogenism and Asperger's syndromeD, it is recommended subjects diagnosed with an Asperger's syndromeD should undergo routine screening for elevated androgens, and appropriate treatment should be initiated for those with elevated androgens.
hyperandrogenism	disease_to_anatomy	of the	1	1.541	22508080	PMID:22508080; Original text:Data from multiple animals and human clinical trials suggest that antiandrogen medications have the ability to significantly reduce traits in patients diagnosed with an Asperger's syndromeD. In light of the robust association between hyperandrogenism and Asperger's syndromeD, it is recommended subjects diagnosed with an Asperger's syndromeD should undergo routine screening for elevated androgens, and appropriate treatment should be initiated for those with elevated androgens.
hyperandrogenism	disease_to_anatomy	, and	1	1.541	22508080	PMID:22508080; Original text:Data from multiple animals and human clinical trials suggest that antiandrogen medications have the ability to significantly reduce traits in patients diagnosed with an Asperger's syndromeD. In light of the robust association between hyperandrogenism and Asperger's syndromeD, it is recommended subjects diagnosed with an Asperger's syndromeD should undergo routine screening for elevated androgens, and appropriate treatment should be initiated for those with elevated androgens.
asperger's syndromed	disease_to_anatomy	of the	1	1.541	22508080	PMID:22508080; Original text:Data from multiple animals and human clinical trials suggest that antiandrogen medications have the ability to significantly reduce traits in patients diagnosed with an Asperger's syndromeD. In light of the robust association between hyperandrogenism and Asperger's syndromeD, it is recommended subjects diagnosed with an Asperger's syndromeD should undergo routine screening for elevated androgens, and appropriate treatment should be initiated for those with elevated androgens.
asperger's syndromed	disease_to_anatomy	, and	1	1.541	22508080	PMID:22508080; Original text:Data from multiple animals and human clinical trials suggest that antiandrogen medications have the ability to significantly reduce traits in patients diagnosed with an Asperger's syndromeD. In light of the robust association between hyperandrogenism and Asperger's syndromeD, it is recommended subjects diagnosed with an Asperger's syndromeD should undergo routine screening for elevated androgens, and appropriate treatment should be initiated for those with elevated androgens.
metabolic abnormalities	disease_to_anatomy	, and	1	1.0	21813076	PMID:21813076; Original text:The percentages of subjects with clinically significant fasting metabolic abnormalities at > 9 months were 2% for glucose, 5% for total cholesterol, 7% for low-density lipoprotein cholesterol, 30% for high-density lipoprotein cholesterol, and 5% for triglycerides.
autism	disease_to_anatomy	sex chromosomes	1	1.267	11525418	PMID:11525418; Original text:These data support the contribution of chromosomal abnormalities to a small but significant number of cases of autism, and highlight the involvement of chromosome 15 and the sex chromosomes.
autism	disease_to_anatomy	chromosomes	1	1.267	11525418	PMID:11525418; Original text:These data support the contribution of chromosomal abnormalities to a small but significant number of cases of autism, and highlight the involvement of chromosome 15 and the sex chromosomes.
autism	disease_to_anatomy	chromosome 15	1	1.267	11525418	PMID:11525418; Original text:These data support the contribution of chromosomal abnormalities to a small but significant number of cases of autism, and highlight the involvement of chromosome 15 and the sex chromosomes.
chromosomal abnormalities	disease_to_anatomy	sex chromosomes	1	1.267	11525418	PMID:11525418; Original text:These data support the contribution of chromosomal abnormalities to a small but significant number of cases of autism, and highlight the involvement of chromosome 15 and the sex chromosomes.
chromosomal abnormalities	disease_to_anatomy	chromosomes	1	1.267	11525418	PMID:11525418; Original text:These data support the contribution of chromosomal abnormalities to a small but significant number of cases of autism, and highlight the involvement of chromosome 15 and the sex chromosomes.
chromosomal abnormalities	disease_to_anatomy	, and	1	1.267	11525418	PMID:11525418; Original text:These data support the contribution of chromosomal abnormalities to a small but significant number of cases of autism, and highlight the involvement of chromosome 15 and the sex chromosomes.
chromosomal abnormalities	disease_to_anatomy	chromosome 15	1	1.267	11525418	PMID:11525418; Original text:These data support the contribution of chromosomal abnormalities to a small but significant number of cases of autism, and highlight the involvement of chromosome 15 and the sex chromosomes.
chromosomal abnormalities	disease_to_anatomy	chromosome	1	1.267	11525418	PMID:11525418; Original text:These data support the contribution of chromosomal abnormalities to a small but significant number of cases of autism, and highlight the involvement of chromosome 15 and the sex chromosomes.
asd	disease_to_anatomy	of lower	1	5.28	22832731	PMID:22832731; Original text:Meta-regression analysis further revealed that the effect size of lower frontal NAA levels linearly declined with older mean age in ASD (n=844, P<0.05 Bonferroni-corrected).
autism	disease_to_anatomy	contact	1	1.909	19284641	PMID:19284641; Original text:Children with autism who received hyperbaric tre1.3 atmosphereent at 1.3 1.3 atmosphere and 24% oxygen for 40 hourly sessions had significant improvements in overall functioning, receptive language, social interaction, eye contact, and sensory/cognitive awareness compared to children who received slightly pressurized room air.
autism	disease_to_anatomy	, eye	1	1.909	19284641	PMID:19284641; Original text:Children with autism who received hyperbaric tre1.3 atmosphereent at 1.3 1.3 atmosphere and 24% oxygen for 40 hourly sessions had significant improvements in overall functioning, receptive language, social interaction, eye contact, and sensory/cognitive awareness compared to children who received slightly pressurized room air.
stereotypy	disease_to_anatomy	(p	1	1.909	19284641	PMID:19284641; Original text:On the Aberrant Behavior Checklist, significant improvements were observed in the tre1.3 atmosphereent group in total score, irritability, stereotypy, hyperactivity, and speech (p < 0.03 for each), but not in the control group.
impaired	disease_to_anatomy	, and	1	5.869	28138381	PMID:28138381; Original text:Study participants included 60 outpatient youth with disorder, ages 5-11 years, all with IQ above 70, and significantly impaired social functioning who completed a 10-week active treatment phase during which they received weekly single doses of 50 mg of DCS or placebo administered 30 min prior to group social skills training.
gastrointestinal symptoms	disease_to_anatomy	, gastrointestinal	1	1.0	20204691	PMID:20204691; Original text:Compared with placebo, treatment with enzyme was not associated with clinically significant improvement in behaviour, food variety, gastrointestinal symptoms, sleep quality, engagement with therapist, or the Language Development Survey Vocabulary or Sentence Complexity Scores.
autism spectrum disorders	disease_to_anatomy	is	1	12.384	22801412	PMID:22801412; Original text:The aim of this review is, therefore, to summarize some of these important new findings and highlight their potential significant translational value to the future of Autism Spectrum Disorders research.
autistic mannerisms	disease_to_anatomy	, and	1	1.0	30143950	PMID:30143950; Original text:The 14-week parent-assisted training significantly improved social skills knowledge and social functioning, and also reduced autistic mannerisms.
opposition/defiance behaviors	disease_to_anatomy	of the	1	4.546	30979038	PMID:30979038; Original text:The results showed that PS128 ameliorated opposition/defiance behaviors, and that the total score of The Swanson, Nolan, and Pelham-IV-Taiwan version for younger children (aged 712) improved significantly compared with the placebo group.
opposition/defiance behaviors	disease_to_anatomy	, and	1	4.546	30979038	PMID:30979038; Original text:The results showed that PS128 ameliorated opposition/defiance behaviors, and that the total score of The Swanson, Nolan, and Pelham-IV-Taiwan version for younger children (aged 712) improved significantly compared with the placebo group.
metabolic disorders	disease_to_anatomy	of the	1	1.713	18079313	PMID:18079313; Original text:In some patients, early diagnosis of the metabolic disorders and proper therapeutic interventions may significantly improve the long-term cognitive and behavioral outcome.
autism spectrum disorders	disease_to_anatomy	areas of	1	1.0	19365716	PMID:19365716; Original text:The findings indicated that each Autism Spectrum Disorders intervention group demonstrated significant gains on the WMS and significant improvement in the areas of anxiety management, joint attention, and flexibility/transitions.
autism spectrum disorders	disease_to_anatomy	, joint	1	1.0	19365716	PMID:19365716; Original text:The findings indicated that each Autism Spectrum Disorders intervention group demonstrated significant gains on the WMS and significant improvement in the areas of anxiety management, joint attention, and flexibility/transitions.
anxiety	disease_to_anatomy	areas of	1	1.0	19365716	PMID:19365716; Original text:The findings indicated that each Autism Spectrum Disorders intervention group demonstrated significant gains on the WMS and significant improvement in the areas of anxiety management, joint attention, and flexibility/transitions.
anxiety	disease_to_anatomy	, joint	1	1.0	19365716	PMID:19365716; Original text:The findings indicated that each Autism Spectrum Disorders intervention group demonstrated significant gains on the WMS and significant improvement in the areas of anxiety management, joint attention, and flexibility/transitions.
asd	disease_to_anatomy	regions	1	1.0	30758329	PMID:30758329; Original text:Across regions, its major non-intoxicating component cannabidiol increased GABA+ in controls, but decreased GABA+ in ASD; the group difference in change in GABA + in the the dorsomedial prefrontal cortex was significant.
autism	disease_to_anatomy	and 2	1	1.713	16948927	PMID:16948927; Original text:In the risperidone group, 12 of 19 children showed improvement in the total Childhood Autism Rating Scale score and 17 of 19 children in the Children's Global Assessment Scale score compared with 0 of 20 children for the Childhood Autism Rating Scale score and 2 of 20 children for the Children's Global Assessment Scale score in the placebo group (P < .001 and P = .035, respectively).
autism	disease_to_anatomy	2 of	1	1.713	16948927	PMID:16948927; Original text:In the risperidone group, 12 of 19 children showed improvement in the total Childhood Autism Rating Scale score and 17 of 19 children in the Children's Global Assessment Scale score compared with 0 of 20 children for the Childhood Autism Rating Scale score and 2 of 20 children for the Children's Global Assessment Scale score in the placebo group (P < .001 and P = .035, respectively).
gut microbiome	disease_to_anatomy	immune system	1	5.793	31837704	PMID:31837704; Original text:More recent data, however, have shown that elevated salt consumption has a significant effect on the immune system and gut microbiome, often resulting in gut dysbiosis and induction of pro-inflammatory pathways.
gut dysbiosis	disease_to_anatomy	immune system	1	5.793	31837704	PMID:31837704; Original text:More recent data, however, have shown that elevated salt consumption has a significant effect on the immune system and gut microbiome, often resulting in gut dysbiosis and induction of pro-inflammatory pathways.
increases	disease_to_anatomy	of the	1	1.0	23821414	PMID:23821414; Original text:Children in the riluzole group experienced significantly more increases in their appetite and bodyweight than children in the placebo group by the end of the study.
increases	disease_to_anatomy	end of	1	1.0	23821414	PMID:23821414; Original text:Children in the riluzole group experienced significantly more increases in their appetite and bodyweight than children in the placebo group by the end of the study.
spontaneous abortion	disease_to_anatomy	pulmonary	1	2.425	32840005	PMID:32840005; Original text:Most of the meta-analyses reported that compared to non-users, the risks of preterm birth, low birth weight, spontaneous abortion, persistent pulmonary hypertension, autism spectrum disorders, and attention deficit hyperactivity disorder in offspring of antidepressant users were significantly higher.
spontaneous abortion	disease_to_anatomy	of the	1	2.425	32840005	PMID:32840005; Original text:Most of the meta-analyses reported that compared to non-users, the risks of preterm birth, low birth weight, spontaneous abortion, persistent pulmonary hypertension, autism spectrum disorders, and attention deficit hyperactivity disorder in offspring of antidepressant users were significantly higher.
spontaneous abortion	disease_to_anatomy	, and	1	2.425	32840005	PMID:32840005; Original text:Most of the meta-analyses reported that compared to non-users, the risks of preterm birth, low birth weight, spontaneous abortion, persistent pulmonary hypertension, autism spectrum disorders, and attention deficit hyperactivity disorder in offspring of antidepressant users were significantly higher.
pulmonary hypertension	disease_to_anatomy	pulmonary	1	2.425	32840005	PMID:32840005; Original text:Most of the meta-analyses reported that compared to non-users, the risks of preterm birth, low birth weight, spontaneous abortion, persistent pulmonary hypertension, autism spectrum disorders, and attention deficit hyperactivity disorder in offspring of antidepressant users were significantly higher.
pulmonary hypertension	disease_to_anatomy	of the	1	2.425	32840005	PMID:32840005; Original text:Most of the meta-analyses reported that compared to non-users, the risks of preterm birth, low birth weight, spontaneous abortion, persistent pulmonary hypertension, autism spectrum disorders, and attention deficit hyperactivity disorder in offspring of antidepressant users were significantly higher.
pulmonary hypertension	disease_to_anatomy	, and	1	2.425	32840005	PMID:32840005; Original text:Most of the meta-analyses reported that compared to non-users, the risks of preterm birth, low birth weight, spontaneous abortion, persistent pulmonary hypertension, autism spectrum disorders, and attention deficit hyperactivity disorder in offspring of antidepressant users were significantly higher.
preterm birth	disease_to_anatomy	pulmonary	1	2.425	32840005	PMID:32840005; Original text:Most of the meta-analyses reported that compared to non-users, the risks of preterm birth, low birth weight, spontaneous abortion, persistent pulmonary hypertension, autism spectrum disorders, and attention deficit hyperactivity disorder in offspring of antidepressant users were significantly higher.
preterm birth	disease_to_anatomy	of the	1	2.425	32840005	PMID:32840005; Original text:Most of the meta-analyses reported that compared to non-users, the risks of preterm birth, low birth weight, spontaneous abortion, persistent pulmonary hypertension, autism spectrum disorders, and attention deficit hyperactivity disorder in offspring of antidepressant users were significantly higher.
preterm birth	disease_to_anatomy	, and	1	2.425	32840005	PMID:32840005; Original text:Most of the meta-analyses reported that compared to non-users, the risks of preterm birth, low birth weight, spontaneous abortion, persistent pulmonary hypertension, autism spectrum disorders, and attention deficit hyperactivity disorder in offspring of antidepressant users were significantly higher.
attention deficit hyperactivity disorder	disease_to_anatomy	pulmonary	1	2.425	32840005	PMID:32840005; Original text:Most of the meta-analyses reported that compared to non-users, the risks of preterm birth, low birth weight, spontaneous abortion, persistent pulmonary hypertension, autism spectrum disorders, and attention deficit hyperactivity disorder in offspring of antidepressant users were significantly higher.
attention deficit hyperactivity disorder	disease_to_anatomy	of the	1	2.425	32840005	PMID:32840005; Original text:Most of the meta-analyses reported that compared to non-users, the risks of preterm birth, low birth weight, spontaneous abortion, persistent pulmonary hypertension, autism spectrum disorders, and attention deficit hyperactivity disorder in offspring of antidepressant users were significantly higher.
low birth weight	disease_to_anatomy	pulmonary	1	2.425	32840005	PMID:32840005; Original text:Most of the meta-analyses reported that compared to non-users, the risks of preterm birth, low birth weight, spontaneous abortion, persistent pulmonary hypertension, autism spectrum disorders, and attention deficit hyperactivity disorder in offspring of antidepressant users were significantly higher.
low birth weight	disease_to_anatomy	of the	1	2.425	32840005	PMID:32840005; Original text:Most of the meta-analyses reported that compared to non-users, the risks of preterm birth, low birth weight, spontaneous abortion, persistent pulmonary hypertension, autism spectrum disorders, and attention deficit hyperactivity disorder in offspring of antidepressant users were significantly higher.
low birth weight	disease_to_anatomy	, and	1	2.425	32840005	PMID:32840005; Original text:Most of the meta-analyses reported that compared to non-users, the risks of preterm birth, low birth weight, spontaneous abortion, persistent pulmonary hypertension, autism spectrum disorders, and attention deficit hyperactivity disorder in offspring of antidepressant users were significantly higher.
autism spectrum disorders	disease_to_anatomy	pulmonary	1	2.425	32840005	PMID:32840005; Original text:Most of the meta-analyses reported that compared to non-users, the risks of preterm birth, low birth weight, spontaneous abortion, persistent pulmonary hypertension, autism spectrum disorders, and attention deficit hyperactivity disorder in offspring of antidepressant users were significantly higher.
pdd	disease_to_anatomy	, and	1	3.941	9442997	PMID:9442997; Original text:A significant effect of informant was found for the PDD group, and this effect was particularly pronounced when children with autism were considered separately.
pdd	disease_to_anatomy	group	1	3.941	9442997	PMID:9442997; Original text:A significant effect of informant was found for the PDD group, and this effect was particularly pronounced when children with autism were considered separately.
autistic symptoms	disease_to_anatomy	group	1	2.74	23874533	PMID:23874533; Original text:The results show that the experimental group demonstrated significantly greater improvement in self-control than the control group, which concurs with the parental reports of reduced autistic symptoms and increased control of temper and behaviors.
gastrointestinal symptoms	disease_to_anatomy	, and	1	1.0	11459079	PMID:11459079; Original text:We studied 9 Caucasian boys, 3.8-8.1 years old, with a DSM-IV diagnosis of a pervasive developmental disorder, living with their families, receiving no chronic medications, and without significant gastrointestinal symptoms.
autism spectrum disorder	disease_to_anatomy	of eye	1	8.33	19538990	PMID:19538990; Original text:An atypical pattern of eye contact behaviour is one of the most significant symptoms of Autism Spectrum Disorder (Autism Spectrum Disorder).
asd	disease_to_anatomy	region	1	4.421	21692142	PMID:21692142; Original text:We found six significant clusters of convergence indicating disturbances in the brain structure of ASD patients, including the lateral occipital lobe, the pericentral region, the medial temporal lobe, the basal ganglia, and proximate to the right parietal operculum.
asd	disease_to_anatomy	basal ganglia	1	4.421	21692142	PMID:21692142; Original text:We found six significant clusters of convergence indicating disturbances in the brain structure of ASD patients, including the lateral occipital lobe, the pericentral region, the medial temporal lobe, the basal ganglia, and proximate to the right parietal operculum.
asd	disease_to_anatomy	parietal	1	4.421	21692142	PMID:21692142; Original text:We found six significant clusters of convergence indicating disturbances in the brain structure of ASD patients, including the lateral occipital lobe, the pericentral region, the medial temporal lobe, the basal ganglia, and proximate to the right parietal operculum.
asd	disease_to_anatomy	the lateral	1	4.421	21692142	PMID:21692142; Original text:We found six significant clusters of convergence indicating disturbances in the brain structure of ASD patients, including the lateral occipital lobe, the pericentral region, the medial temporal lobe, the basal ganglia, and proximate to the right parietal operculum.
asd	disease_to_anatomy	ganglia	1	4.421	21692142	PMID:21692142; Original text:We found six significant clusters of convergence indicating disturbances in the brain structure of ASD patients, including the lateral occipital lobe, the pericentral region, the medial temporal lobe, the basal ganglia, and proximate to the right parietal operculum.
asd	disease_to_anatomy	temporal	1	4.421	21692142	PMID:21692142; Original text:We found six significant clusters of convergence indicating disturbances in the brain structure of ASD patients, including the lateral occipital lobe, the pericentral region, the medial temporal lobe, the basal ganglia, and proximate to the right parietal operculum.
asd	disease_to_anatomy	temporal lobe	1	4.421	21692142	PMID:21692142; Original text:We found six significant clusters of convergence indicating disturbances in the brain structure of ASD patients, including the lateral occipital lobe, the pericentral region, the medial temporal lobe, the basal ganglia, and proximate to the right parietal operculum.
asd	disease_to_anatomy	occipital lobe	1	4.421	21692142	PMID:21692142; Original text:We found six significant clusters of convergence indicating disturbances in the brain structure of ASD patients, including the lateral occipital lobe, the pericentral region, the medial temporal lobe, the basal ganglia, and proximate to the right parietal operculum.
asd	disease_to_anatomy	lobe	1	4.421	21692142	PMID:21692142; Original text:We found six significant clusters of convergence indicating disturbances in the brain structure of ASD patients, including the lateral occipital lobe, the pericentral region, the medial temporal lobe, the basal ganglia, and proximate to the right parietal operculum.
behavioral impairments	disease_to_anatomy	of primary	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
behavioral impairments	disease_to_anatomy	neuronal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
behavioral impairments	disease_to_anatomy	of temporal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
behavioral impairments	disease_to_anatomy	of the	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
behavioral impairments	disease_to_anatomy	parietal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
behavioral impairments	disease_to_anatomy	temporal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
neuronal	disease_to_anatomy	of primary	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
neuronal	disease_to_anatomy	neuronal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
neuronal	disease_to_anatomy	of temporal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
neuronal	disease_to_anatomy	of the	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
neuronal	disease_to_anatomy	parietal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
neuronal	disease_to_anatomy	temporal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
neurofunctional impairments	disease_to_anatomy	of primary	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
neurofunctional impairments	disease_to_anatomy	neuronal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
neurofunctional impairments	disease_to_anatomy	of temporal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
neurofunctional impairments	disease_to_anatomy	of the	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
neurofunctional impairments	disease_to_anatomy	parietal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
neurofunctional impairments	disease_to_anatomy	temporal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
asociality	disease_to_anatomy	of primary	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
asociality	disease_to_anatomy	neuronal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
asociality	disease_to_anatomy	of temporal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
asociality	disease_to_anatomy	of the	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
asociality	disease_to_anatomy	parietal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
asociality	disease_to_anatomy	temporal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
autism	disease_to_anatomy	of primary	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
autism	disease_to_anatomy	of temporal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
autism	disease_to_anatomy	parietal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
autism	disease_to_anatomy	temporal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
extended selective attention	disease_to_anatomy	of primary	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
extended selective attention	disease_to_anatomy	neuronal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
extended selective attention	disease_to_anatomy	of temporal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
extended selective attention	disease_to_anatomy	of the	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
extended selective attention	disease_to_anatomy	parietal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
extended selective attention	disease_to_anatomy	temporal	1	6.857	8759044	"PMID:8759044; Original text:Behavioral impairments in autism are theorized to result from abnormal neuronal organization in brain development generating 4 systemically related neurofunctional impairments: (a) canalesthesia, wherein abnormal hippocampal system function ""canalizes"" sensory records, disrupting integration of information; (b) impaired assignment of the affective significance of stimuli, wherein abnormal amygdaloid system function disrupts affect association; (c) asociality, wherein impaired oxytocin system function flattens social bonding and affiliativeness; and (d) extended selective attention, wherein abnormal organization of temporal and parietal polysensory regions yields aberrant overprocessing of primary representations."
dravet syndrome	disease_to_anatomy	, a	1	2.74	28036350	PMID:28036350; Original text:Introduction of the 2.8MM probe-chromosomal microarray test led to significant improvements in condition-specific interventions including an 8.3% (p = 0.04) improvement in evaluation and therapy for gross motor delays caused by Hunter syndrome, a 27.5% (p = 0.03) increase in early cognitive intervention for FOXG1-related disorder, and an 18.2% (p<0.001) improvement in referrals to child neurology for Dravet syndrome.
dravet syndrome	disease_to_anatomy	of the	1	2.74	28036350	PMID:28036350; Original text:Introduction of the 2.8MM probe-chromosomal microarray test led to significant improvements in condition-specific interventions including an 8.3% (p = 0.04) improvement in evaluation and therapy for gross motor delays caused by Hunter syndrome, a 27.5% (p = 0.03) increase in early cognitive intervention for FOXG1-related disorder, and an 18.2% (p<0.001) improvement in referrals to child neurology for Dravet syndrome.
dravet syndrome	disease_to_anatomy	(p	1	2.74	28036350	PMID:28036350; Original text:Introduction of the 2.8MM probe-chromosomal microarray test led to significant improvements in condition-specific interventions including an 8.3% (p = 0.04) improvement in evaluation and therapy for gross motor delays caused by Hunter syndrome, a 27.5% (p = 0.03) increase in early cognitive intervention for FOXG1-related disorder, and an 18.2% (p<0.001) improvement in referrals to child neurology for Dravet syndrome.
dravet syndrome	disease_to_anatomy	, and	1	2.74	28036350	PMID:28036350; Original text:Introduction of the 2.8MM probe-chromosomal microarray test led to significant improvements in condition-specific interventions including an 8.3% (p = 0.04) improvement in evaluation and therapy for gross motor delays caused by Hunter syndrome, a 27.5% (p = 0.03) increase in early cognitive intervention for FOXG1-related disorder, and an 18.2% (p<0.001) improvement in referrals to child neurology for Dravet syndrome.
hunter syndrome	disease_to_anatomy	, a	1	2.74	28036350	PMID:28036350; Original text:Introduction of the 2.8MM probe-chromosomal microarray test led to significant improvements in condition-specific interventions including an 8.3% (p = 0.04) improvement in evaluation and therapy for gross motor delays caused by Hunter syndrome, a 27.5% (p = 0.03) increase in early cognitive intervention for FOXG1-related disorder, and an 18.2% (p<0.001) improvement in referrals to child neurology for Dravet syndrome.
hunter syndrome	disease_to_anatomy	of the	1	2.74	28036350	PMID:28036350; Original text:Introduction of the 2.8MM probe-chromosomal microarray test led to significant improvements in condition-specific interventions including an 8.3% (p = 0.04) improvement in evaluation and therapy for gross motor delays caused by Hunter syndrome, a 27.5% (p = 0.03) increase in early cognitive intervention for FOXG1-related disorder, and an 18.2% (p<0.001) improvement in referrals to child neurology for Dravet syndrome.
hunter syndrome	disease_to_anatomy	(p	1	2.74	28036350	PMID:28036350; Original text:Introduction of the 2.8MM probe-chromosomal microarray test led to significant improvements in condition-specific interventions including an 8.3% (p = 0.04) improvement in evaluation and therapy for gross motor delays caused by Hunter syndrome, a 27.5% (p = 0.03) increase in early cognitive intervention for FOXG1-related disorder, and an 18.2% (p<0.001) improvement in referrals to child neurology for Dravet syndrome.
hunter syndrome	disease_to_anatomy	, and	1	2.74	28036350	PMID:28036350; Original text:Introduction of the 2.8MM probe-chromosomal microarray test led to significant improvements in condition-specific interventions including an 8.3% (p = 0.04) improvement in evaluation and therapy for gross motor delays caused by Hunter syndrome, a 27.5% (p = 0.03) increase in early cognitive intervention for FOXG1-related disorder, and an 18.2% (p<0.001) improvement in referrals to child neurology for Dravet syndrome.
motor delays	disease_to_anatomy	, a	1	2.74	28036350	PMID:28036350; Original text:Introduction of the 2.8MM probe-chromosomal microarray test led to significant improvements in condition-specific interventions including an 8.3% (p = 0.04) improvement in evaluation and therapy for gross motor delays caused by Hunter syndrome, a 27.5% (p = 0.03) increase in early cognitive intervention for FOXG1-related disorder, and an 18.2% (p<0.001) improvement in referrals to child neurology for Dravet syndrome.
motor delays	disease_to_anatomy	of the	1	2.74	28036350	PMID:28036350; Original text:Introduction of the 2.8MM probe-chromosomal microarray test led to significant improvements in condition-specific interventions including an 8.3% (p = 0.04) improvement in evaluation and therapy for gross motor delays caused by Hunter syndrome, a 27.5% (p = 0.03) increase in early cognitive intervention for FOXG1-related disorder, and an 18.2% (p<0.001) improvement in referrals to child neurology for Dravet syndrome.
motor delays	disease_to_anatomy	(p	1	2.74	28036350	PMID:28036350; Original text:Introduction of the 2.8MM probe-chromosomal microarray test led to significant improvements in condition-specific interventions including an 8.3% (p = 0.04) improvement in evaluation and therapy for gross motor delays caused by Hunter syndrome, a 27.5% (p = 0.03) increase in early cognitive intervention for FOXG1-related disorder, and an 18.2% (p<0.001) improvement in referrals to child neurology for Dravet syndrome.
motor delays	disease_to_anatomy	, and	1	2.74	28036350	PMID:28036350; Original text:Introduction of the 2.8MM probe-chromosomal microarray test led to significant improvements in condition-specific interventions including an 8.3% (p = 0.04) improvement in evaluation and therapy for gross motor delays caused by Hunter syndrome, a 27.5% (p = 0.03) increase in early cognitive intervention for FOXG1-related disorder, and an 18.2% (p<0.001) improvement in referrals to child neurology for Dravet syndrome.
intellectual disability	disease_to_anatomy	of the	1	2.74	28036350	PMID:28036350; Original text:Physician use of the 2.8MM probe-chromosomal microarray test significantly improves overall quality as well as diagnosis and treatment quality for simulated cases of pediatric Developmental disorders/ASD/intellectual disability patients, and delivers additional clinical utility over existing chromosomal microarray tests.
developmental disorders	disease_to_anatomy	of the	1	2.74	28036350	PMID:28036350; Original text:Physician use of the 2.8MM probe-chromosomal microarray test significantly improves overall quality as well as diagnosis and treatment quality for simulated cases of pediatric Developmental disorders/ASD/intellectual disability patients, and delivers additional clinical utility over existing chromosomal microarray tests.
repetitive behaviors	disease_to_anatomy	, joint	1	2.74	31703073	PMID:31703073; Original text:A significant improvement was noted in child distress (SMD = 0.55), communication (SMD = 0.23), expressive language (SMD = 0.47), joint engagement (SMD = 0.63), motor skills (SMD = 0.25), parental distress (SMD = 0.33) parental self-efficacy (SMD = 0.42) parent-child relationship (SMD = 0.67) repetitive behaviors (SMD = 0.33), self-regulation (SMD = 0.54), social skills (SMD = 0.53) symptom severity (SMD = 0.44) and visual reception (SMD = 0.29).
repetitive behaviors	disease_to_anatomy	, motor	1	2.74	31703073	PMID:31703073; Original text:A significant improvement was noted in child distress (SMD = 0.55), communication (SMD = 0.23), expressive language (SMD = 0.47), joint engagement (SMD = 0.63), motor skills (SMD = 0.25), parental distress (SMD = 0.33) parental self-efficacy (SMD = 0.42) parent-child relationship (SMD = 0.67) repetitive behaviors (SMD = 0.33), self-regulation (SMD = 0.54), social skills (SMD = 0.53) symptom severity (SMD = 0.44) and visual reception (SMD = 0.29).
cerebral palsy	disease_to_anatomy	, and	1	1.0	30446273	PMID:30446273; Original text:Assessing the occurrence of ASD and Attention-Deficit/Hyperactivity Disorder would improve the significant cost of healthcare, therapies, and overall daily living for families with children affected by Cerebral Palsy.
fear	disease_to_anatomy	, and	1	8.33	28467893	PMID:28467893; Original text:A single dose of intranasal oxytocin significantly improved the recognition of basic emotions, particularly fear, and increased the expression of positive emotions among the healthy individuals.
patent ductus arteriosus	disease_to_anatomy	ductus arteriosus	4	4.0	31985831|31985831|29624206|29624206	PMID:31985831; Original text:Two studies compared prophylactic administration of paracetamol for a the patent ductus arteriosus with placebo or no intervention in 80 infants.|PMID:31985831; Original text:There was no significant difference in the failure to close a the patent ductus arteriosus (typical typical risk ratio 0.96, 95% 95% confidence interval 0.55 to 1.65; I² = 11%; typical typical risk difference -0.01, 95% 95% confidence interval -0.09 to 0.08; I² = 17%) (low quality of evidence).|PMID:29624206; Original text:Two studies compared prophylactic administration of paracetamol for a the patent ductus arteriosus with placebo or no intervention in 80 infants.|PMID:29624206; Original text:There was no significant difference in the failure to close a the patent ductus arteriosus (typical typical risk ratio 0.96, 95% 95% confidence interval 0.55 to 1.65; I² = 11%; typical typical risk difference -0.01, 95% 95% confidence interval -0.09 to 0.08; I² = 17%) (low quality of evidence).
autism spectrum	disease_to_anatomy	levels of	1	1.0	22129897	PMID:22129897; Original text:Recent evidence shows that subjects diagnosed with an autism spectrum disorder (disorder) have significantly lower levels of glutathione than typically developing children.
mental retardation	disease_to_anatomy	(p	1	1.0	19736351	PMID:19736351; Original text:The collective frequency of rare copy number variations at these loci is significantly increased in cases with autism, in cases with schizophrenia, and in cases with mental retardation compared with controls (P < .001, P = .01, and P = .001, respectively, Fisher exact test).
schizophrenia	disease_to_anatomy	(p	1	1.0	19736351	PMID:19736351; Original text:The collective frequency of rare copy number variations at these loci is significantly increased in cases with autism, in cases with schizophrenia, and in cases with mental retardation compared with controls (P < .001, P = .01, and P = .001, respectively, Fisher exact test).
behavioral abnormalities	disease_to_anatomy	area of	1	1.0	796586	PMID:796586; Original text:Childhood psychosis is a group of disorders characterized by numerous behavioral abnormalities, the most significant of which may well be in the area of language.
behavioral abnormalities	disease_to_anatomy	group of	1	1.0	796586	PMID:796586; Original text:Childhood psychosis is a group of disorders characterized by numerous behavioral abnormalities, the most significant of which may well be in the area of language.
psychosis	disease_to_anatomy	area of	1	1.0	796586	PMID:796586; Original text:Childhood psychosis is a group of disorders characterized by numerous behavioral abnormalities, the most significant of which may well be in the area of language.
psychosis	disease_to_anatomy	group of	1	1.0	796586	PMID:796586; Original text:Childhood psychosis is a group of disorders characterized by numerous behavioral abnormalities, the most significant of which may well be in the area of language.
autism spectrum disorder	disease_to_anatomy	peripheral blood	1	3.998	33420109	PMID:33420109; Original text:The results of random effect meta-analysis showed that the peripheral blood levels of brain-derived neurotrophic factor (Hedges' g = 0.302; 95% CI = 0.014 to 0.591; P = 0.040) , nerve growth factor (Hedges' g = 0.395; 95% CI = 0.104 to 0.686; P = 0.008) and vascular endothelial growth factor (VEGF) (Hedges' g = 0.097; 95% CI = 0.018 to 0.175; P = 0.016) in children with Autism Spectrum Disorder were significantly higher than that of healthy controls, whereas blood neurotrophin-3 (Hedges' g =
autism spectrum disorder	disease_to_anatomy	of brain	1	3.998	33420109	PMID:33420109; Original text:The results of random effect meta-analysis showed that the peripheral blood levels of brain-derived neurotrophic factor (Hedges' g = 0.302; 95% CI = 0.014 to 0.591; P = 0.040) , nerve growth factor (Hedges' g = 0.395; 95% CI = 0.104 to 0.686; P = 0.008) and vascular endothelial growth factor (VEGF) (Hedges' g = 0.097; 95% CI = 0.018 to 0.175; P = 0.016) in children with Autism Spectrum Disorder were significantly higher than that of healthy controls, whereas blood neurotrophin-3 (Hedges' g =
autism spectrum disorder	disease_to_anatomy	vascular endothelial	1	3.998	33420109	PMID:33420109; Original text:The results of random effect meta-analysis showed that the peripheral blood levels of brain-derived neurotrophic factor (Hedges' g = 0.302; 95% CI = 0.014 to 0.591; P = 0.040) , nerve growth factor (Hedges' g = 0.395; 95% CI = 0.104 to 0.686; P = 0.008) and vascular endothelial growth factor (VEGF) (Hedges' g = 0.097; 95% CI = 0.018 to 0.175; P = 0.016) in children with Autism Spectrum Disorder were significantly higher than that of healthy controls, whereas blood neurotrophin-3 (Hedges' g =
autism spectrum disorder	disease_to_anatomy	levels of	1	3.998	33420109	PMID:33420109; Original text:The results of random effect meta-analysis showed that the peripheral blood levels of brain-derived neurotrophic factor (Hedges' g = 0.302; 95% CI = 0.014 to 0.591; P = 0.040) , nerve growth factor (Hedges' g = 0.395; 95% CI = 0.104 to 0.686; P = 0.008) and vascular endothelial growth factor (VEGF) (Hedges' g = 0.097; 95% CI = 0.018 to 0.175; P = 0.016) in children with Autism Spectrum Disorder were significantly higher than that of healthy controls, whereas blood neurotrophin-3 (Hedges' g =
autism spectrum disorder	disease_to_anatomy	, nerve	1	3.998	33420109	PMID:33420109; Original text:The results of random effect meta-analysis showed that the peripheral blood levels of brain-derived neurotrophic factor (Hedges' g = 0.302; 95% CI = 0.014 to 0.591; P = 0.040) , nerve growth factor (Hedges' g = 0.395; 95% CI = 0.104 to 0.686; P = 0.008) and vascular endothelial growth factor (VEGF) (Hedges' g = 0.097; 95% CI = 0.018 to 0.175; P = 0.016) in children with Autism Spectrum Disorder were significantly higher than that of healthy controls, whereas blood neurotrophin-3 (Hedges' g =
autism spectrum disorder	disease_to_anatomy	endothelial	1	3.998	33420109	PMID:33420109; Original text:The results of random effect meta-analysis showed that the peripheral blood levels of brain-derived neurotrophic factor (Hedges' g = 0.302; 95% CI = 0.014 to 0.591; P = 0.040) , nerve growth factor (Hedges' g = 0.395; 95% CI = 0.104 to 0.686; P = 0.008) and vascular endothelial growth factor (VEGF) (Hedges' g = 0.097; 95% CI = 0.018 to 0.175; P = 0.016) in children with Autism Spectrum Disorder were significantly higher than that of healthy controls, whereas blood neurotrophin-3 (Hedges' g =
autism	disease_to_anatomy	areas of	1	1.0	29726269	PMID:29726269; Original text:Between baseline and posttreatment, children showed significant gains in most areas of intellectual functioning and a significant decrease of autism symptom severity, but no change in adaptive behavior.
autism spectrum disorders	disease_to_anatomy	the brain	1	1.0	15749245	PMID:15749245; Original text:Autism spectrum disorders affect behaviors that emerge at ages when typically developing children become increasingly social and communicative, but many lines of evidence suggest that the underlying alterations in the brain occur long before the period when symptoms become obvious.
adhd	disease_to_anatomy	of the	1	1.0	28000020	PMID:28000020; Original text:The aim of the present narrative review was to explore if structural brain imaging studies may shed light on key brain areas that are linked to both ASD and ADHD symptoms and undergo significant changes during development.
abc)-irritability	disease_to_anatomy	(p	1	1.0	24849255	PMID:24849255; Original text:Pregnenolone yielded a statistically significant improvement in the primary measure, Aberrant Behavior Checklist (ABC)-Irritability [from 17.4 ± 7.4 at baseline to 11.2 ± 7.0 at 12 weeks (p = 0.028)].
disorders of cognitive development	disease_to_anatomy	large	1	6.936	23582872	PMID:23582872; Original text:It is clear that statistically significant large, highly recurrent copy number variants across disorders of cognitive development are highly enriched for biological processes related to the synapse.
autism	disease_to_anatomy	cortex	1	5.174	22457638	PMID:22457638; Original text:Genes regulating cell cycle also exhibited autism-specific number variations in DNA derived from prefrontal cortex, and these genes were significantly associated with autism in genome-wide association study datasets.
autism	disease_to_anatomy	prefrontal cortex	1	5.174	22457638	PMID:22457638; Original text:Genes regulating cell cycle also exhibited autism-specific number variations in DNA derived from prefrontal cortex, and these genes were significantly associated with autism in genome-wide association study datasets.
inflammation	disease_to_anatomy	platelet	1	1.0	19852789	PMID:19852789; Original text:The Phase 1 single round of DMSA led to a dramatic normalization of RBC glutathione in almost all cases, and greatly improved abnormal platelet counts, suggesting a significant decrease in inflammation.
intellectual disability	disease_to_anatomy	field of	1	1.0	24246273	PMID:24246273; Original text:Although there are numerous quality of life instruments in the, field of intellectual disability, most of them are addressed to those, people with the highest levels of functioning, while only a few are, suitable for people with the lowest levels (i.e., people with profound, and severe intellectual disabilities, or people with intellectual and, developmental disabilities and other significant medical conditions or, disabilities).
intellectual disability	disease_to_anatomy	levels of	1	1.0	24246273	PMID:24246273; Original text:Although there are numerous quality of life instruments in the, field of intellectual disability, most of them are addressed to those, people with the highest levels of functioning, while only a few are, suitable for people with the lowest levels (i.e., people with profound, and severe intellectual disabilities, or people with intellectual and, developmental disabilities and other significant medical conditions or, disabilities).
intellectual	disease_to_anatomy	field of	1	1.0	24246273	PMID:24246273; Original text:Although there are numerous quality of life instruments in the, field of intellectual disability, most of them are addressed to those, people with the highest levels of functioning, while only a few are, suitable for people with the lowest levels (i.e., people with profound, and severe intellectual disabilities, or people with intellectual and, developmental disabilities and other significant medical conditions or, disabilities).
intellectual	disease_to_anatomy	, and	1	1.0	24246273	PMID:24246273; Original text:Although there are numerous quality of life instruments in the, field of intellectual disability, most of them are addressed to those, people with the highest levels of functioning, while only a few are, suitable for people with the lowest levels (i.e., people with profound, and severe intellectual disabilities, or people with intellectual and, developmental disabilities and other significant medical conditions or, disabilities).
intellectual	disease_to_anatomy	levels of	1	1.0	24246273	PMID:24246273; Original text:Although there are numerous quality of life instruments in the, field of intellectual disability, most of them are addressed to those, people with the highest levels of functioning, while only a few are, suitable for people with the lowest levels (i.e., people with profound, and severe intellectual disabilities, or people with intellectual and, developmental disabilities and other significant medical conditions or, disabilities).
overweight	disease_to_anatomy	risk	1	3.941	30470952	PMID:30470952; Original text:Relative to normal weight, maternal obesity and overweight were significantly associated with increased disorder risk, while maternal underweight was not associated with disorder.
underweight	disease_to_anatomy	risk	1	3.941	30470952	PMID:30470952; Original text:Relative to normal weight, maternal obesity and overweight were significantly associated with increased disorder risk, while maternal underweight was not associated with disorder.
obesity	disease_to_anatomy	risk	1	3.941	30470952	PMID:30470952; Original text:Relative to normal weight, maternal obesity and overweight were significantly associated with increased disorder risk, while maternal underweight was not associated with disorder.
insulin	disease_to_anatomy	, and	1	6.936	27126856	PMID:27126856; Original text:From before treatment to week 16, there were significant increases in glucose (p = .02), hemoglobin A1c (p = .01), insulin (p <.0001), homeostatic model assessment-insulin resistance (HOMA-IR; p < .001), alanine aminotransferase (p = .01), and leptin (p < .0001).
insulin	disease_to_anatomy	(p	1	6.936	27126856	PMID:27126856; Original text:From before treatment to week 16, there were significant increases in glucose (p = .02), hemoglobin A1c (p = .01), insulin (p <.0001), homeostatic model assessment-insulin resistance (HOMA-IR; p < .001), alanine aminotransferase (p = .01), and leptin (p < .0001).
insulin	disease_to_anatomy	16	1	6.936	27126856	PMID:27126856; Original text:From before treatment to week 16, there were significant increases in glucose (p = .02), hemoglobin A1c (p = .01), insulin (p <.0001), homeostatic model assessment-insulin resistance (HOMA-IR; p < .001), alanine aminotransferase (p = .01), and leptin (p < .0001).
anatomical and functional abnormalities in frontal lobe, basal ganglia and the limbic system	disease_to_anatomy	, basal	1	2.733	20969835	PMID:20969835; Original text:We report evidence that brain anatomy and aging in people with disorder is significantly different as compared to controls-so that in adulthood they no longer have a significantly larger overall brain volume, but they do have anatomical and functional abnormalities in frontal lobe, basal ganglia and the limbic system.
anatomical and functional abnormalities in frontal lobe, basal ganglia and the limbic system	disease_to_anatomy	frontal lobe	1	2.733	20969835	PMID:20969835; Original text:We report evidence that brain anatomy and aging in people with disorder is significantly different as compared to controls-so that in adulthood they no longer have a significantly larger overall brain volume, but they do have anatomical and functional abnormalities in frontal lobe, basal ganglia and the limbic system.
anatomical and functional abnormalities in frontal lobe, basal ganglia and the limbic system	disease_to_anatomy	basal ganglia	1	2.733	20969835	PMID:20969835; Original text:We report evidence that brain anatomy and aging in people with disorder is significantly different as compared to controls-so that in adulthood they no longer have a significantly larger overall brain volume, but they do have anatomical and functional abnormalities in frontal lobe, basal ganglia and the limbic system.
anatomical and functional abnormalities in frontal lobe, basal ganglia and the limbic system	disease_to_anatomy	limbic system	1	2.733	20969835	PMID:20969835; Original text:We report evidence that brain anatomy and aging in people with disorder is significantly different as compared to controls-so that in adulthood they no longer have a significantly larger overall brain volume, but they do have anatomical and functional abnormalities in frontal lobe, basal ganglia and the limbic system.
anatomical and functional abnormalities in frontal lobe, basal ganglia and the limbic system	disease_to_anatomy	lobe	1	2.733	20969835	PMID:20969835; Original text:We report evidence that brain anatomy and aging in people with disorder is significantly different as compared to controls-so that in adulthood they no longer have a significantly larger overall brain volume, but they do have anatomical and functional abnormalities in frontal lobe, basal ganglia and the limbic system.
aggressive behaviors	disease_to_anatomy	2	1	4.361	26361994	PMID:26361994; Original text:For an additional set of variables (the Aberrant Behavior Checklist factor 2, Behavior Problems Inventory frequency of aggressive behaviors, hematic ammonia at Day 28, and zuclopenthixol and clonazepam intake), the separation between the two samples was statistically significant as was the Bartlett's test, but the Kaiser–Meyer–Olkin Measure of Sampling Adequacy was below the accepted threshold.
aggressive behaviors	disease_to_anatomy	28	1	4.361	26361994	PMID:26361994; Original text:For an additional set of variables (the Aberrant Behavior Checklist factor 2, Behavior Problems Inventory frequency of aggressive behaviors, hematic ammonia at Day 28, and zuclopenthixol and clonazepam intake), the separation between the two samples was statistically significant as was the Bartlett's test, but the Kaiser–Meyer–Olkin Measure of Sampling Adequacy was below the accepted threshold.
aggressive behaviors	disease_to_anatomy	set of	1	4.361	26361994	PMID:26361994; Original text:For an additional set of variables (the Aberrant Behavior Checklist factor 2, Behavior Problems Inventory frequency of aggressive behaviors, hematic ammonia at Day 28, and zuclopenthixol and clonazepam intake), the separation between the two samples was statistically significant as was the Bartlett's test, but the Kaiser–Meyer–Olkin Measure of Sampling Adequacy was below the accepted threshold.
aggressive behaviors	disease_to_anatomy	, and	1	4.361	26361994	PMID:26361994; Original text:For an additional set of variables (the Aberrant Behavior Checklist factor 2, Behavior Problems Inventory frequency of aggressive behaviors, hematic ammonia at Day 28, and zuclopenthixol and clonazepam intake), the separation between the two samples was statistically significant as was the Bartlett's test, but the Kaiser–Meyer–Olkin Measure of Sampling Adequacy was below the accepted threshold.
aggressive behaviors	disease_to_anatomy	test	1	4.361	26361994	PMID:26361994; Original text:For an additional set of variables (the Aberrant Behavior Checklist factor 2, Behavior Problems Inventory frequency of aggressive behaviors, hematic ammonia at Day 28, and zuclopenthixol and clonazepam intake), the separation between the two samples was statistically significant as was the Bartlett's test, but the Kaiser–Meyer–Olkin Measure of Sampling Adequacy was below the accepted threshold.
weight gain	disease_to_anatomy	of the	1	3.473	31063671	PMID:31063671; Original text:Weight gain occurred to a greater degree with risperidone than aripiprazole initially, but the differences became nonsignificant by the end of the trial.
weight gain	disease_to_anatomy	end of	1	3.473	31063671	PMID:31063671; Original text:Weight gain occurred to a greater degree with risperidone than aripiprazole initially, but the differences became nonsignificant by the end of the trial.
autism	disease_to_anatomy	site	1	2.093	25861158	PMID:25861158; Original text:tDCS also significantly increased at the stimulation site, and an increase in tDCS was significantly associated with improvements in the two domains of autism treatment evaluation checklist impacted by tDCS.
hyperactive	disease_to_anatomy	of the	1	5.359	15492353	PMID:15492353; Original text:Risperidone-treated subjects also exhibited significantly greater decreases on the other 4 subscales of the the Aberrant Behavior Checklist; on the conduct problem, insecure/anxious, hyperactive, and overly sensitive subscales of the Nisonger Child Behavior Rating Form (parent version); and on the Visual Analog Scale of the most troublesome symptom.
hyperactive	disease_to_anatomy	, and	1	5.359	15492353	PMID:15492353; Original text:Risperidone-treated subjects also exhibited significantly greater decreases on the other 4 subscales of the the Aberrant Behavior Checklist; on the conduct problem, insecure/anxious, hyperactive, and overly sensitive subscales of the Nisonger Child Behavior Rating Form (parent version); and on the Visual Analog Scale of the most troublesome symptom.
attention-deficit hyperactivity disorder	disease_to_anatomy	(p	1	3.998	33376247	PMID:33376247; Original text:When combining the presence of magnetic resonance imaging findings, facial morphological variants, and genetic copy number variants, statistically significant relationships were found with disorder and attention-deficit hyperactivity disorder diagnoses (p = 0.0006 and p = 0.002, respectively).
attention-deficit hyperactivity disorder	disease_to_anatomy	, facial	1	3.998	33376247	PMID:33376247; Original text:When combining the presence of magnetic resonance imaging findings, facial morphological variants, and genetic copy number variants, statistically significant relationships were found with disorder and attention-deficit hyperactivity disorder diagnoses (p = 0.0006 and p = 0.002, respectively).
hyperandrogenemia	disease_to_anatomy	, and	1	0.75	17187010	PMID:17187010; Original text:Significant improvements in sociability, cognitive awareness, behavior, and clinical symptoms/behaviors of hyperandrogenemia were also observed.
